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Abstract 
 
 
The ability to distinguish self from nonself is a fundamental property of the innate 
and adaptive immune system. For the somatically generated repertoire of T cell 
and B cell antigen receptors (TCR and BCR, respectively), self–nonself 
discrimination is primarily achieved through clonal deletion of lymphocytes 
expressing strongly auto-reactive receptors. Removal of such receptors from the 
TCR and BCR repertoires causes irreversible self-tolerance. For a T cell, this is a 
precarious life. During development in the thymus it must adopt a certain degree of 
self-reactivity in order to pass selection criteria, yet this must fall below a threshold, 
which would flag it to be negatively selected. This rigorous purging sees only 
approximately 3-5% of candidate thymocytes making it through the process. Once 
in the periphery, the quality of TCR signaling continues to be important and is 
heavily censored by extrinsic factors, which actively shape and condition both the 
pre-immune and antigen-responding repertoire. Although it is very clear that the 
signaling capacity of the TCR, whether this be towards self or nonself, is a key 
determinant in defining the trajectory of a T cell, the degree to which it governs 
these fate decisions remains ill defined. This thesis examines the relationship that 
exists between the T cell and its TCR throughout the life of a T cell. 
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Chapter 1. Introduction 
1.1 The Immune system  
The mammalian immune system has evolved to provide protection against a 
hugely varied range of pathogens. Here, its architectural framework allows for a 
sophisticated and multi-layered approach to defence. Although there are many, 
defence strategies are broadly termed as either being part of the innate or adaptive 
arms of immunity. These differ both temporally and qualitatively, and whilst each 
confers its own distinct advantages, efficient protection requires the intimate 
crosstalk and co-operation between the two. 
1.1.1 Innate immunity  
Early responses to infection are initiated by components of the innate wing of 
immunity; these consist of chemical and physical barriers as well as cellular 
components. Innate immunity plays an important role in providing fast and efficient 
protection against pathogenic challenges, and in many cases it is sufficient. In 
other cases, where clearance cannot be achieved alone, innate immune responses 
act to delay the requirement of the adaptive immune system (Iwasaki and 
Medzhitov, 2010). Primarily, skin and mucosal surfaces secrete anti-microbial 
agents and provide a peripheral shield, restricting the free entry of pathogens. 
However, if these barriers are breached, innate cellular components, such as 
neutrophils (eosinophils/basophils), natural killer (NK) cells, monocytes/ 
macrophages, and dendritic cells (DC) are recruited to the compromised sites. The 
recruitment and activation of innate immune cells is achieved primarily via their 
expression of pattern recognition receptors (PRR). These receptors either 
recognise indicators of cellular damage, danger associated patterns (DAMPS), or 
conserved pathogen associated molecular patterns (PAMPS); which are expressed 
on the invading pathogen or damaged tissues. PRRs have many functions from 
opsonisation of invading bodies, to their roles in the initiation and activation of 
complement pathways, inflammation and cellular death (Vivier and Medzhitov, 
2016, Akira et al., 2006, Iwasaki and Medzhitov, 2010).  PRRs can be subdivided 
into four main families; Toll like receptors (TLR), Nucleotide oligomerisation (NLR), 
C-type Lectin like receptors (CLR), and RIG-1 like receptors (RLR).  
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Toll receptors play a major role in innate immunity (Janeway and Medzhitov, 2002). 
Perhaps highlighted by the fact that they are evolutionarily conserved between 
worm, fly, mouse and human and to this day remain the largest documented family 
of PRRs (Hoffmann, 2003, Hashimoto et al., 1988, Akira et al., 2006, Belvin and 
Anderson, 1996, Lemaitre et al., 1997, Irazoqui et al., 2010). So far, 13 different 
TLRs have been annotated, and collectively they can orchestrate diverse 
responses towards viruses, bacterial, fungi and parasites (Bordon, 2012, 
Oldenburg et al., 2012). TLR families are categorised according to their pathogen 
specificity and their cellular localisation (Akira et al., 2006). Broadly, TLRs 1,2,6 
recognise microbial lipids and are positioned at the cell membrane. TLRs 7,8,9 are 
located intracellulary and predominately recognise nucleic acids, such as bacterial 
and viral derived genetic material. TLR4 famously recognises bacterial-derived LPS, 
and forms a heterodimeric complex with MD-2 at the cell membrane (Kim et al., 
2007). Briefly CLRs, another family of PRRs, are often endocytic and work in 
conjunction with TLRs to recognise bacterial and fungal derived PAMPS. Whilst the 
cytoplasmic PRRs, including NOD and RIG-1 receptors and are mainly responsible 
for recognising foreign ribonucleic acid (RNA). In addition to their localisation and 
specificities, PRRs also differ in their function, presumably achieved via their 
associations with different target genes. Thus downstream signalling of PRRs, 
allows for the induction of qualitatively and/or quantitatively diverse innate immune 
responses, according to the flavour of pathogen recognised (Lemaitre et al., 1997).  
 
Upon infection, phagocytes such as the monocytes/macrophages and neutrophils 
are the first cellular recruits to the scene. These cells utilise their PRRs to sense 
damage signals that in conjunction with chemokines and chemo-attracts aid in their 
navigation to the infected tissues. Upon entry, neutrophils come together in tight 
clusters to isolate the local site and the pathogen, in a behavior which has been 
described to be reminiscent of the swarming of insects (Lammermann, 2016, 
Lammermann et al., 2013). In addition to neutrophils, monocytes from the blood 
are quick to traffic to the infected tissues, where they then differentiate into either 
inflammatory macrophages or DCs. Once activated, macrophages and neutrophils 
share common mechanisms of action, from cytokine production to direct pathogen 
killing either via phagocytosis or via the release of lytic granules or reactive oxygen 
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species (ROS) (Segal, 2005, Lammermann, 2016). In addition, neutrophils may 
also selectively release extracellular traps (NETs) in response to large pathogens 
(Branzk et al., 2014). Activation of DCs at the sites of infection leads a successive 
wave of cytokine production, which along with those produced by macrophages 
and neutrophils, act to limit pathogen spread as well as recruit cells of the adaptive 
immune system (Chiesa et al., 2005, Moretta, 2002). In addition, activation of DCs 
induces their maturation into highly proficient antigen presenting cells (APCs), 
capable of priming T lymphocytes (T cells); thus making them critical 
communicators between the innate and adaptive forms of immunity. However, 
although cells of the innate immune systems are clearly effective in providing 
protection against many pathogens, they are limited by the nature of their germline-
encoded, and non-clonally distributed receptors. This significantly limits their range 
of recognition to conserved molecules on pathogens, and caps their capacity to 
provide protection against a fast evolving pathogen. 
1.1.2 Adaptive immunity 
Adaptive immunity is characterised by a comparatively broader and more tailored 
response to infection. Although cells of the adaptive immune system are recruited 
comparatively later on in responses to infection, forming the basis of immunological 
memory (a phenomenon first theorized by the ancient Greeks). The cells of the 
adaptive immune system are the T and B-lymphocytes (T cells/ B cells). Similarly, 
to innate cells, T and B cells too express PRRs and thus can receive activation 
signals via these receptors. However, their unique antigen-specificity is derived 
from their generation and expression of highly diverse and clonally distributed 
receptors, the T cell receptor and B cell receptor respectively (TCR and BCR). 
Unlike innate immune cells, these antigen receptors are not fixed by germ-line 
encoded sequences (Bonilla and Oettgen, 2010); instead they are somatically 
generated or ‘custom made’ via gene-shuffling events that occur during their 
development. Although T and B cells are both derived from common hematopoietic 
stem cells that reside in bone marrow, their later development occurs in separate 
anatomical locations (Kondo et al., 1997). In this regard B cell development starts 
and continues in the bone marrow, whilst T cell development requires common 
lymphoid progenitor (CLP) cells to leave the bone marrow and traffic to the thymus 
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in order to complete development. For the purpose of this thesis we will focus on T 
cell development. 
1.2 T cell development 
1.2.1 Thymocyte development 
Self-determination in concert with the generation of diversity, are central principles 
in immunology. In this regard, the T cell repertoire must be sufficiently varied in 
order to provide protective coverage to the host against an unpredictable range of 
antigens, whilst also remaining tolerant to self. This makes lymphocyte 
development a tricky business, demanding mechanisms capable of manufacturing 
highly diverse antigen-receptors; coupled with strategies to examine and then 
remove potentially deleterious receptors. The cross-reactive nature of the TCR 
toward self-antigens, a property selected for during development but continually 
necessary during peripheral life, poses an inherent challenge for a T cell; where 
one must balance the necessity to recognise self with overt self-reactivity. In this 
regard, and similarly to the Goldilocks principles, a ‘model’ T cell must be able to 
recognise self-antigen to just the right amount, neither too much nor too little. 
1.2.2 Progenitor to Thymocyte: Initial events 
Although the site of T cell development is the thymus, this process requires a 
constant supply of CLP cells from the bone marrow. Although incompletely 
understood, the decision of a CLP cell to become a T cell progenitor, versus a B 
cell progenitor, seems to be associated with Notch derived signalling (Radtke et al., 
2013, Germain, 2002, Zuniga-Pflucker, 2004, Pui et al., 1999, Radtke et al., 1999). 
Here it is thought, that the initiation of Notch signalling in CLP cells, blocks B cell 
development and favours T cell commitment (Pui et al., 1999, Vicente et al., 2010, 
Radtke et al., 1999). T cell-committed CLP cells must then leave the bone marrow 
and navigate the peripheral circulation before seeding the thymus. Still surprisingly 
little is known about the mechanisms that underpin the successful migration and 
homing of CLPs to the thymus. Nonetheless, upon their successful arrival to the 
outer cortical region of the thymus, migrants undergo multiple rounds of cellular 
divisions driven by interleukin (IL)-7 and Notch signaling which initiates the start of 
thymic T cell development (Zuniga-Pflucker, 2004, Patra et al., 2013). 
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Thymic T cell development is a spatially organised process where thymocytes must 
navigate a full thymic circuit, journeying through the cortex and medullary regions, 
in order to complete development. During which time, thymocytes must also 
negotiate strict selection-based obstacles, which are associated with discrete 
thymic microenvironments, to permit entry in to the next stage of development. This 
competitive process results in only a lucky few thymocytes that actually succeed to 
maturity. Fundamental to the process is the step-by-step generation and 
expression of a functional TCR by a developing thymocyte.  
 
Differentiation can also be visualised by the expression of cell surface markers on 
developing thymocytes, most notably the expression of cluster of differentiation 
(CD)-4 and CD8 molecules. The most immature thymocytes, CD4-CD8-, are termed 
double-negative (DN) cells and at this stage express no TCR at all. Instead, these 
cells harbour non-recombined germline encoded TCR gene segments. At this point, 
each thymocyte retains the potential to give rise to either the αβ or γδ T cell lineage. 
DN thymocytes progressively transit through the outer cortex and into the inner 
cortex, with this migratory pattern accompanied by the oscillating expression of 
CD44 and CD25. Accordingly, DN cells can be further subcategorised into the 
following: DN1 (CD44+CD25−), DN2 (CD44+CD25+), DN3 (CD44−CD25+), DN4 
(CD44−CD25−) (Germain, 2002, Pillai, 2000, Godfrey et al., 1993). At the DN3 
stage, thymocytes begin to recombine genetic regions within their TCR β, δ, γ loci. 
Successful recombination within the TCR δ and TCR γ loci promotes the early 
assemblage of the γδ TCR complex at the cell membrane. Here the two chains 
may be tested together. Engagement of a γδ TCR leads to strong expression of 
extracellular signal-regulated kinase (ERK), early growth response (EGR) and 
inhibitor of differentiation (ID3) within the cell, which act in concert to drive its 
commitment towards the γδ T cell lineage (Prinz et al., 2006). It has been noted, 
that it is this combination of early and strong TCR signalling that is imperative to γδ 
lineage decisions. Indeed, in certain TCR transgenic mice and as a consequence 
of the premature expression of TCR transgenes, αβTCRs of sufficient avidity have 
been shown to instruct for the γδ T cell lineage (Bruno et al.). Conversely, 
attenuated signaling via a γδ TCR has been described to result in a switch in 
thymocyte commitment towards the αβ T cell lineage (Haks et al., 2005). These 
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data highlight the strict temporal and signalling guidelines surrounding γδ T cell 
development. 
 
Unlike γδ TCR chains, the TCRβ and TCRα chains are expressed successively. 
This involves the sequential recombination of first the TCRβ chain followed by the 
TCRα chain and is orchestrated through developmentally associated changes in 
chromatin conformation and accessibility (Krangel, 2009, Mathieu et al., 2000). 
Here at the DN3 stage, the expression of a re-arranged TCRβ chain first leads to 
its pairing with a surrogate invariant alpha chain, to form the pre-TCR complex (van 
Oers et al., 1995, Born et al., 1985). Successful signalling through the complex, 
then leads in the allelic exclusion and silencing of the second TCRβ locus; which 
acts to ensure that each thymocyte expresses only a single recombined TCRβ 
chain. At this stage thymocytes also undergo several rounds of cellular proliferation 
fuelled by IL-7 (TCRβ selection) (Robey and Fowlkes, 1994) and also begin to 
recombine gene segments within their TCRα loci. Next, the productive re-
arrangement of the TCRα locus, drives the substitution of the surrogate chain for 
the newly recombined TCRα chain. This leads to the assemblage of the mature 
TCR complex, and the expression of CD3, a complex of five polypeptides, CD3 
γ,η,δ,ζ,ε (Strominger, 1989). Following its productive surface expression, 
thymocytes may then proceed to differentiate into, CD4+CD8+ double positive (DP) 
cells destined for the αβ lineage. Hence the first fate decision dictated by the TCR 
is made; to continue as a γδ or αβ T cell. 
1.2.3 TCR recombination  
The generation of diversity within the TCR repertoire is achieved through several 
mechanisms. These include somatic recombination, non-templated nucleotide 
insertions and TCR (α and β) chain coupling; generating combinatorial, junctional 
and pairing diversity respectively.  
 
The germline TCR locus consists of many back-to-back genetic regions that 
contain discrete TCR gene families. These are defined as: (C) constant, variable 
(V) and joining (J) and (in the TCRβ locus) diversity (D) regions. Each family 
encodes within it many functional genes segments, for example the TCRα locus is 
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estimated to consist of 70-80 Vα gene segments (Janeway Jr, 2000).  However, 
just one gene segment (from each gene family) is required to make a functional 
TCR chain. Therefore, site-specific recombination must occur between the multiple 
V, (D) and J (C) gene segments in order to generate functional VJCα (TCRβα 
chain) or VDJCβ (TCRβ chain) TCR transcripts. This ‘gene shuffling’ process 
generates combinatorial diversity. The mechanics of this process involves the 
binding of recombinase proteins (Rag), encoded by the Rag1 or Rag2 genes 
(Mombaerts et al., 1992, Schatz et al., 1989), to recombination signal sequences 
(RSS) which flank individual gene segments (Dudley et al., 1994). Binding of Rag 
proteins to these RSS sites, results in double-stranded-breaks within the 
Deoxyribonucleic acid (DNA) (Oettinger et al., 1990, Sawchuk et al., 1997), which 
are then resolved by non-homologous end joining (Krangel, 2009). Specific 
nucleotide sequences, called spacer sequences, are also contained within the RSS. 
Importantly these differ in length, either consisting of 12 base-pairs (bp) or 23 bp 
depending on the TCR gene family from which they originate from (van Gent et al., 
1996). This discrepancy in spacer sequence length is then utilised during the re-
joining process, whereby pairing can only occur between fragments with terminal 
12bp spacer sequences and fragments with terminal 23bp spacer sequences (van 
Gent et al., 1996, Pillai, 2000). This ensures that recombination only occurs 
between distinct gene segments, which acts to maximise the potential for 
productive re-arrangements. In addition, during the recombination process the 
addition of non-template nucleotides to the double-stranded end breaks increases 
diversity further, this is known as junctional diversification (Janeway Jr, 2000). 
Lastly, the pairing of different TCRα with different TCRβ chains adds another layer 
of multeity to the process, and finalizes the TCR signature of an individual T 
lymphocyte. This quasi-random re-combinatorial process leads to the generation of 
highly variable complementary determining (CDR) regions within the TCR 
molecules, which are critical in determining the antigen specificity of each T cell 
(Davis and Bjorkman, 1988). Specifically, CDR1 and CDR2 regions are thought to 
be responsible for the binding of the TCRs to exposed areas of the MHC molecule, 
whereas the CDR3 region binds and determines peptide specificity (Marrack et al., 
2008). 
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1.2.4 Thymocytes to T cell: Selection and Tolerance 
The theoretical generation of an almost exhaustive TCR repertoire of up to 1015 
TCRs is much larger than the diversity observed in the immune system of the host 
(Davis and Bjorkman, 1988). This discrepancy between the potential TCR diversity 
and the realised diversity suggests that only a small fraction of TCRs are 
represented in the periphery at any given time (Attridge and Walker, 2014). Here it 
is thought that competition, the relatively low success rate of T cell development as 
well as the physical size of the host organism all contribute in limiting the overall 
population size (Tough and Sprent, 1994, Smith et al., 2001).  
 
During development, thymocytes are screened against a diverse repertoire of self-
peptides and survival is determined by the quality of TCR signalling upheld by a 
cell (summarised in Schematic 1). The ectopic expression of many peripheral 
tissue antigens (PTA) on thymic APCs is exquisitely controlled by the transcription 
factor known as autoimmune regulator (Aire), and allows for the high-throughput 
screening of thymocytes against many self-antigens in the thymus. Here, Aire binds 
to polymerase complexes, which are associated with a respective genes promoter. 
Binding then acts to prevent ‘RNA polymerase pausing’; normally an inhibitory 
(‘stalling’) mechanism that restricts transcription of the downstream gene (Giraud et 
al., 2012). Once the ‘stalled’ RNA polymerase is ‘unleashed’, transcription 
proceeds, driving the promiscuous expression of many PTA in thymic APCs. 
Importantly, mutations within the Aire gene have been shown to significantly reduce 
the repertoire of self-antigens presented during thymic selection (Anderson et al., 
2002), consequently generating a pathogenic TCR repertoire within such hosts 
(Venanzi et al., 2008). Thus the recognition of self-antigens forms the basis for the 
examination and conditioning of the newly generated TCR repertoire in 
mechanisms known as thymic selection. 
 
Thymic selection involves two steps, positive and negative selection. This occurs at 
the DP development stage, and requires each TCR to be tested for its major 
histocompatibility complex (MHC) restriction and its innate signalling capacity (Surh 
and Sprent, 1994). Here TCR signalling (or lack of) is used to choreograph three 
types of developmental outcomes: 1) death by neglect 2) positive selection 3) 
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negative selection (Schematic 1). Positive selection occurs in the cortex, precedes 
negative selection and is examined by a unique population of thymic APCs called 
cortical thymic epithelial cells (cTECs). During positive selection, the vast majority 
of ‘auditioning’ thymocytes (90%) interact too poorly with cTECs, thus fail to meet 
TCR signalling requirements and as a result die by neglect (Klein et al., 2014). 
Thymocytes expressing TCRs whom meet the qualitative requirements, are 
positively selected for, and transit to the medulla where negative selection events 
operate. Here thymocytes encounter a distinct and more heterogeneous population 
of thymic APCs that also present PTAs; these are the medullary thymic epithelial 
cells (mTEC), thymic dendritic cells (DC) and migratory DCs. The observation that 
distinct APCs colonise different thymic compartments is suggestive that they each 
may have specialised roles in thymocyte selection, something discussed in much 
greater detail within 5.1.3 (Klein et al., 2014, Mandl et al., 2013, Yasutomo et al., 
2000). During negative selection, thymocytes with TCRs that recognise self-antigen 
too strongly are irreversibly removed from the repertoire by clonal deletion, which 
involves cellular death by apoptosis. In addition to clonal deletion, very strong TCR 
signaling (overlapping with those normally associated with negative selection) can 
also lead to the thymic differentiation of regulatory (Treg) cells (Fu et al., 2014).  
This will be discussed in more depth below.   
 
In addition to the TCR itself, several different molecules may also contribute to the 
perceived TCR signal strength during thymic selection. In this regard, the 
expression of such molecules can play an important role in the management of 
optimal TCR signalling. For example, excessively high signalling can be tuned 
down, either via the up-regulation of negative regulators of signalling such as CD5 
(Mujal and Krummel, 2015, Azzam et al., 1998, Persaud et al., 2014, Mandl et al., 
2013, Tarakhovsky et al., 1995) or via the down-modulation of positive regulators of 
TCR signalling such as CD4/CD8 (Fu et al., 2014). Themis and microRNA 18 are 
also widely known to negatively and positively regulate TCR signalling 
(respectively) via the modulation of important cellular phosphatases (Fu et al., 
2014). In this way, the fine-tuning of T cell receptor signalling by accessory 
molecules, can provide a rescue mechanism for otherwise doomed thymocytes. 
Whether and to what extent the quality of these thymic interactions with self-
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antigen may leave a long lasting impression on a T cell, is a question explored in 
this thesis. 
 
 
 
Schematic 1. 
 
 
 
 
 
An affinity based model for thymocyte selection 
 
This model uses the strength of TCR signalling (colour coded) as a predictor of T 
cell fate decisions made during thymic selection. To this end, the vast majority of 
thymocytes receive TCR signalling which is too low to allow for their selection and 
hence they die as a result of neglect. Conversely, thymocytes receiving the highest 
TCR signalling are conventionally negatively selected against and die as a result. 
High levels of TCR signalling, can also (in certain instances) drive clonal deviation, 
which is the differentiation of thymocytes into thymic regulatory T cells (tTreg). In 
this model only thymocytes that manage to sustain optimal range of signalling, 
somewhere positive selection and negative selection are selected to become naïve 
peripheral T cells. 
 
 
 
 
 
  
low high 
signalling 
Death by neglect Negative selection tTreg Positive selection 
overlapping signalling 
90% 5% 5% 
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1.2.5 Lineage fate decisions 
Intertwined with TCR signalling during thymic selection is CD4/CD8 lineage 
commitment. Exactly how DP thymocytes, which express both the above co-
receptors, transition into either SP CD4 or SP CD8 T cells has been the subject of 
much scientific interest and debate. Traditionally, two models the ‘instructive’ or 
‘stochastic’, have been applied to make sense of how cells may make this decision 
(Germain, 2002). The instructive model, proposes that distinct signalling pathways 
are supported by TCRs engaging different classes of MHC molecules, leading to a 
commitment decision based on the nature of the MHC interacting partner (Boehmer, 
1986). In comparison, the ‘stochastic’ model suggests that lineage commitment is 
already pre-wired within a thymocyte prior to TCR recombination, with expression 
of either CD4 or CD8 occurring in a TCR independent fashion. Following which, 
those cells that chose incorrectly and as a consequence are MHC mismatched are 
subsequently eliminated (Germain, 2002). An increasing body of evidence now 
suggests that the decision to become either a CD8 or a CD4 T cell is instructed for 
by the strength, duration and quality of TCR signalling encountered, collectively 
defined by the ‘strength of signal model’. Here, it is suggested that sustained high 
levels of TCR signalling are supported by MHCII-mediated interactions, leading to 
increased intracellular calcium and ERK signaling, in turn instructing for CD4 T cell 
commitment (Sharp et al., 1997). In contrast low-level signalling for shorter 
durations of time upon MHCI mediated binding, is suggested to favour CD8 
differentiation (Adachi and Iwata, 2002). Irrespective of how these decisions are 
made, CD4/CD8 commitment must be consummated by the expression of lineage 
specific (and mutually exclusive) transcription factors. In this regard, ThPOK (He et 
al., 2005), TOX (Aliahmad and Kaye, 2008, Wilkinson et al., 2002) and GATA3 
(Hernandez-Hoyos et al., 2003) are established as key players in authorizing the 
CD4 T cell lineage; whilst the expression of Runt-related transcription factor 3 
(RUNX3) is associated with the CD8 T cell lineage (Taniuchi et al., 2002, Singer et 
al., 2008). Positively selected mature SP thymocytes then migrate through th 
perivascular space into the cortico-medullary junction and medulla to eventually 
become peripheral naive T lymphocytes (Germain, 2002). 
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1.2.6 T regulatory cell fate  
During thymic selection events, a window of ‘acceptable’ signalling potential, allows 
for the selection of thymocytes and TCRs of a spectrum of signalling capacities. 
Thymic Treg cell (tTreg) commitment is thought to be supported by TCR signaling 
at the higher end of this range (Bains et al., 2013). Although the conditions for 
tTreg development, remain relatively elusive, it is thought to be a two-step process 
requiring high avidity TCR mediated interactions to licence Forkhead box P3 
(Foxp3) and IL-2 receptor (IL-2R) up-regulation (Burchill et al., 2008, Yoshikura, 
1975, Merkenschlager and von Boehmer, 2010). Thus under the right conditions 
high levels of TCR signalling can result in this CD4 effector differentiation program 
rather than resulting in clonal deletion. Here it is suggested that IL-7 signalling 
(Simonetta et al., 2012) and enhanced expression of Bcl-2 (Bouillet et al., 2002) 
may provide protection to some developing cells from being negatively selected 
(Tischner et al., 2012, Simonetta et al., 2012). Presumably, this protective blanket 
allows for continued TCR signalling, driving the expression of the Forkhead box P3 
(FoxP3) and IL-2R and successively the acquisition of the Treg cell lineage 
(Brunkow et al., 2001, Fontenot et al., 2003a, Cabarrocas et al., 2006, Hori et al., 
2003). 
 
1.3 Life in the periphery  
For the remainder of this thesis we will concentrate on the life of a committed CD4 
T cell. 
1.3.1 Homeostasis 
At the ‘steady state’ the overall number of peripheral CD4 T cells does not fluctuate 
greatly. This is perhaps surprising considering the continuous arrival of new T cells 
from the thymus. However, behind the calm façade the periphery is a highly 
competitive arena, where the TCR repertoire remains under constant selection 
pressure. Here, maximal diversity must be maintained but in a limited space.  Thus 
in order to survive, CD4 T cells must actively compete between each other for self-
peptide major-histocompatibility-class II (spMHCII) derived and IL-7 mediated 
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signalling, with the availability of such factors collectively defining the ‘niche space’ 
available (Takada and Jameson, 2009, Stockinger et al., 2004). Although 
responsiveness to self-antigens is largely reduced in the periphery, compared to 
that observed in the thymus, it continues to play a central role. Here, mature T cells 
must receive tonic TCR signalling upon recognition of self-antigens, in a process 
reminiscent of thymic positive selection, in order to stay alive (Takada and 
Jameson, 2009, Troy and Shen, 2003, Viret et al., 1999). Cells failing to initiate 
such tonic signalling die or are outcompeted (Martin et al., 2006, Viret et al., 1999, 
Witherden et al., 2000, Kassiotis et al., 2003). In addition to quantity the quality of 
these interactions are fundamentally important. In this regard the quality (or avidity) 
of spMHCII-TCR interactions govern the relative fitness a CD4 T cell, whereby T 
cells capable of higher avidity interactions with spMHCII will outperform those of 
lower avidity (Kassiotis et al., 2003). 
 
In addition to TCR derived signalling, IL-7 derived signalling or the expression of IL-
7 receptor is also critical for T cell survival in the periphery (Vivien et al., 2001, 
Kondrack et al., 2003). However, as IL-7 also plays an essential role during early T 
cell and B cell development, IL-7 or IL7R-/- mice (whom do no generate mature 
lymphocytes as a consequence of early blocks in lymphocyte development) could 
not be used to study a role for IL-7 in T cell homeostasis. This had made studying 
the contribution of IL-7 to the peripheral maintenance of CD4 T cells challenging. 
This was until experiments, which involved the treatment of adult thymectomized 
mice with monoclonal anti-IL-7 antibodies, presented the best evidence for a role 
for lL-7 in this regard. Here, treatment resulted in the rapid decay of polyclonal T 
cell populations in a strictly anti-IL-7 dosage dependent fashion (Vivien et al., 2001). 
It is now well recognised that both IL-7 signalling and self-recognition are required 
for CD4 T cell maintenance homeostatic function. What remains relatively unknown 
is how downstream MHCII and IL-7 pro survival pathways may integrate and thus 
contribute to the overall competitive fitness of a CD4 T cell.  
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1.3.2 Central and Peripheral Tolerance 
Although the TCR repertoire is now recognized as being broadly self-reactive, TCR 
signaling as a consequence of self-recognition must be maintained at sub-
threshold levels and be tightly regulated in order to prevent auto-immunity. 
However, the generation of TCRs is a random process, and thus the products of 
TCR recombination are unpredictable. Therefore, along with the generation of 
protective receptors, this process will also generate potentially deleterious and 
overtly auto-reactive TCRs. In order to limit the potential of such clones, 
multilayered censorship mechanisms exist known as immune tolerance. These can 
be subcategorized into either central or peripheral tolerance mechanisms. 
 
Central tolerance involves the irreversible elimination of highly self-reactive T cell 
clones during development in the thymus (as discussed previously). This involves 
the negative selection of T cells that elicit TCR signaling above acceptable 
thresholds. Whilst very efficient, this process is never complete, always allowing for 
the escape of some auto-reactive T cells. This is impart due to the impossibility of 
screening every single thymocyte against (and in anticipation of) all the self or food-
derived antigens it may encounter. However, this shortcoming may also be 
strategic: as central tolerance mechanisms, if complete, could prohibitory limit the 
TCR diversity required for a protective TCR repertoire. Thus, as a compromise, 
additional tolerance mechanisms (peripheral tolerance) have evolved. These act to 
continually prune and condition the peripheral TCR repertoire, in attempts to 
safeguard the host. In addition to clonal deletion, clonal deviation in the thymus 
(and to some extent in the periphery) is also an effective mode of tolerance. This 
process removes a population of overtly self-reactive T cells from the conventional 
T cell (Tcon) repertoire, via their diversion into the Treg lineage. The decision 
between clonal deletion vs clonal diversion is still not fully understood (Xing and 
Hogquist, 2012). 
 
Peripheral tolerance exists in many forms, but effectively results in the suppression 
or inhibition of auto-reactive T cells once in the periphery. Treg T cells are a form of 
peripheral tolerance, acting as cellular gatekeepers that regulate immune 
responses elicited by conventional T cells, in response to both self and non-self-
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antigens. Ignorance is an additional peripheral tolerance mechanism and involves 
the incapacity of auto-reactive T cells to respond to self-antigens due to physical 
barriers that separate TCRs from potential self-ligands in vivo (Xing and Hogquist, 
2012). In scenarios where T cells are able to recognize a self-antigen to sufficiently 
high levels, peripheral anergy may act to halt T cell activation. Anergy occurs when 
TCR signaling is elicited in the absence of appropriate co-stimulatory signals 
(signals required to license and promote T-cell activation) and results in the T cell 
becoming functionally inert. 
1.4 T cell activation 
CD4 T cell activation requires specific cell-to-cell and cognate receptor-ligand 
interactions. Naïve CD4 T cells continually circulate through the blood to the 
lymphoid organs and back again; during which time they patrol and sample pMHCII 
complexes expressed on the APCs that they encounter. In the context of infection, 
APCs become activated and take up antigen and process it into smaller peptide 
fragments. These are then loaded onto MHC display platforms and presented to 
the scanning naïve T cells. CD4 T cell activation requires two signals: 1) TCR 
recognition of the cognate antigen 2) the simultaneous delivery of co-stimulation. 
The initial recognition of pMHCII that results in the activation of a naïve T cell is 
known as T cell priming. The three main professional APCs are DCs, macrophages 
and B cells, whilst DCs are deemed the main contributors to T cell priming. 
Importantly different APC types assume different anatomical locations during 
homeostasis, which may influence their contribution to CD4 T cell responses during 
early stages of infection. In addition, activation status, co-receptor expression and 
the level of recruitment of the APC cell types at different points in an infection vary 
widely, and thus influence an APCs competency accordingly (discussed in more 
detail in 5.1.3) (Constant, 1999).   
1.4.1 Early events in CD4 T cell activation 
T cell activation is initiated by the functional recognition of cognate pMHCII 
complexes by TCRs. Whilst the intricate signalling framework is still to be fully 
realised, an early event is this process is the recruitment of kinases to cytoplasmic 
domains within the TCR complex, immune-receptor tyrosine-based activation 
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motifs (ITAMs). This initiates the activation of a kinase-signalling cascade involving 
CD45, lymphocyte protein tyrosine kinase (LCK) and Zeta Chain of T Cell receptor-
associated protein kinase (Zap70) and leads to the fluxing of calcium inside the T 
cell. This in turn regulates the activity of the calcium sensitive phosphatase 
calcineurin, which mediates the transcription of many genes associated with T cell 
activation (Fracchia et al., 2013). Activation is also (positively) regulated by the 
expression of CD28 and (negatively regulated) by cytotoxic T lymphocyte-
associated protein (CTLA-4), both expressed at the cell membrane. These co-
receptors share common ligands, which are expressed on APCs, CD80 and CD86. 
Therefore, direct competition for CD80 and CD86 between CD28 and CTLA-4 can 
regulate to the degree of activation as measured by IL-2 production and clonal 
expansion (Colombetti et al., 2006). 
 
In addition, TCR triggering leads to the active re-organisation of multiple TCR-
pMHC complexes into clusters that form at the T cell-APC interface. These 
structures eventually form the epicenter of a larger ‘bulls-eye’ like structure referred 
to as the supra-molecular activation cluster (SMAC) or the immunological synapse. 
Around the central clusters of TCR-pMHC (cSMAC), adhesion proteins such as 
lymphocyte function-associated 1 (LFA1), Talin and intracellular adhesion molecule 
1 (ICAM1) are recruited as scaffolding structures that make up the peripheral 
SMAC (pSMAC). In concert, CD43 and CD45 molecules assemble as a third ring 
structure surrounding the pSMAC, to make up the distal SMAC (dSMAC) (Dustin, 
2009, Grakoui et al., 1999). These synapses are postulated to concentrate and 
stabiles interactions acting to amplify signaling and regulate T cell activation 
(Monks et al., 1998).  
 
1.4.2 T cell differentiation 
Following early TCR signaling events, a re-landscaping of the transcriptional 
network allows for the polarization of naïve T cells into diverse T helper (Th) 
effectors subsets: T helper 1 (Th1), T helper 2 (Th2), T helper 17 (Th17), regulatory 
T cells (Treg), T follicular helper cells (Tfh) and more recently (Th9) subsets 
(Schematic 2). This requires the coordinated expression of distinct signal 
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transducers and activators of transcription (STAT) and transcription factors (TFs). 
Each subset can then be defined by the expression of its lineage specific 
transcription factor, functionality and by its cytokine-secreting potential. Here it is 
thought the quality of TCR signaling along with environmental signals such as the 
cytokine milieu and the competency of the co-operating APC are instructive for 
different T-helper (Th) lineages. 
 
IL-12 and IFN-γ are essential for the induction of Th1 differentiation, which is 
marked by the lineage associated transcription factor T-bet. Th1 T cells themselves 
then go onto make large amounts of IFN-γ, IL-2 as well as varying levels of tumour 
necrosis factor β (TNF-β). The production of these cytokines, allows these cell to 
specifically stimulate and activate cellular immunity.  
 
Th2 differentiation requires both IL-4 and IL-2, whilst once activated they produce 
little to no IL-2 themselves. Instead their hallmark cytokines are IL-4, IL-5, and IL-
13. Contrastingly to Th1 cells, Th2 cells mediate humoural immunity, through their 
close co-operation with B cells, as well as allergic responses. GATA3 is the 
hallmark transcription factor for the Th2 lineage, whilst STAT5 and STAT6 co-
operation is required for the stabilisation of the lineage. 
 
Th17 differentiation can either be promoted through cooperation between TGF-β 
and IL-6 or TGF-β and IL-21. With differentiated cells then characterised by the 
hallmark transcription factor RORγt and by their unique expression of IL-17A, IL-
17F (Bettelli et al., 2006). Th17 T cells are critical regulators of neutrophils and 
macrophages and heavily contribute to immune responses against extracellular 
pathogens. 
 
Tfh differentiation is thought to be promoted by high avidity interactions made 
between B celrs, and requires IL-6 derived signalling. Lineage commitment is 
controlled by the transcription factor Bcl-6 which is mutually exclusive to Blimp1, 
hence Tfh differentiation presents the opposing differentiation program to Th1. Tfh 
cells are essential in the clonal selection of the B cell response during the germinal 
centre (GC) reaction and thus play a prominent role in shaping the antibody 
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repertoire. Central to their role is their production of IL-21 and their expression of 
CXCR5 (Reinhardt et al., 2009).  
 
Th9 cells are the most recently described CD4 T cell subset, defined by their 
expression of IL-9 and exhibit pleiotropic functions in immunity and 
immunopathology (reviewed (Kaplan et al., 2015). 
 
 
Schematic 2. 
 
 
 
CD4 T cell effector subsets 
A stylized depiction of CD4 T cell differentiation, which outlines the conventional T 
cell effector subsets. Here, optimal TCR signal strength is indicated by the length of 
the dotted line, which are also annotated with the necessary polarizing factors. 
Lineage defining transcription factors are annotated within the cells types. 
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1.4.3 Memory cell differentiation 
Upon resolution of infection and the clearance of antigen, the vast majority of 
clonally expanded T cells die via apoptosis. However, some privileged effector cells 
remain and further differentiate into memory T cells. These cells form the basis of 
immunological memory, capable of generating fast and efficient responses upon 
secondary infection. The factors that govern memory selection, allowing for the 
emergence of a select few from a much larger population, remains somewhat 
unresolved (discussed in more depth in 1.5.5.) 
1.5 Clonal selection and TCR avidity   
1.5.1 TCR affinity, avidity and functional avidity 
TCR affinity, avidity and functional avidity all contribute or refer to aspects of TCR 
signal strength (Schematic 3) (Vigan et al., 2012). Specifically, TCR affinity 
measures the strength of binding/ interaction made between a single TCR and a 
pMHCII molecule. Instead, TCR avidity is the sum of multiple interactions between 
TCRs and pMHCII complexes, but on a single T cell. Next the functional avidity of a 
T cell clone is a measure of performance or sensitivity towards antigen. In this 
regard, the functional avidity is inversely proportional to the amount of antigen 
required to elicit a response. Usually, the amount of peptide antigen that is required 
to elicit 50% of a T cell clones’ maximal response in vitro remains the gold standard 
determinant of functional avidity. Importantly, functional avidity is subject to many 
cell intrinsic parameters (on top of the TCR itself) that act to additionally tune a T 
cell’s responsiveness. However, the cross talk or relationship between these 
parameters are often complicated, and how signals are eventually interpreted by a 
cell remains to be fully understood. For example, two T cell clones may have 
equivalent overall functional avidities, but very different affinities (clone A: low TCR 
density but high TCR affinity versus clone B: high TCR density but low TCR affinity) 
in this way similar TCR strength may be translated into dramatically distinct fates or 
functional responses. Clearly a better understanding of the factors that contribute to 
a T cells sensitivity, their mechanisms of action and their relative hierarchy remains 
important (Martin et al., 2006). 
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1.5.2 TCR avidity and selection 
A set of cells expressing the same TCR (at the protein level), are collectively 
defined as a clonotype. During homeostasis, but arguably more prominently during 
antigen-selected responses, those clonotypes most "fit" as opposed to "unfit" are 
selected for. Fitness is largely dictated by the quality of a T cells TCR. For example, 
during homeostasis competition between clonotypes for MHC derived signaling 
acts to weed out the cells least efficient at recognizing spMHC. During infection, 
competition for growth factors as well as for antigen results in the rapid outgrowth 
of clonotypes receiving the strongest TCR signals (Tubo et al., 2013a, Thorborn et 
al., 2014, Tubo and Jenkins, Fasso et al., 2000). Although TCR based selection is 
well recognized in acute responses, whether it continues to be as important in 
shaping the composition of protracted responses is not well understood. However, 
hypothesizing that TCR signaling continues to be the major selecting force 
throughout the response: would predict the progressive outgrowth of only the 
highest avidity clonotypes over time. Conceptually, although this would act to focus 
the TCR response this would also be at expense of immune coverage and could 
potentially narrow the TCR repertoire to dangerously few clonotypes. Indeed, 
extensive analysis of evolving TCR repertoires during immune responses has now 
began to highlight that discrepancies between the clonotypic composition of 
primary and memory repertoires exists. This would suggest that diverse 
parameters may exist for effector cell and memory cell recruitment. Therefore, it 
seems, TCR based clonal selection must be counterbalanced against other 
mechanisms that are in place to preserve a level of clonotypic diversity in 
responding repertoires. These will be discussed in more depth in 5.1.2. 
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Schematic 3 
 
 
Affinity, Avidity and Functional Avidity (in brief) 
TCR affinity refers to the monomeric interaction between one T cell receptor (TCR) 
and one peptide loaded major histocompatibility complex molecule (pMHCII). TCR 
avidity is the sum of multiple interactions between TCRs and pMHCII molecule, on 
a single T cell. Functional avidity is a measure of the biological responsiveness or 
sensitivity of a single T cell clone, which is contributed to by both TCR affinity and T 
cell avidity.  
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1.5.3 TCR avidity and differentiation 
Due to the specialised role of Th subsets in controlling different types of immune 
challenge, a large interest remains in understanding how commitment to these 
programs are installed or may be predicted. The TCRs role in this regard can be 
viewed in two ways, either as a simple on/off switch or as more complex tuning or 
‘diming’ device. 
 
Conventionally, it was thought that effector differentiation was predominately 
dictated by T cell extrinsic and environmental factors such as the cytokines milieu 
(Hsieh et al., 1993, Coffman et al., 1991). Thus, the TCR was largely viewed as a 
simple ‘off/on’ switch, which simply acted to license activation opposed to having a 
qualitatively role in determining cell fate decisions. This was largely born out of 
experiments that were able to polarize polyclonal populations of CD4 T cells into 
almost every flavour of effector T cell desired, via the addition of exogenous 
cytokines (Hsieh et al., 1993). Indeed, if the role of the TCR was just to switch the 
cell into a permissive states to allow for programming by cytokines, you would 
assume that every TCR should be equally able to produce a given effector subset.  
 
However, more recently the quality of TCR signalling has become recognised as 
being an important determinant (in addition to the cytokine environment), in tuning 
the quality of effector T cell responses. Hereof, it has been suggested that high and 
low avidity interactions may favour Th1 and Th2 cell differentiation respectively 
(Constant et al., 1995, Rogers et al., 1998). Thus the cell-intrinsic ability of a given  
TCR to recognize foreign antigen may be used to predict its future effector cell 
differentiation. This would theoretically result in the segregation of clonotypes into 
certain subsets according to TCR specificity and TCR avidity. In addition to 
conventional T cells, it has also been suggested that the strength of TCR signalling, 
upon recognition of self-antigen rather than foreign-antigen, is a mechanism that 
also exists in Treg T cells to distribute functional properties between Treg 
clonotypes (Wyss et al., 2016). 
 
To more accurately determine the role of the TCR in this regard (simple switch vs 
dimmer switch) the potential of a single T cell clonotype to give rise to distinct 
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effector T cell populations in vivo was accessed. Here, transfer of individual wild-
type T cells into allogenic hosts (achieved via limiting dilution adoptive T cell 
transfer approaches), revealed that although single naïve cells are able to initiate 
diverse differentiation programs they also have clear preferences towards certain 
cell fates (Tubo et al., 2013a). This seemed to indicate a potential role for the TCR 
in effector cell differentiation. In a similar approach but now using TCR transgenic 
(Tg) CD4 T cells, which have a fixed TCR, the contribution of the TCR in effector 
cell differentiation was further emphasised. Here, effector populations (derived from 
single cells) were now less heterogeneous suggesting that intrinsic differences in 
TCR signalling could predetermine effector T cell fate to some extent (Tubo et al., 
2013b). However, although less varied, Tg T cells did also show some variability in 
their effector cell differentiation, presumably achieved via the presence of other cell 
intrinsic or cell-extrinsic factors that also contribute to differentiation (Tubo and 
Jenkins). These data clearly highlight the role for the TCR in this process, whilst 
also highlighting the importance of other factors in this process also.  
1.5.4 TCR avidity towards self 
In addition to TCR signalling in response to foreign-antigen, more recent evidence 
suggests avidity towards self-antigen may be just as important in influencing cell 
fate decisions. Here, a T cell may be influenced by the quality of TCR signalling 
received during thymic selection and/or via life-long interactions with spMHCII 
complexes once in the periphery. Clearly the most pronounced effect of self-
antigen avidity is the thymic selection of Treg cells. However, self-recognition may 
also act to imprint conventional naïve CD4 T cells in a much subtler manner, which 
will be discussed further in 4.1.  
 
1.5.5 TCR avidity and memory formation 
Upon the clearance of antigen, the fate of the majority of clonally expanded T cells 
is apoptosis, this is known as clonal contraction. However, some privileged effector 
cells remain; and may further differentiate into memory T cells. This is known as 
the linear model of memory differentiation (Ahmed et al., 2009). The factors that 
govern T cell memory selection and formation remain somewhat of a mystery. 
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However, early characterization studies of memory T cell populations demonstrated 
a progressive loss of diversity with memory T cell repertoires enriched for 
clonotypes with the strongest pMHC tetramer binding (McHeyzer-Williams and 
Davis, 1995, Savage et al., 1999) or highest functional avidity (Fasso et al., 2000). 
This would favor an antigen selection model, whereby the strength of TCR 
signaling continues to be important for the persistence of effector cells and in the 
selection of memory T cells. Accordingly, T cells capable of the strongest TCR 
signaling at the peak of infection would be the most likely contributors to the 
memory pool, as they are also the most efficient clonotypes at responding to 
antigen when levels are diminishing. Recently studies, which utilized TCR 
sequencing of the CD4 T cell response to Lymphocytic choriomeningitis virus 
(LCMV), also demonstrated that high avidity CD4 T cells dominated memory T cell 
populations (Kim et al., 2013b). However, and unlike in previous studies, these 
(memory) clonotypes were distinct from those that dominated the acute response. 
This suggesting that the composition of the primary TCR repertoire cannot be used 
to predict the clonotypes that will go onto to contribute to T cell memory. To 
complicate findings further, other studies have shown that the composition of the 
memory T cell repertoire could not be predicted by TCR avidity to antigen, 
suggesting that multiple parameters probably exist for memory cell formation 
(Persaud et al., 2014). 
1.6 Friend Virus 
1.6.1 The Friend Virus Model 
Charlotte Friend first discovered Friend Virus in 1957. Initially, it was described as a 
disease causing agent that resulted in leukemia in Swiss mice, and was capable of 
cell-free transmission (Friend, 1957). FV is now known to be complex of two 
viruses, a replication defective spleen focus forming virus (SFFV) and the 
replication competent Friend-murine leukaemia virus (F-MLV) (Hasenkrug and 
Chesebro, 1997). Furthermore, FV has been shown to have different capabilities to 
induce pathology depending on several host genetic-associated factors. This has 
allowed FV to be used as a model for a broad range of pathologies, depending on 
the strain of the murine host it is used in.  For example, it provides a model for 
cancer-related studies when used to infect susceptible hosts whilst it is used as a 
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model for studying protective immune responses to retroviral infection when 
studied in resistant murine hosts. Still very little is known about the protective 
forces driving immunity to retroviral infection in humans, the most obvious example 
being what mediates defence in long-term survivors of HIV infection. Hence the 
now well-established model of the FV infection in adult resistant mice, contributes 
greatly to the understanding of immunity to human retroviruses. 
 
1.6.2 Immunity to Friend Virus 
Efficient clearance of FV infection in adult resistant mice, requires three major 
types of lymphocytes and their associated responses: 1) cytotoxic lymphocyte 
(CTLs) (Manzke et al., 2013, Chesebro et al., 1990) 2) CD4 Th cells 3) B cells 
(Dittmer et al., 1999).  
1.6.2.1  T cell immunity 
The haplotype of the hosts MHCII genes plays an important role in the resistance 
to FV infection as it controls the quality of the conventional CD4 T cell response. 
CD4 T cells can recognise two epitope variants derived from the FV envelope 
glycoprotein 70 (gp70) (Iwashiro et al., 1993). The first is located within the N 
terminus of the gp70 glycoprotein at amino acids 122 to 141 and is presented in the 
context of H-2A MHCII alleles. The second epitope, was mapped to the C-terminus 
of gp70, spanning amino acids 462 to 479 and is associated with presentation by 
H2-E alleles (Iwashiro et al., 1993). As C57BL/6 (B6/WT) mice have a natural 
mutation within the H2-E allele, which renders it non-functional, CD4 T cells from 
B6 mice are limited to recognising a single epitope presented by H-2A alleles 
(env122-141) (Hasenkrug and Chesebro, 1997). In mice expressing functional forms 
of both H-2A and H-2E alleles, recovery is better associated with peptide 
presentation by H-2A. Thus, the expression of the H-2A MHCII allele plays an 
important role in resistance and recovery of B6 mice to FV infection. 
 
In addition to conventional CD4 T cell responses, more recently it has been 
suggested that CD4 T cells with cytotoxic potential (CD4 CTL) may also play a role 
in mediating protection to FV infection in certain settings (Manzke et al., 2013). As 
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B cells are a major reservoir for FV in persistent infection, the ability for CD4 CTLs 
to direct killing towards MHCII presenting cells may be critical for limiting viral 
persistence and spread (Hasenkrug et al., 1998). However, the keys players in 
cytotoxic responses, in a competent immune system are undoubtedly CD8 T cells. 
CD8 T cells recognise peptide variants in the context of MHCI alleles and direct 
killing towards MHCI expressing cells (Hasenkrug and Chesebro, 1997, Chesebro 
et al., 1990) 
1.6.2.2  B cell immunity  
B cells elicit their own immune responses to FV infection and heavily contribute to 
efficient viral clearance, where B cell deficient mice are very poorly protected 
(Hasenkrug et al., 1995). Their major role in protection is thought to be through 
their production of virus-specific neutralising antibodies which act to control the 
level of FV infection and replication (Messer et al., 2004). This was highlighted in 
studies that showed that treatment of B cell deficient mice with neutralising 
antibodies compensated for the complete absence of B cell within these animals 
(Messer et al., 2004). In addition, B cells can also function as APCs capable of 
influencing T cell responses. Upon activation, antigen specific B cells are able to 
endocytose antigen 1000 fold more efficiently than non-specific cells by virtue of 
their specific BCRs (Chen and Jensen, 2008, Schultz et al., 1990). This is achieved 
through extensive cytoskeleton reorganization that not only allows for increased 
internalization, but also for the preferential processing and loading of BCR bound 
antigens onto MHCII molecules. This process acts as an ‘antigen focusing’ 
mechanism and allows activated B cells to serve as proficient APCs that can 
contribute to CD4 T cell priming in vivo. Therefore during FV infection in vivo, B 
cells may not only contribute to FV control via the production of antibodies but may 
also contribute to the quality of CD4 T cell immune responses (Schultz et al., 1990).   
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Chapter 2. Materials & Methods 
2.1 Mice 
All mouse strains used in this study are listed in Table 1. All animal experiments 
were approved by the ethical committee of the Francis Crick institute, and 
conducted according to local guidelines and UK Home Office regulations under the 
Animals Scientific Procedures Act 1986 (ASPA). Male or female mice were used in 
separate experiments and were age and gender-matched accordingly. Mice were 
used at 8–12 weeks of age, with the exception of experiments involving neonatal 
infections, which were carried out on 1–2 day-old mice. 
 
Table 1 A brief description of the mice utilised in this study 
 
Mouse strains Descriptions Reference/source 
129S8 An inbred mouse strain which is 
commonly used in immunological 
research 
Jackson Laboratory 
(JAX)  
 
3G7A Mice carry  TCRα and TCRβ transgenes 
derived from a Treg T cell 
un-published 
3G7A Rag-/- Monoclonal TCRαβ Treg TCR transgenic 
mouse 
un-published 
 
3G7B Mice carry TCRα and TCRβ transgenes 
derived from a Treg T cell 
un-published 
3G7B Rag-/- Monoclonal TCRαβ Treg TCR transgenic 
mouse. 
un-published 
A (A/J) An inbred mouse strain, which is 
commonly used in immunological 
research. 
Jackson Laboratory 
(JAX)  
 
B6 CD45.1 Otherwise wild-type mice expressing the 
CD45.1 allele, which is atypical on the 
C57BL/6 background, allowing for the 
marking of transferred cells. 
Jackson Laboratory 
(JAX)  
 
B6 
CD45.1/CD45.2 
Otherwise wild-type mice that express 
both a CD45.1 and a CD45.2 allele, and 
thus can serve as recipients for cell 
transfer experiments. 
Jackson Laboratory 
(JAX)  
 
B6 EF4.1 Bcl6c An EF4.1 mouse with addition OX40cre 
and YFP reporter alleles. 
(Merkenschlager et al., 
2016) 
B6 EF4.1 
Prdm1GFP 
An EF4.1 mouse heterozygote for 
Prdm1GFP allele. 
un-published 
B6 EF4.1 TCRβ TCRβ transgenic mouse strain, with an (Antunes et al., 2008) 
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enriched frequency of env-specific CD4 
T cells. 
 
B6.129H2<dlAB1-
Ea> 
Mice are homozygous null for MHC class 
II genes H2-Ab1, H2-Aa, H2-Eb1, H2-
Eb2, H2-Ea and thus express no MHCII. 
Jackson Laboratory 
(JAX)  
 
B6.TCRα-/- Mice have a targeted disruption in the 
TCRα chain gene, and therefore have 
disrupted T cell development. 
Jackson Laboratory 
(JAX)  
 
C57BL/6 /WT/ 
B6 CD45.2 
Wild-type mice. 
 
Jackson Laboratory 
(JAX)  
 
C57BL/6 Rag-/- Mice are deficient in recombination 
activation gene, and are thus are 
deficient in T and B lymphocytes 
Jackson Laboratory 
(JAX)  
 
CBA  An inbred mouse strain which is 
commonly used in immunological 
research 
Jackson Laboratory 
(JAX)  
 
EVa2 Mice carry TCR Vα2 and TCRβ 
transgenes, derived from a high avidity 
env-reactive clonotype (red clonotype) 
(Merkenschlager et al., 
2016) 
 
EVa2 Rag-/- Monoclonal TCRαβ TCR transgenic 
mouse specific for the env peptide (red 
clonotype) 
 
EVa3 Mice carry TCR Vα3 and TCRβ 
transgenes, derived from a low avidity 
env-reactive clonotype (blue clonotype) 
(Merkenschlager et al., 
2016) 
 
EVa3 Rag-/- Monoclonal TCRαβ TCR transgenic 
mouse specific for the env peptide (blue 
clonotype) 
(Merkenschlager et al., 
2016) 
L23 Rag-/- Monoclonal TCRαβ TCR transgenic 
mouse specific for the env peptide 
(green clonotype) 
un-published 
 
MuMT/ Igh6-/- Mice have a targeted disruption in the 
immunoglobulin heavy chain gene, and 
therefore have disrupted B cell 
development 
Jackson Laboratory 
(JAX)  
 
Nur77-GFP The Cre recombinase/green fluorescent 
protein fusion protein, driven by the 
Nr4a1 (Nur77) promoter in these mice 
 
Jackson Laboratory 
(JAX)  
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2.1.1 Generation of the TCR transgenic mice 
2.1.1.1  EF4.1 
The EF4.1 mouse is a TCRβ Tg mouse previously generated in the lab. The fixed 
TCRβ of the EF4.1 mouse, was originally template from the SB14-31 CD4 T cell 
clone, which recognising the N-terminal region of the envelope glycoprotein of FV 
(gp70) (Iwashiro et al., 1993).  
2.1.1.2  New TCR transgenic mice 
Briefly, cDNAs encoding the TCRα chains of CD4 T cell clones, respectively, were 
cloned and inserted into the hCD2-VA expression cassette (Antunes et al., 2008). 
Each of these constructs was then mixed with a construct encoding the TCRβ 
chain of EF4.1 mice and integrated into the DNA of fertilized B6 oocytes following 
pronuclear microinjection. Transgenic founders were then identified by flow 
cytometry and genotyping for the presence of the TCRα and TCRβ transgenes. 
These new transgenic mice were crossed onto the Rag1−/− background, to limit 
TCR expression to that encoded by the transgenes alone. Following which mice 
were rendered deficient in Emv2, a single copy endogenous retrovirus, to prevent 
the spontaneous resurrection or expression of Emv2-derived agents (Young et al., 
2012b (Young et al., 2012a)).  
2.2 Tissue and cell preparation 
2.2.1 Media and culture conditions 
Room temperature (RT) cell incubation, antibody staining, cell sorting, and tissue 
collection was performed with Air-Buffered Iscove’s-Modified-Dulbecco’s-Medium 
(AB-IMDM) containing 25mM HEPES buffer and L-glutamine, and supplemented 
with 0.21% NaCl,60 µg/ml penicillin, and 100 µg/ml streptomycin (Invitrogen). 
Erythrocyte lysis was performed with Ammonium-Chloride-Potassium (ACK) buffer 
(0.15 M NH4Cl, 1 mM KHCO3, 0.1 mM EDTA, pH 7.2-7.4). Cells were cultured with 
complete Iscove’s-Modified-Dulbecco’s-Medium (IMDM) (Sigma-Aldrich) which was 
supplemented with 5% heat inactivated foetal calf serum (FCS) (BioSera, Ringmer, 
UK), 2mM L-glutamine, 100µg/ml penicillin, 100µg/ml streptomycin, and 10-5M 
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mercaptoethanol. For experiments looking at the role of foetal calf serum (FCS), we 
used Protein free Hybridoma media (PFHM), or IMDM supplemented with only 
2mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10-50M 
mercaptoethanol (Invitrogen). For experiments requiring the long-term culture of 
activated primary T cells we used, Roswell Park Memorial Institute medium (RPMI) 
supplemented with 10% FCS, 2mM L-glutamine, 100 U/ml penicillin, 100 µg/ml 
streptomycin and 10-50M mercaptoethanol and recombinant interleukin 2 (IL-2) 
(Invitrogen). All flow cytometric straining was performed in fluorescence-activated 
cell (FACS) sorting buffer (PBS, 2% FCS, 0.1% Azide). Primary cells and cell lines 
were cultured at 95% humidity, 5% CO2, and 37◦C. 
2.2.2 Single cell suspensions 
Single cell suspensions were prepared from the spleens, thymi and lymph node of 
mice via their mechanical disruption through 40um or 70um cell-strainers (Falcon, 
Becton Dickinson Labware) using a 5mL syringe plug.  Spleen suspensions were 
also treated with ACK for a short time, before being re-suspended in AB-IMDM. 
Bone marrow cell suspensions were prepared by flushing the bone cavities of the 
femur and tibiae of donor mice with AB-IMDM. This was followed by treatment with 
ACK lysis buffer. Live cells were then counted using a Neubauer haemocytometer 
(Marienfield). 
2.2.3  Cell purification and enrichment 
Enrichment and isolation of primary cells, was performed using a PE immuno-
magnetic selection kit (StemCell EasySep). Single cell suspensions were prepared 
to a concentration of 1x108 ml in AB-IMDM and then incubated with the required 
PE- conjugated antibody for 30 minutes in the dark. Cells were then washed once 
in AB-IMDM (to remove excess antibody) before being re-suspended in the starting 
volume of AB-IMDM. Following which, the EasyStep Selection cocktail was added 
(25 µl/ml of cells) and the suspension was incubated at RT for 15-20 mins. 
EasySep Magnetic Nanoparticle beads were then added (25 µl/ml of cells), and the 
suspensions was gently re-suspended every 5 minutes to ensure the uniform 
distribution of the beads. After 20 minutes, the suspension was further diluted X2 in 
AB-IMDM and transferred into 5ml round bottom polystyrene tubes (StemCell) 
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before being placed onto the separating magnet (EasySep™ Magnet). The magnet 
generates a high-gradient magnetic field around the polystyrene tube, allowing for 
the separation of cells labeled with the EasySep™ Magnetic Particles.  For positive 
selection: After 5 minutes the non-labelled cells were poured off in the supernatant 
by inverting the magnet and tube. This is repeated 2 more times to increase purity, 
before the walls of the tube, containing the selected cells, were washed with AB-
IMDM. For negative selection of cells: The supernatant was collected with cells 
captured by the magnet being discarded. Purity can them be ascertained using flow 
cytometry and was typically over 95%. 
2.3  In vitro  
2.3.1 In vitro T cell activation 
Single cell suspensions were prepared from the spleens and lymph nodes of donor 
mice. Cells were then re-suspended in the required media (as described in 2.2.1) 
and plated at a final concentration of 1x106ml in 96-well plates or in Corning 
T25/T75 cell culture flasks (Sigma Aldrich). Cells were then stimulated with the 
indicated amount of the index env122-141 epitope (DEPLTSLTPRCNTAWNRLKL) or 
with CD3-CD28 T cell-activating Dyna Beads (Thermo-Fisher). 
 
Alternatively, for the activation of monoclonal populations of CD4 T cells or T cell 
hybridomas, or to access the capacity of distinct APCs to prime cells, T cells were 
plated at a 1:1 ratio with pre-prepared APCs of choice (see preparation 2.3.4, 
2.3.5) and subsequently stimulated as descried above. 
 
T cell activation was assessed, 18 hours following stimulation, by flow cytometric 
detection of early markers of activation; or 3-4 days later by the detection of IL-2 via 
the CTLL-2 assay (2.3.2), cytokine production or cell trace dye dilution by FACS. 
For long-term culture of T cells following activation, cells were culture in RPMI 
supplemented with recombinant IL-2 (2.2.1). 
2.3.2 IL-2 CTLL-2 assay 
Upon activation, CD4 T cells rapidly start to produce IL-2. The production of IL-2, 
by activated T cell populations, is proportional to the degree of activation they 
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receive. CTLL-2 cells are mouse-derived cytotoxic T cells, which are dependent on 
IL-2 for their continued growth and survival and thus their cellular growth can be 
utilized for an in vitro measurement of IL-2 production by recently activated CD4 T 
cells. 
 
Briefly, CD4 T cell are stimulated overnight with the desired concentration of 
peptide (env122-141) or with CD3-CD28 T cell activating Dyna Beads (Thermo-
Fisher). Following which 100ul of supernatant, containing the newly produced IL2, 
is collected. Supernatants may then be frozen in 100ul aliquots to reduce potential 
contaminants, or used fresh to re-suspend IL-2 deprived CTLL-2 cells. CTLL-2 cells 
are plated in 96-well plates at a concentration of 5x103 cells/well in 100µl of the 
supernatant. Following overnight culture, Alamar blue (Biosoure) is added at 1:10 
dilution. Respiration, as a consequence of cellular proliferation, results in a change 
in the colour on the AlamarBlue reagent, allowing the use of fluorescence intensity 
collected as a measure of cellular growth and hence the determination of relative 
concentrations of IL-2. On day 2, fluorescence at 590 nm (excitation at 530 nm) 
was determined with a Safire2 plate reader (Tecan Group, Switzerland). Results 
were expressed as fluorescence units, with higher intensity indicating higher CTLL-
2 growth and, therefore, higher IL-2 amounts. 
2.3.3 CFSE labelling 
For carboxyfluorescein succinimidyl ester (CFSE) labelling, cells were washed in 
Dulbecco’s Phosphate Buffered Saline solution (D-PBS) (GIBCO) and re-
suspended in CFSE (Molecular Probes). For labeling more than 1x106 cells, CFSE 
was used at 2.5µM, while for lower cell numbers the concentration was 0.6µM. 
Cells were incubated for 10 minutes in tissue culture conditions and then washed in 
culture medium. Dividing cells were identified by CFSE dilution via Fluorescence 
Activated Cell Sorter (FACS) analysis in the subsequent days. 
2.3.4 Preparation of Bone Marrow Derived Dendritic Cells 
For the production of bone marrow derived dendritic cells (BMDC), bone cavities of 
femurs and tibiae from donor mice were flushed with 5ml of complete AB-IMDM 
media which was supplemented with 10% granulocyte macrophage colony-
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stimulating factor (GM-CSF). Suspensions were plated in 10 cm cell culture plates 
and incubated for 7 days. Dendritic cells were harvested by gently washing the 
culture plates in AB-IMDM to capture loosely adherent cells.  
2.3.5 Preparation of Peritoneal Macrophages 
For the preparation of ex vivo macrophages, approximately 5ml of AB-IMDM was 
injected into the peritoneal cavity of euthanized mice.  The abdomen of mice was 
then gently massaged to increase cellular yield, following which the cell-enriched 
media was then carefully aspirated using a 5ml syringe. The aspirated media was 
kept on ice before being plated in flat-bottomed tissue culture plates for 1-2 hours 
at 37◦C, thus allowing time for the peritoneal macrophages to adhere to the plastic. 
Following this time, non-adherent cells were washed away, and the wasted media 
replenished. 
2.3.6 Preparation of Splenic B cells 
Enrichment and isolation of primary cells, was performed using an PE-immuno-
magnetic selection kit (StemCell EasySep). Single cell suspensions were prepared 
to a concentration of 1x108 ml in AB-IMDM and then incubated with the B220- PE 
conjugated antibody for 30 minutes. Cells were then process according to Cell 
purification and enrichment methods 2.2.3 
 
2.3.7  Generation of novel Hybridoma cell lines 
The generation of novel T cell hybridoma cell lines involved the fusion of primary T 
lymphocytes to partner thymoma cells, resulting in the immortalization of the 
primary T cell. Briefly, activated virus-specific CD4 T cells were sorted ex vivo from 
immunized mice and mixed at a 1:1 ratio with TCRα/β-negative BW5147 thymoma 
cells (Letourneur and Malissen, 1989). Cells were pelleted and polyethylene glycol 
(PEG) was added drop-wise to mediate the fusion between partner cells. Fused 
cells were then re-suspended in Hypoxanthine Aminopterin Thymidine (HAT) 
selection media at limiting dilutions.  Fusion partners were plated on-top of a layer 
of ex vivo peritoneal macrophages (2.3.5) which act to phagocytise dead cells and 
keep the culture conditions optimal. Following 10-14 days, individual hybridoma 
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colonies could then be harvested and gradually weaned off the HAT selection 
media and onto complete IMDM. T cell hybridomas were subsequently probed by 
staining with an anti-Vα2 (clone B20.1) or anti-Vα3.2 (clone RR3-16) monoclonal 
antibodies, or via the sequencing of expressed Trav genes (. 
2.4  In vivo 
2.4.1  T-cell purification and adoptive transfer 
Single-cell suspensions were prepared from the spleens and lymph nodes of donor 
B6/CD45.1 or B6/CD45.2 mice and CD4 T cells were isolated using CD4-PE 
immune-magnetic positive selection (2.2.3). A total of 1x106 CD4 T cells were 
intravenously injected (i.v) into B6 CD45.1/CD45.2 recipients.  Where indicated, 
EF4.1 CD4 T cells were instead purified by cell sorting (at > 99% purity), performed 
on MoFlo cell sorters (Dako-Cytomation, Fort Collins, CO, USA). 
2.4.2 Generation of mixed bone-marrow chimeras 
Bone marrow cell suspensions were prepared from separate donor mice by 
flushing the bone cavities of femurs and tibiae in AB-IMDM. Cell suspension were 
briefly treated in ACK lysis buffer for 2-5 min at room temperature to erupt 
erythrocyte cells, following which live cells were then counted using a 
haemocytometer.  
 
For the generation of bone marrow chimeras MHCII-sufficient or -deficient bone 
marrow cells were injected separately into non-irradiated Ighm−/− recipients. In this 
setting, only the missing lymphocyte population (B cells) was properly reconstituted, 
creating B-cell-specific loss of MHCII. Each recipient received between 1x107 and 
3x107 bone marrow cells. Mice were bled for assessment of reconstitution and 
were used for infection 8–10 weeks post bone marrow transfer. 
 
For the generation of mixed bone marrow chimeras, B6 CD45.1 and 3G7 Rag-/- 
bone marrow were mixed at the desired ratios and injected together into non-
irradiated TCRα-/- recipients. This generating a mixed T cell population derived from 
both donors in the recipient mice. Each recipient received between 1x107 bone 
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marrow cells. Mice were bled for assessment of reconstitution and were used for 
infection 8–10 weeks post bone marrow transfer. 
2.5 Retroviral infection and immunization 
2.5.1 FV infection 
The FV used in this study was a retroviral complex of a replication-competent B-
tropic F-MLV and a replication-defective SFFV. Stocks were propagated in vivo and 
prepared from the spleens of infected susceptible mice. A pool of 20 LDV-free 
BALB/c mice was infected with FV, spleens were isolated 12 days later and 
homogenized (10% w/v) in PBS. Aliquots of spleen homogenates were frozen and 
were subsequently used for infection. Mice received an inoculum of ∼1,000 spleen 
focus-forming units of FV by intravenous injection. Stocks of F-MLV-B and F-MLV-
N helper viruses were grown in Mus dunni fibroblast cells. Mice received an 
inoculum of ∼104 infectious units of F-MLV by intravenous injection. Neonatal F-
MLV infection was performed by administering an inoculum of ∼4,000 infectious 
units of F-MLV-B to 1-day-old mice by intraperitoneal injection. All stocks were free 
of Sendai virus, Murine hepatitis virus, Parvoviruses 1 and 2, Reovirus 3, Theiler’s 
murine encephalomyelitis virus, Murine rotavirus, Ectromelia virus, Murine 
cytomegalovirus, K virus, Polyomavirus, Hantaan virus, Murine norovirus, 
Lymphocytic choriomeningitis virus, Murine adenoviruses FL and K87, Mycoplasma 
sp. and LDV. For co-infection of FV and LDV, a similarly prepared stock of FV 
additionally containing LDV was also used.  
2.5.2 F-MLV copy number analysis 
DNA copy numbers of F-MLV were determined by real-time quantitative PCR 
(qPCR) on DNA samples isolated from the spleen cell suspensions from infected 
mice, using primers specific to F-MLV env DNA (125 bp product): 
forward 5′ -AAGTCTCCCCCCGCCTCTA-3′  
Reverse 5′ -AGTGCCTGGTAAGCTCCCTGT-3′  
Signals were normalized for the amount of DNA used in the reactions based on 
amplification of the single-copy Ifnar1 gene (150 bp product) with primers: 
Forward 5′ -AAGATGTGCTGTTCCCTTCCTCTGCTCTGA-3′  
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Reverse 5′ -ATTATTAAAAGAAAAGACGAGGCGAAGTGG-3′  
Copy numbers were calculated with a ΔΔCT method and are expressed as copies 
per million cells. 
2.5.3  Peptide Immunization 
For peptide immunization, WT or Ighm−/− recipient mice received an intra-peritoneal 
(i.p) injection of a total of 12.5 nmol of synthetic env122-141 peptide mixed in Sigma 
Adjuvant System®  (adjuvant was used to provide the necessary stimulus to the 
immune system to allow CD4 T cell responses). 
2.5.4  FBL3 tumour challenge 
FBL3 is a FV-induced cell line that expressed the FV CD4 epitipe (gp70) as 
described (Klarnet et al., 1989).  WT or Ighm−/− recipient mice were inoculated with 
3 × 106 FBL-3 cells via intravenous injected followed by T cell transfer. 
2.6 Flow cytometric analyse 
2.6.1 Reagents and list of antibodies 
Table 2 List of reagents and antibodies 
 
Antibody Description Fluoropho
re 
Source Clone Dilution 
Ab-env125-135 
tetramer 
Tetramer APC Dr Marion 
pepper 
N/A 1 in 25 
Alexa Fluor 
488 kit  
Alexa Fluor 488 
amplification kit 
for fluorescein 
Alexa 
fluro 647 
Invitrogen N/A 1/200 
B220 PE-TR Rat 
Anti-
MouseCD45R 
(B220) 
Pe-Texas 
Red  
Invitrogen RA3-
6B2 
1/300 
B220 Brilliant Violet 
605™ anti-
mouse/human 
CD45R/B220 
Antibody 
BV605 Biolegend RA3-
6B2 
1/200 
CD19 Anti-Mouse 
CD19 APC 
APC Life 
technologies 
6D5 1/100 
CD2 PE/Cy7 anti-
mouse CD2 
Antibody 
PECY7 Biolegend RM2-5 1/200 
CD25 Anti-Mouse APC Ebioscience PC61.5 1/200 
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CD25 APC 
CD38 APC anti-
Mouse CD38 
APC Ebioscience 90 1/200 
CD38 FITC anti-
Mouse CD38 
FITC Ebioscience 90 1/200 
CD4 Anti-Mouse 
CD4 PE-
Cyanine7 
PE-Texas 
Red 
Ebioscience GK1.5 1/200 
CD4 APC anti-
Mouse CD4, 
APC EBioscience GK1.5 1/200 
CD4 PE anti-mouse 
CD4 (L3T4) 
PE Ebioscience GK1.5 1/200 
CD4 Anti-Mouse 
CD4 PE-
Cyanine7 
PE-
Cyanine7 
Ebioscience GK1.5 1/200 
CD4 FITC anti-
Mouse CD4 
(L3T4) 
FITC Insight 
Biotech 
RM4-5 1/200 
CD43 PE - CD43 
Activation-
Associated 
Glycoform 
PE BD  1B11 1/200 
CD44 V500 Rat anti-
Mouse CD44 
V500 BD 
Biosciences 
IM7 (RU
O) 
1/200 
CD44 Pacific Blue® 
anti-
Mouse/Human 
CD44 (Pgp-1, 
Ly-24), 
Pacific-
Blue 
Biolegend IM7 1/200 
CD45.1 Anti-Mouse 
CD45.1 
eFluor® 450 
Efluoro-
450 
Ebioscience A20 1/300 
CD45.1 APC/Cy7 anti-
mouse CD45.2 
Antibody 
APCy7 Biolegend 104 1/200 
CD45.1 PE anti-Mouse 
CD45.1 
PE EBioscience A20 1/200 
CD45.2 Anti-Mouse 
CD25 APC 
APC Ebioscience PCB1.5 1/200 
CD45.2 APC-eFluor® 
780 anti-mouse 
CD45.2 
APC-
eFluor 
780  
Ebioscience 104 1/200 
CD45.2 APC/Cy7 anti-
mouse CD45.2 
Antibody 
APCy7 Biolegend 104 1/200 
CD45.2 APC-eFluor® 
780 anti-mouse 
CD45.2 
APC-
eFluor® 
780  
Ebioscience 104 1/200 
CD5 Anti-Mouse 
CD5 PE 
PE Ebioscience 53-7.3 1/500 
CD69 FITC anti-
Mouse CD69 
FITC EBioscience H1.2F3 1/200 
CD69 Pacific Blue 
anti-Mouse 
CD69,  
PB BioLegend 
(Cambridge 
Bioscience) 
H1.2F3  1/200 
CD8α Anti-Mouse 
CD8a FITC 
FITC Ebioscience 53-6.7 1/300 
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Fcγ III 2.4G2 blocking 
antibody 
N/A NIMR/Franci
s Crick 
N/A 1/200 
Foxp3  Anti-Mouse/Rat 
Foxp3 PE (FJK-
16s) 
PE EBiosciences KIT 1/200 
GL7 T- and B-cell 
activation 
antigen, FITC-
GL7 
FITC BD GL7 1/200 
Glyco-gag 34 FITC NIMR/Franci
s Crick 
N/A 1/300 
IFN-γ Anti-Mouse IFN 
gamma 
FITC Biolegend XMG1.2 1/200 
IFN-γ Anti-Mouse IFN 
gamma 
APC EBiosciences XMG1.2 1/200 
IgD PE anti-mouse 
IgD 
PE Ebioscience 11-26c 1/200 
IgD(b) Brilliant Violet 
711™ anti-
mouse IgD 
Antibody 
BV711 Biolegend 11-
26C.2A 
1/200 
IgM(b) FITC anti-
mouse IgM 
Antibody 
FITC Biolegend RMM-1 1/200 
IL-2 Anti-Mouse IL-2 
APC 
APC EBiosciences JES6-
5H4 
1/200 
Ly6c Biotin Rat Anti-
Mouse Ly-6C 
Biotin BD AL-21 1/200 
MHCII FITC anti-
Mouse MHC 
Class II (I-A/I-E) 
Fitc Ebioscience  
M5/114.
15.2 
1/300 
Streptavidin Streptavidin Pe-
Texas Red 
conjugated 
Pe-Texas 
Red 
conjugate
d 
Invitrogen SA1017 1/300 
Streptavidin Streptavidin PE PE BD 
Pharmingen 
N/A 1/300 
TCR Vα2 Anti-mouse V_2 
TCR APC 
APC ebioscience B20.1 1/200 
TCR Vα3.2 FITC Rat ant- 
Mouse Va 
3.2b,c TCR 
FITC BD RR3-16 1/200 
TCR Vα3.2 FITC Rat ant- 
Mouse Va 3.2 
FITC EBioscience RR3-16 1/200 
TCR Vβ Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
Vb 
various 
1/300 
TCRVβ 10b Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
RR3-15 1/200 
TCRVβ 11 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
RR3-15 1/200 
TCRVβ 12 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
MR11-1 1/200 
TCRVβ 13 Vb TCR 
Screening 
FITC BD 
Biosciences 
MR12-3 1/200 
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Panel (kit) 
TCRVβ 14 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
142 1/200 
TCRVβ 17a Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
KJ23 1/200 
TCRVβ 2 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
B20.6 1/200 
TCRVβ 3 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
KJ25 1/200 
TCRVβ 4 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
KT4 1/200 
TCRVβ 5.1 
and 5.2 
Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
MR9-4 1/200 
TCRVβ 6 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
RR4-7 1/200 
TCRVβ 7 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
TR310 1/200 
TCRVβ 8.1 
and 8.2 
Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
MR5-2 1/200 
TCRVβ 8.3 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
MR10-2 1/200 
TCRVβ 9 Vb TCR 
Screening 
Panel (kit) 
FITC BD 
Biosciences 
B21.5 1/200 
TCRβ Anti-Mouse 
TCR beta APC-
eFluor® 780 
Apc-efluro 
780 
Ebioscience H57-597 1/200 
TCRβ APC-Cy7 anti-
Mouse TCRb 
APC-Cy7 Ebioscience H57-597 1/200 
TCRβ APC anti-
Mouse TCRb 
APC Ebioscience H57-597 1/200 
Vα2 FITC anti-
Mouse Va2 
TCR,  
FITC BD B20.1 1/200 
Vα2 Anti-mouse V_2 
TCR APC 
APC Ebioscience B20.1 1/200 
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2.6.2 Calculations and absolute numbers 
Single-cell suspensions were diluted in AB-IMDM. Live cells were counted using a 
Neubauer haemocytometer (Marienfield). 
2.6.3 Cell surface staining (CSS) 
Single-cell suspensions were stained with directly-conjugated antibodies to cell 
surface markers, obtained from eBiosciences (San Diego, CA, USA), 
CALTAG/Invitrogen,BD Biosciences (San Jose, CA, USA) or BioLegend (San 
Diego, CA, USA) and anti-FcR monoclonal antibody (2.4G2) was to block non-
specific binding. All staining was performed at 4°C in the dark and were incubated 
in FACS buffer.  
2.6.4 Intracellular cytokine staining (ICS) 
For the intracellular detection of cytokines cells were stimulated with phorbol 12,13-
dibutyrate (PDBu) and Ionomycin (both at 0.5 µg/ml) at 37°C in AB-IMDM.  Here, 
Ionomycin and PDBu synergise to activate protein kinase C (PKC) and mobilise 
intracellular calcium, resulting the putative activation of the T cell independently of 
TCR specificity. After 1 hour, cells were treated with monensin (at 1µg/ml) for a 
further three hours, to allow for the accumulation of cytokines within the activated T 
cells. Following this cell were then washed and stained for cell surface antibodies in 
FACs buffer. Following cell-surface antibody staining cells were then washed and 
resuspended in fixation buffer (eBioscience) for 20 minutes. Cell were then washed 
again before being resuspended in permeabilization buffer (eBioscience) 
supplemented with antibodies for cytokine staining for one hour at RT.  After the 
combined permeabilisation on staining step, cells were washed a further two times 
before finally being re-suspended in FACS buffer for analysis. 
 
2.6.5 Intra-nuclear Foxp3 staining (INS) 
FoxP3 expression was accessed by intranuclear staining using a FoxP3-staining kit 
(eBiosciences). Following cell-surface antibody staining cells were fixed and 
permeabilisaton using an anti-mouse/rat FoxP3 staining kit (eBbioscience), 
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according to manufactures instructions. Cells were washed before being re-
suspended in FACS buffer for analysis. 
 
2.6.6 Tetramer staining 
Cells were incubated with the conjugated Abenv135-141 tetramers (kindly provided by 
Dr Marion Pepper) and incubated at 37°C for 3 hours in RPMI. Cells were mixed 
gently at 30 minute intervals to ensure uniform distribution and staining. Cell 
surface antibodies were then added and the cells were incubated in the dark at RT 
for 20 minutes. Cells were washed and re-suspended in FACS buffer before 
analysis. 
2.6.6.1  Acquisition and cell sorting 
Data were collected on BD FACSCantoII (BD Biosciences), BD FACSFortessaX20 
(BD Biosciences), BD FACSFortessaX30, FACSCalibur (BD Biosciences) and 
CyAn (Dako, Fort Collins, CO) flow cytometers. Cells were sorted on BD FACSAria 
II (BD Biosciences), BD Influx (BD Biosciences) or Beckman Coulter MoFlo XDP 
cell sorters (BD Biosciences) (at purity>98%). Data was processed and analyzed 
using BD FACSDiva Software, FlowJo v10 (TreeStar) or Summit v4.3 (Dako) 
analysis software. 
 
2.7 RNA preparation and TCR sequencing 
2.7.1 RNA purification and extraction from cells 
Total RNA from single cell suspensions was extracted with the RNEasy Mini and 
Micro Plus kits (Qiagen) according to the manufacturer’s instructions or isolated 
using the QIAcube (QIAGEN, Crawley, UK). Synthesis of cDNA was carried out 
with the High Capacity Reverse Transcription kit (Applied Biosystems, Carlsbad, 
US) with an added RNase-inhibitor (Promega Biosciences, Madison, US) according 
to the manufacturer’s instructions. Final RNA concentrations could be quantified 
using a Nanodrop 1000 (ThermoScientific) 
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2.7.2 Next-generation sequencing of the TCR repertoire 
For TCR sequencing, naive or primed env-specific EF4.1 CD4 T cell subsets were 
purified by cell sorting (>98%) and RNA was isolated using the QIAcube (QIAGEN, 
Crawley, UK). Synthesis of cDNA was carried out with the High Capacity Reverse 
Transcription kit (Applied Biosystems, Carlsbad, CA, USA) with an added RNase-
inhibitor (Promega Biosciences, Madison, WI, USA). A final clean-up was 
performed with the QIAquick PCR purification kit (Qiagen). Purified cDNA was then 
used as template for the amplification of Trav14 (encoding Vα2)- or Trav9 
(encoding Vα3)-containing rearrangements, using the following primers:  
Trav14 forward:              5′-CAAGCTTCAGTCTAGGAGGAATGGAC-3′ 
Trav9 forward:                5′-CCAAGGCTCAGCCATGCTCCTGGC-3′ 
Trac common reverse:  5′-TAACTGGTACACAGCAGGTTCTGGG-3′ 
 The forward Trav-specific primers were located in a promoter region common to all 
members of the respective Trav family and the common reverse was in the 
common constant region, thus amplifying the entire variable and joining coding 
region (∼500 bp product). Between 4,500 and 43,000 sequences per sample 
(450 bp median size) were obtained on a GS FLX System by GATC Biotech 
(Constance, Germany).  
2.7.2.1 Analysis 
Identification of productive rearrangements, Trav and Traj gene segment 
annotation, protein translation and CDR3 segment prediction were performed by 
the ImMunoGeneTics (IMGT) online tool HighV-QUEST. 
2.8  Genomic DNA preparation 
2.8.1 Extraction from cells 
For the isolation of DNA from cells, cell suspensions were washed in PBS to 
remove FCS contaminants. Pelleted cells were then re suspended in 500ul of Tail 
buffer (1% SDS, 0.1M NaCl, 0.1M EDTA, 0.05M Tris,315ml sterile distilled H2O) 
and digested with10ul of protease k (20mg/ml) added. This is left at 56°C for 2 
hours on a heat block or overnight. To these samples, 0.7 volumes of isopropanol 
was added and vigorously re-suspended. The material was pelleted, the 
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supernatant aspirated, and the material re-suspended in 100% ethanol. The 
material was pelleted, the supernatant aspirated and then the pellet was air dried 
before being re suspended is distilled H2O at the desired concentration. 
2.8.2 F-MLV copy number analysis 
DNA copy numbers of F-MLV were determined by real-time quantitative PCR 
(qPCR) on DNA samples isolated from the spleen cell suspensions from infected 
mice, using primers specific to F-MLV env DNA (125 bp product): 
 forward 5′ -AAGTCTCCCCCCGCCTCTA-3′  
 reverse 5′ -AGTGCCTGGTAAGCTCCCTGT-3′ 
Signals were normalized for the amount of DNA used in the reactions based on 
amplification of the single-copy Ifnar1 gene (150 bp product) with primers: 
 forward 5′ -AAGATGTGCTGTTCCCTTCCTCTGCTCTGA-3′   
 reverse 5′ -ATTATTAAAAGAAAAGACGAGGCGAAGTGG-3′  
Copy numbers were calculated with a ΔΔCT method and are expressed as copies 
per million cells. 
2.9 Micropipette adhesion frequency assay 
Two-dimensional TCR affinities were measured by a micropipette adhesion 
frequency assay, using the T-cell hybridomas H5, L23 and H18 and Ab-env125–135 
tetramer. Cells were brought into contact 50 times with the same contact time and 
area (Ac), and an adhesion frequency (Pa) was calculated. Surface pMHC and 
TCRβ densities were determined by flow cytometry and BD QuantiBRITE PE 
Beads for standardization (BD Biosciences). These parameters were then used to 
calculate two-dimensional affinity using the following equation: Ac × Ka=−ln[1—
Pa(∞)] mr−1 ml−1 where mr and ml represent TCR and pMHC surface densities, 
respectively. 
2.10  Statistical analysis 
Statistical comparisons were made using SigmaPlot 12.0 (Systat Software, 
Germany). Parametric comparisons of normally distributed values that satisfied the 
variance criteria were made by unpaired Student’s t-tests. Data that did not pass 
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the variance test were compared with non-parametric two-tailed Mann–Whitney 
rank sum test. Comparison of Vβ family expression, hierarchical clustering and 
heat-map production was with Qlucore Omics Explorer (Qlucore, Lund, Sweden). 
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Chapter 3. TCR specificity and avidity in Treg T cells  
3.1 Introduction 
Treg T cells play a pivotal role in maintaining tolerance to self and in restraining the 
pathogenic potential of auto-reactive T cells that exist in the periphery. Although 
indispensable, these cells also exist as a niche subset, restricted to approximately 
10% of the peripheral CD4 T cell population. Clearly too many Tregs, as well as too 
few, can be detrimental to the host. Understanding how this balance is met and 
maintained may lie in better defining the parameters surrounding their development 
and selection. What instructs for the illusive Treg fate remains a very important 
question.  
 
3.1.1 A brief history 
The idea of a T cell population with innate suppressor capacity first came about 
during the 1960s and 1970s. Here, an initial publication in Science, presented two 
major findings 1) that neonatal thymectomy in mice lead to their spontaneous 
development of autoimmunity 2) and that this could be rescued by thymic grafting 
(Nishizuka and Sakakura, 1969). This work was shortly followed by a study from 
Gershon and colleagues that demonstrated that some T cells might also suppress 
antibody mediated responses (Gershon and Kondo, 1970). Two years later, 
Gershon and Kondo went on to publish their seminal work, the first to propose and 
define a subset of T cells capable of suppressing antigen-induced responses of 
other Th subsets (Gershon et al., 1972). These cells were christened the 
‘suppressor T cells’, and these findings gave birth to a new field in immunology 
(Gershon et al., 1972). Following which, interest in the suppressor T cell subset 
was explosive and they remained intensively studied over the following years. 
However, the field took a major hit during the 1980s, which saw it virtually collapse 
in both popularity and integrity. Although this was most likely a result of a 
combination of failings, it was heavily contributed toward by the absence of lineage 
specific markers and the lack of the theoretical I-J region, thought to be encoded 
between the I-A and I-E sub regions of MHCII locus and suggested to be implicit in 
suppressor function (Kronenberg et al., 1983). However, experiments conducted in 
Chapter 3 Results 
 
62 
 
the 1990’s, saw the field revised and revitalised, featuring the rebranding of the 
suppressor T cell as the regulatory T cell. Here, the discovery of markers that could 
be used to define Treg T cell populations (firstly CD5 and CD45R and then 
progressively CD25) allowed for their isolation and characterisation (Sakaguchi et 
al., 2007). Work published by Sakaguchi et al in 1995 then went on to show that 
antibody-mediated depletion of CD25positive T cells was sufficient to drive 
spontaneous autoimmunity in previously healthy hosts, pheno-copying the early 
pathologies observed in thymectomized mice (Sakaguchi et al., 1995). This 
suggested that although auto-reactive T cells (with the potential to cause immune-
pathology) existed in healthy mice, under-normal conditions these could be kept in 
check by a subset of regulatory CD25positive T cells. In 2001, the disease-associated 
gene in Scurfy mice, mice that present with fatal lympho-proliferative autoimmune 
disorder, was identified as being Foxp3 (Brunkow et al., 2001). By 2003, Foxp3 
was shown to be important in the development and function of Treg T cells 
(Fontenot et al., 2003b, Hori et al., 2003). Moving forward, retroviral transduction of 
Foxp3 into naïve conventional T cells was shown to be sufficient to illicit the Treg 
phenotype in those cells, and thus established Foxp3 as the master regulator of the 
Treg lineage (Hori et al., 2003). The culmination of this work now means that Treg 
T cells are widely accepted as playing an indispensable role in the maintenance of 
peripheral tolerance. Whilst many fundamental questions remain unanswered or at 
least highly debated, popularity in the field is still driven by the prospect that a 
better understanding of this cell type could have revolutionary consequences on 
the treatment and management of autoimmune diseases, transplantation and 
cancer therapeutics.  
3.1.2 Origin of T regulatory cells 
Thymic generation of Treg T cells seems to require TCR signalling, upon self-
recognition, of sufficiently high levels to drive the expression of Foxp3 (as has been 
discussed previously). In addition, Treg T cells can also be generated via the 
conversion of conventional T cells once in the periphery, these are known as 
peripherally converted Treg (pTreg) T cells.  
Although the exact events that drive peripheral conversion remain unclear, 
evidence suggests that the TCR and hence the quality of TCR signaling may be 
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important (Lathrop et al., 2008, Pacholczyk et al., 2006, Mantel et al., 2006, Long et 
al., 2011, Sauer et al., 2008).  
3.1.3 TCR specificity in T regulatory cells 
Still relatively little is known about the TCR requirements of a Treg T cell, whether 
this be during development, homeostasis or in their peripheral function. However, 
the TCR repertoire has long been associated with self-reactivity, suggesting that 
certain traits, associated with select TCRs, may be important for this lineage. In this 
vein, TCR repertoire analysis, which compared conventional T cell TCR repertoires 
to Treg TCR repertoires, first highlighted the utilisation of different receptors by the 
two populations. In addition to being distinct, the Treg TCR repertoire was also 
reportedly enriched for self-reactive clones (Romagnoli et al., 2002, Hsieh et al., 
2004, Hsieh et al., 2006). In line with this, characterisation of Foxp3 deficient mice 
revealed that the pathogenic T cells in these animals, had overlapping TCR 
repertoires to Treg T cells found in healthy (Foxp3 sufficient) mice; hence re-
installing the self-reactive nature of the Treg TCR repertoire (Hsieh et al., 2006). 
Treg T cells are also notably absent from conventional double TCRαβTg mice 
suggesting that specific TCRs are required for Treg T cell development. However, 
studies have also shown that Treg T cell development can be restored in 
conventional TCRαβ Tg mice once cognate-antigen is expressed via the 
introduction of second transgene in the thymus (Jordan et al., 2001). This 
suggested that it was the self-reactive capacity of a given TCR that allowed it to be 
instructive for the Treg T cell fate. On the other hand, some studies have also 
reported substantial overlap between the TCR repertoires of Tcon and Treg T cells 
(Pacholczyk et al., 2007, Kasow et al., 2004). Again, their self-reactive nature was 
called into question when it was shown that Treg T cells were also capable of 
recognising foreign-antigens such as Mycobacterium Tuberculosis (Shafiani et al., 
2010), Candida albicans (Montagnoli et al., 2002) and Leishmania major (Belkaid 
et al., 2002) and Mycobacterium Tuberculosis among others (Pacholczyk et al., 
2007, Kasow et al., 2004). This has complicated the finer assessment of the TCR 
requirements necessary for Treg T cell development, maintenance and function. 
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3.1.4 TCR usage in T regulatory cells 
In Tcon cells, TCR signalling is required for both tonic pro-survival signalling and 
for the initiation of T cell activation in response to infection. However, the role for 
TCR signalling in Treg T cell homeostasis and peripheral function had remained 
largely unexplored up until a recent study from Rudensky’s lab (Levine et al., 2014). 
Here, conditional ablation of the TCR on Treg T cells revealed that although the 
maintenance of the Treg cell–specific gene signature was TCR independent, 
suppressor function was critically dependent on TCR expression (Levine et al., 
2014). However, what remained relatively un-explored was to what degree the 
quality of the TCR (and its signalling), rather than the presence of any TCR at all, 
played a role in aspects of Treg T cell fate and function. Whether TCR specificity, 
avidity and self-reactivity continue to play important roles in maintaining the Treg 
phenotype once in periphery, remains an interesting question. 
 
3.1.5 Aim 
Given the fundamental role of the quality of TCR signalling in many aspects of T 
cell fate decisions, the instructive capacity of certain TCRs to give rise to Treg T 
cells was of interest to us. In light of many studies reporting the preferential use of 
self-reactive TCRs by Treg T cells, we were particularly interested in exploring the 
role of self-reactivity in their development. To interrogate if Treg T cell lineage 
commitment was a ‘TCR instructive process’ and to explore to what degree self-
reactivity was implicit in this, we generated Treg TCR TCRαβ transgenic (Tg) 
mouse strains within the lab. 
 
3.2 Results 
3.2.1 Generation of transgenic mouse with a TCR derived from a Treg T cell. 
To ask, if the specificity of Treg TCRs, was intrinsically prescriptive for the 
regulatory program we wanted to study Treg cell development in the Treg derived-
TCRαβ transgenic mice. We therefore needed to identify, isolate and subsequently 
clone TCRs derived from Treg T cells to template for TCRα and TCRβ transgenes. 
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A major topic in our lab is the study of CD4 T cell immune responses to Friend 
Virus (FV) infection. In WT mice the precursor frequency of CD4 T cells specific to 
FV is low, thus limiting the capacity to study CD4 T cell kinetics to FV infection. In 
order to achieve better resolution of CD4 T cell responses to FV, our studies 
extensively make use of a TCRβ Tg mouse which was generated within the lab, the 
EF4.1 mouse (Antunes et al., 2008). The TCRβ transgene expressed by the EF4.1 
mouse strain was originally derived from a CD4 T cell clone reactive to the 
envelope glycoprotein of FV (gp70). Expression of this TCRβ transgene, and its 
subsequent pairing to endogenous TCRα chains, results in an increased frequency 
of FV specific CD4 T cells in these mice. Importantly, and in keeping with other 
observations made in TCRβ Tg mice, the expression of the transgene also allowed 
for Treg T cell development, although perhaps to a slightly lesser extent than in WT 
mice (Antunes et al., 2008). In addition, specificity of these Tregs T cells, did not 
seem to overlap with the pool of FV-reactive T cells (Antunes et al., 2008). This 
permissiveness for near-normal T cell development in the EF4.1 mice allowed us to 
use them as a source of Treg T cells. 
 
In order to identify and then isolate Treg T cell clones and their TCRs, the EF4.1 
mouse was crossed to a B6.Cg-Foxp3tm1Mal/J (Foxp3GFP) reporter mouse (Wang 
et al., 2008). This reporter allows for the expression of a green fluorescent protein 
(GFP) within cells expressing Foxp3. The targeting of the IRES-GFP cassette to 
exon 11, downstream of the endogenous Foxp3 ‘STOP” codon, allows for the 
insertion of a GFP reporter without disruption to Foxp3 expression itself. Ultimately 
this provided a method to allow for the identification of Foxp3 Treg T cells by GFP 
fluorescence. Using Fluorescence-activated cell sorting, CD4high, CD44low, CD25high, 
Foxp3-GFPhigh Treg T cells were sorted from EF4.1 Foxp3GFP reporter mice. These 
cells were then used to generate Treg T cell hybridomas via their fusion to 
thymoma partners (BW5147) in vitro.  
 
One clone, the 3G7, was selected and used to create the 3G7 A, B, C Treg-TCRαβ 
transgenic founder strains. These lines were backcrossed onto the C57BL/6 (B6) 
background for 10 generations, with the exception of the 3G7C strain which did not 
propagate beyond n=6 generations. Hereon in, we only use the 3G7A and 3G7B 
founder strains in our analysis. The decision to use two founder strains instead of 
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just the one, was in foresight of the random integration and hence copy number of 
TCR transgenes within each founders genome. We reasoned that both the location 
and the number of successful integrations would influence the levels of 
transgene/TCR expression. Potentially, this would then allow for the same TCR to 
have differing signaling potentials between the founder mice as a consequence. 
 
The generation of these transgenic mice, using standard techniques, was all done 
prior to my arrival in the lab whilst the characterisation of these mice was work 
conducted by myself.  
3.2.2 Reactivity 3G7 T cells with self and foreign antigen. 
To study the properties of the 3G7 TCR we utilised the 3G7 hybridoma cell line, 
propagated from the original fusion event between an ex vivo Treg T cell and a 
thymoma partner. Importantly, although the 3G7 hybridoma retained the TCR 
specificity of the parental Treg T cell, it did not retain the Treg cell phenotype. This 
then allowed us to use conventional T cell assays to study T cell reactivity and 
activation.  
 
Preliminary results showed, the 3G7 hybridoma to spontaneously activate in vitro 
when co-cultured with C57BL/6 splenocytes, as accessed by CD69 up-regulation 
and later by IL-2 production (Figure 1a-b). To define if this activation was TCR 
driven, we co-cultured 3G7 hybridoma with MHCII deficient antigen presenting cells 
(APCs) derived from B6.129H2<dlAB1-Ea> mice. Lack of stimulation in this setting 
suggested activation to be dependent on TCR-MHCII derived interactions. T cell 
TCRs can recognise peptide MHCII complexes (pMHCII), however it was possible 
that the 3G7 TCR could be recognising exposed MHCII backbone residues rather 
than specific peptides complexed with MHCII. Therefore, we next sought to 
delineate if cross-reactivity of the TCR to the MHCII backbone, or conventional 
peptide presentation by MHCII was accounting for 3G7 hybridoma activation. To do 
so, we co-cultured 3G7 hybridoma with a range of allogenically distinct APCs 
(Table 3). These experiments showed activation to be restricted to the H2b 
haplotype, shared by only 129 and C57BL/6 mice (Figure 1b). This was suggestive 
that the TCR was not alloreactive, as the 3G7 hybridoma could not tolerate diverse 
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MHCII haplotypes. But without an understanding of whether this restriction was 
driven by altered peptide presentation between diverse haplotypes, or driven by 
alterations to the exposed MHCII residues (that the TCR may be recognising) we 
could not conclusively prove this. 
 
 
Table 3 MHCII haplotypes 
The MHC haplotype in these strains is designated by a small letter.  
 
Mouse strain MHCII haplotypes 
C57BL/6 
 
b 
B6.129H2<dlAB1-Ea> 
 
null 
A 
 
a 
129S8 
 
b 
BALB/c 
 
d 
CBA/Ca 
 
k 
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Figure 1 3G7 Hybridoma cells are restricted to MHCII haplotype H2b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In vitro determination of hybridoma responses upon co-culture with splenocytes of diverse 
MHCII haplotypes for 18-hours. 
(a) Responsiveness of the 3G7 hybridoma cell line, as measured by CD69 induction. 
Numbering denotes the percentages of cells determined as CD69+, where percentage less than 
5% are not marked (b) or fluorescence quantitation of AlamarBlue, representing relative 
concentrations of IL-2 produced by 3G7 hybridoma cells, where the dashed line represents un 
stimulated control cells. (The statistical significance was compared between non-responding cell 
and responding cells and was p=0.001 in both instances) 
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In unimmunized mice the majority of MHCII molecules are filled with endogenous/ 
self-peptides. It was intuitive to think, especially considering the Treg origin of the 
receptor, that the TCR was recognising a self-derived peptide presented by the 
APCs. However, it was also plausible that the TCR could be recognising 
exogenous peptides derived from the culture conditions, which may also be 
presented by the APCs. To verify the degree of self-reactivity of the TCR, 
hybridoma cells were co-cultured with ex vivo B cells or peritoneal macrophages in 
Protein-Free Hybridoma Medium (PFHM). We reasoned that the usage of PFHM, 
would restrict presentation to endogenously derived peptides only (Figure 2a). For 
comparison, we used another hybridoma, the H5 (Figure 2b). The H5 TCR was 
originally templated from a conventional CD4 T cell, and is specific for a F-MLV 
envelope derived peptide (env122-141). In contrast to the H5, which remained 
unresponsive to co-culture in the absence of exogenous env122-141 peptide, 3G7 
hybridoma activated in the presence of both ex vivo B cells and peritoneal 
macrophages. 3G7 hybridoma activation, in the presence of both cell types, and in 
the absence of serum components, suggested that the TCR was recognising a self-
derived peptide. In addition, levels of CD69 induced in the 3G7 co-cultures were 
comparable to those exhibited by the H5 hybridoma cells when responding to their 
cognate peptide, advocating bona fide T cell activation (rather than tonic signalling) 
in the 3G7 cultures.  
 
Interesting, 3G7 hybridoma cells were even more strongly reactive to the same 
APCs when cultured in media supplemented with Foetal Calf Serum (FCS) or in the 
presence of Bovine Serum Albumin supplement (BSA) (Figure 2c). Whilst this 
could suggest cross-reactivity of the 3G7 TCR to epitopes conserved between BSA 
and FCS, it was also plausible that these proteins may be indirectly facilitating 
activation. This was hard to decipher, as although the activated H5 hybridoma 
showed a preference for FCS containing media (increasing activation by 
approximately 10%), activation was not affected by the addition of BSA alone 
(Figure 2d). This potential cross-reactivity of 3G7 TCR to a serum component 
hindered further analysis of its fine specificity in vitro. Nevertheless, the strong 
reaction of 3G7 hybridoma cells to peritoneal macrophages or B cells in the 
complete absence of exogenously derived peptides confirmed the self-reactive 
nature of this TCR. 
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Figure 2 3G7 and H5 reactivity towards self or foreign-antigens. 
 
 
 
 
(a) Responsiveness of 3G7 T cell hybridoma cells, as measured by CD69 induction, either 
alone or upon 18-hours of co-culture with C57BL/6 ex vivo peritoneal macrophages or splenic B 
cells. (b) Responsiveness of H5 hybridoma cells, as measured by CD69 induction, either alone 
or upon 18-hours of co-culture with C57BL/6 peritoneal macrophages or splenic B cells and in 
the presence of absence of cognate 10-5 M env122–141 peptide. (c) Responsiveness of 3G7 T cell 
hybridoma cells, as measured by CD69 induction, either alone or upon 18-hours of co-culture 
with C57BL/6 peritoneal macrophages or splenic B cells in the presence or absence of the 
serum components bovine serum albumin (BSA) or foetal calf serum (FCS). (d) 
Responsiveness of H5 T cell hybridoma cells, as measured by the frequency of cells inducing 
CD69 expression, either alone or upon 18-hours of co-culture with C57BL/6 peritoneal 
macrophages or splenic B cells in the presence cognate env122–141 peptide and in the presence 
or absence of serum components. 
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3.3 Characterisation of the 3G7 TCRαβ Treg transgenic mice. 
Two Treg TCRαβ transgenic founder lines, expressing the same 3G7 TCR 
transgenes were generated and backcrossed to the C57BL/6 background. In these 
mice the presence of functional copies of the recombinase activating genes also 
allowed for expression of endogenous TCR chains. To limit TCR expression to the 
transgenes alone, 3G7 mice were subsequently backcrossed onto the Rag1-/- 
background precluding endogenous TCR rearrangements (3G7A/B Rag1-/-). This 
allowed us to study the role of expressing a Treg derived TCR in firstly a semi-
polyclonal system and secondly in a strictly monoclonal setting. 
3.3.1 T cell development in 3G7 TCRαβ transgenic mice. 
The 3G7 TCRαβ transgenic strains A and B, were analysed in terms of T cell 
development. Typical gating for flow cytometric analysis of lymphocytes is shown 
for WT mice, in direct comparison to Tg mice analysed. Total numbers of each cell 
type were calculated from their observed frequencies, as ascertained by flow 
cytometric analysis, multiplied by total cell counts.  
 
Analysis of spleens revealed similar overall cellularity between mice, however 
closer characterisation of the CD4 compartment revealed that pronounced 
differences existed between all the three cohorts of mice (Figure 3a-c). In 3G7A 
mice, as may have been predicted when utilising a TCR originally derived from a 
CD4 T cell, total CD4 T cell numbers were increased at the expense of CD8 T cells. 
This increase, was primarily driven by an expanded naïve T cell compartment, as 
absolute numbers of memory CD4 T cells and Treg T cells were comparable to 
those observed in WT control mice (Figure 3c). Perhaps, this was an early 
indication that this TCR, at least expressed in the 3G7A mice, was more conducive 
with naïve CD4 T cell development rather than memory or Treg T cell development.  
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Figure 3 Characterisation of lymphocyte development in 3G7 TCRαβ Treg 
transgenic mice. 
 
 
 
 
(a) Flow cytometric example of the gating applied to define splenic lymphocyte populations from 
C57BL/6 or 3G7A and 3G7B TCRαβ Treg transgenic mice. Numbering denotes the 
percentages of cells in each gate (b) Absolute numbers of total splenocytes (b) and naïve 
(CD25-CD44-), memory (CD25-CD44+) and Treg (CD25+CD44-) CD4 T cell subsets. Closed 
symbols are the means (±s.e.m.); open symbols are individual mice; numbers within the graph 
denote the P values accordingly.  
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Contrastingly naïve CD4 T cell numbers, in the context of the 3G7B mouse, were 
significantly reduced as compared to 3G7A comparators and somewhat when 
compared to WT controls (Figure 3c). Considering the apparent auto-reactive 
nature of the 3G7 TCR, we wondered if a decreased naïve T cell compartment in 
3G7B mice could be explained by an increased capacity of the transgenes to divert 
cells to other more differentiated lineages. However, this was not evident at least at 
the population level, as the deficit in naïve CD4 T cells was not recovered by an 
increase in another CD4 T cell compartment. In fact, it would appear that the 
expression of the transgenes in this setting was detrimental to all branches of T cell 
development, although the contribution of endogenous TCR chains must be 
considered in these experiments. 
3.3.2 Expression of the TCRβ transgene in 3G7 TCRαβ CD4 T cells. 
Direct determination of the cell fates associated with the TCR transgenes was 
difficult to access properly thus far, due to the potential contamination of 
endogenous TCR chains to the repertoire. To more directly look at the compatibility 
of the transgenes within different T cell compartments we measured the degree of 
allelic exclusion within CD4 T cells in the Tg mice (Figure 4a-c). In the absence of a 
specific antibody to stain for the TCRVβ1 transgene, we used a panel of antibodies 
capable of staining for up to 75% of all possible endogenous TCRVβ families. 
Considering the efficiency of (TCRβ) allelic exclusion, cells expressing the TCRβ 
transgene should not express any endogenous TCR chains. Hence the estimated 
percentage expression of the transgenes could be extrapolated from the 
percentage expression of endogenous TCRβ chains. In order to do this, we 
calculated the frequency of CD4 T cells not stained by endogenous TCRβ 
antibodies in the 3G7A and 3G7B T cells, in comparison with those observed in WT 
controls, as an estimation of transgene expression. Interestingly, the highest 
percentage of cells expressing the TCRβ transgene was observed in the naïve 
compartments of both 3G7 strains, approximately 95-97% of the total (Fig. 4b). In 
the 3G7A strain, the proportion of CD4 T cells expressing the TCRβ transgene 
progressively decreased to 31% in the memory compartment and to a further 18% 
in the Treg T cell compartment. In contrast, within the 3G7B strain, proportions of 
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cells expressing the TCRβ transgene remained higher at around 55% in both 
memory and Treg T cell compartments. 
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Figure 4 Exclusion of endogenous TCRVβ chains in 3G7 TCRαβ Treg transgenic 
mice. 
 
 
 
 
(a) Expression of endogenous TCRVβ chains in WT, 3G7A and 3G7B TCRαβ Treg transgenic 
mice. Numbering denotes the percentages of cells expressing endogenous TCRVβ chain as 
ascertained by flow cytometric analysis. These TCRVβ chains are used by approximately 75% 
of CD4 T cells in WT mice. (b) The projected percentage expression of the TCR transgenes 
chains in naïve (CD25-CD44-), memory (CD25-CD44+) and Treg (CD25+CD44-) CD4 T cell 
subsets in 3G7A and 3G7B TCRαβ Treg transgenic mice. The sum of measured TCR Vβ 
expression in WT mice was set to 100%, and the expression of endogenous TCRVβ expression 
in 3G7 TCRαβ Treg transgenic CD4 T cells was then projected accordingly. Bars on the graphs 
plot the means; open symbols are individual mice (c) Level of TCRβ chain expression in CD4 T 
cells from 3G7 TCRαβ Treg transgenic mice as compared to WT mice. 
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3.3.3 Expression of the TCR 
Perhaps it was not surprising, considering how the random integration of 
transgenes can effect TCR expression levels, that such diverse phenotypes existed 
between the two founder lines. Here, even small differences in the levels of a TCR 
with intrinsically strong signalling capacity could have large consequences on 
cellular fate and selection. We therefore wondered, if indeed differing levels of TCR 
expression between the founder stains could explain the phenotypic differences 
observed.  
 
TCR expression levels on CD4 T cells was accessed via the intensity of TCRβ 
chain staining in 3G7A and 3G7B CD4 T cells as compared to physiological levels 
as set by WT controls (Figure 4c). Importantly, 3G7A T cells expressed only half of 
WT TCR levels, whilst 3G7B T cells were nearer to 90% of WT TCR levels. Higher 
levels of TCR expression would clearly increase the signalling potential of the TCR 
in the setting of the 3G7B mice. Increased TCR signalling capacity may result in an 
increased propensity for clones to be negatively selected in the thymus, perhaps 
explaining the capping of naïve T cell numbers observed in the periphery of 3G7B 
mice (Figure 3b). As well as negative selection, higher levels of TCR signalling 
during development could also potentially lead to the enrichment of CD4 subsets 
compatible with higher signalling thresholds. This could perhaps explain the higher 
usage of the transgenes, within the more differentiated CD4 T cell subsets 
observed within 3G7B mice compared to 3G7A mice. Of particular interest to us 
was the increased frequency of Treg T cells expressing the TCRβ transgenes, in 
3G7B mice as compared to 3G7A mice (56% and 18% respectively). This was 
perhaps suggestive that the quality of TCR signal strength was important in the 
commitment decision towards the Treg T cell lineage. 
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3.4 Characterisation of 3G7 Rag1-/- TCRαβ Treg transgenic 
mice. 
To prevent the confounding effects of the expression of endogenous TCR chains, 
the 3G7 mice were crossed onto a Rag1-/- background (3G7 Rag1-/-). This 
prevented TCR recombination within endogenous TCR chains, establishing a 
monoclonal population of T cells bearing the 3G7 TCR. 
3.4.1 T cell development 
Using 3G7 monoclonal mice we next examined how the expression of the 3G7 
Treg-derived TCR, either expressed at 50% or 90% of WT levels, effected T cell 
development. The thymi from 3G7A Rag1-/-, 3G7B Rag1-/- and WT mice were 
harvested and analysed to study T cell development. Flow cytometric gating (as 
depicted) was used to characterise discrete stages in T cell development (Figure 
5a). 
 
Thymic cellularity in both 3G7A Rag1-/- and 3G7B Rag1-/- was significantly 
decreased in comparison to WT controls (Figure 5b). However, as CD4/CD8 fate 
commitment was heavily biased towards the CD4 lineage, with the thymus almost 
exclusively devoid of single-positive (SP) CD8 thymocytes, overall numbers of SP 
CD4 thymocytes were comparable to WT controls. 
 
Notably, although CD4 T cell development proceeded normally in 3G7A Rag1-/- 
mice, it was considerably perturbed when the same TCR was expressed at higher 
levels in the 3G7B Rag1-/- mice. Indeed, although total numbers of SP CD4 
numbers were normal in the 3G7B Rag1-/- mice, the expression pattern of key 
markers on the developing thymocytes indicated a severe problem with 
development (as will be discussed).  
 
In accordance with T cell development: the proportion of DN (CD4-CD8-) 
thymocytes in 3G7A Rag1-/- mice was equivalent to that in the WT, whereas it was 
largely increased in the 3G7B Rag1-/- mice. Subsequently the percentage of double 
positive DP (CD4+CD8+) was largely decreased in 3G7B Rag1-/- mice and only 
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mildly so in the 3G7A Rag1-/-. This seemed to be symptomatic of a partial block in 
the transitioning of cells from the double negative DN to DP stage. As this 
phenotype seemed to titrate with expression levels of the TCR, it was likely a result 
of heightened and premature signalling by the TCR.  
 
Selection of SP CD4 cells occurred in both the strains, however the higher 
expression of the TCR in 3G7B Rag1-/- mice continued to result in abnormalities. 
Firstly, expression of CD4 was progressively down modulated during lineage 
commitment in the B strain (Figure 6a). This seemed to suggest that thymocytes 
might be actively adjusting levels of co-stimulatory molecules in an attempt to 
dampen overall TCR signalling. Consistent with this the levels of CD5, a marker of 
TCR signalling, were heavily distorted in 3G7B Rag1-/- thymocytes compared to 
3G7A thymocytes (Figure 6c). In addition, CD25 expression was also significantly 
perturbed again only in the context of the 3G7B Rag1-/- mice (Figure 5a). These 
were likely additional mechanisms employed by developing cells to further curb 
TCR signalling, presumably in an attempt to evade negative selection. 
 
Reassuringly, high levels of CD5 in both 3G7 Rag1-/- strains, compared to WT 
thymocytes seemed to validate the highly self-reactive nature of this TCR (Figure 
6b). Despite this, staining for Foxp3 and CD25 revealed the complete absence of 
tTreg cell development in the thymi of these mice (Figure 5a). 
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Figure 5 Characterisation of thymocyte development in monoclonal 3G7 TCRαβ 
Treg transgenic mice 
 
(a) Flow cytometric analysis of thymocyte development in WT, 3G7A Rag1-/-and 3G7B Rag1-/- 
TCRαβ Treg transgenic mice. Numbering denotes the percentages of cells within each gate. (b) 
Absolute number of total thymocytes, CD4 single-positive and CD8 single-positive thymocytes 
in the same mice as in a. Closed symbols are the means (±s.e.m.); open symbols are individual 
mice; numbers within the graph denote the P values accordingly.  
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Figure 6 Perturbed thymocyte development in monoclonal 3G7 TCRαβ Treg 
transgenic mice. 
 
 
 
 
 
 
 
 
(a) Flow cytometric example of CD4 lineage commitment during thymocyte development in WT, 
3G7A Rag1-/-and 3G7B Rag1-/- TCRαβ Treg transgenic mice. (b) CD5 levels in CD4 single-
positive thymocytes from the same mice as in a. (c) CD5 levels in 3G7B Rag1-/- 
(TCRβhighCD4high) or (TCRβhighCD4low) thymocytes. 
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3.4.2 Peripheral T cells 
We used flow cytometric analysis to look at the peripheral T cell phenotype in the 
spleens of 3G7A Rag1-/- and 3G7B Rag1-/-mice (Figure 7). Overall spleen cellularity 
was much reduced in mice deficient in Rag1 as is widely reported (Figure 7b). 3G7 
Rag1-/- mice were devoid of any mature CD8 T cells, as would have been predicted 
by their absence from the thymus. Profiling of the CD4 T cell populations in these 
mice showed 3G7 Rag1-/- T cells to be mostly naïve in phenotype, and at 
comparable numbers to WT controls (Figure 7a-c). Analysis of Foxp3 and CD25 
expression showed mice to be devoid of Treg T cells in the periphery of these mice, 
as was the case in the thymus. In addition, and consistent with the thymic 
phenotype observed in the 3G7B Rag1-/- mice, CD4 expression was particularly 
heterogeneous in these cells compared to its homogenous expression in WT 
control or 3G7A Rag1-/- T cells (Figure 7d). 
 
These results suggested that comparatively higher expression levels of the 3G7 
TCR in the B strain led to negative selection of an increased proportion of 
developing T cells, as well as varying degrees of CD4 down-regulation in the 
remaining T cells; whereas lower expression of the 3G7 TCR in the A strain had 
little apparent effect. Neither strain however generated Treg T cells. 
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Figure 7  Lymphocyte development in monoclonal 3G7 TCRαβ Treg transgenic 
mice. 
 
 
 
 
 
 
 
(a) Flow cytometric analysis of splenic CD4 subsets in WT, 3G7A Rag1-/-and 3G7B Rag1-/- 
TCRαβ Treg transgenic mice. Numbering denotes the percentages of cells within each gate (b) 
Absolute numbers of total splenocytes (c) and naïve (CD25-CD44-), memory (CD25-CD44+) and 
Treg (CD25+CD44-) CD4 T cell subsets in the same mice as in a. (d) Expression levels of CD4 
on CD4 T cells from mice as described in a. Closed symbols are the means (±s.e.m.); open 
symbols are individual mice; numbers within the graph denote the P values accordingly. (d) 
CD4 levels in CD4 splenic T cells in the same mice as in a.  
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3.5 Effect of precursor frequency of TCRαβ Treg Tg cells on 
Treg development. 
Aware that competition among a clonal repertoire may limit the ability of any 
receptor to give rise to Treg T cells, we next adjusted the precursor frequency of 
3G7 progenitor cells to more-physiological levels; in an attempt to reduce 
intraclonal competition (Bautista et al., 2009, Leung et al., 2009). 
3.5.1 Treg potential was evident in polyclonal control T cells but not from 
3G7, even at adjusted precursor frequencies. 
Mixed bone marrow chimeras were generated whereby 3G7 Rag1-/- bone marrow 
was diluted by allotypically-marked WT bone marrow. Mixed bone marrow 
suspensions were then injected into T cell deficient (TCRα-/-) hosts. Upon 
identification of CD4 T cells in the peripheral blood of recipient mice, mice were 
culled and flow cytometry was used to look for Treg development from within the 
different donor populations (Fig. 8a-c). In both sets of data for 3G7A Rag1-/- or 
3G7B Rag1-/- strains, we saw that reconstitution was successful with a titration of 
the 3G7 progeny according to the input ratio (10%, 5% or 1%) (Figure 8a). In 
addition, we observed that 3G7A Rag-/- reconstitution was more complete than in 
3G7B Rag1-/-, consistent with the propensity for negative selection in the latter. 
Although Treg T cells were present in all recipients, they were exclusively of WT 
origin (Figure 8b-c). Thus, even when environmental and competitive settings were 
adjusted to allow for Treg T cell development, the 3G7 TCR was still not instructive 
for Treg T cell selection. 
 
  
Chapter 3 Results 
 
85 
 
Figure 8 Treg-TCR potential is not restored upon adjusted precursor frequencies 
 
3G7 Rag1-/- TCRαβ Treg transgenic bone marrow was mixed with congenically marked WT 
bone marrow at various ratios (10%, 5%,1%) and injected into T cell deficient hosts (TCRα-/-). 
Recipient mixed were analyzed 8 weeks following bone marrow transfer (a) Flow cytometric 
analysis showing the relative proportions of 3G7A Rag1-/- CD4 T cells from mixed bone marrow 
chimeras when seeded at various input ratios (10%, 5%,1%). Numbers denote the starting input 
percentages of 3G7A Rag1-/-  bone marrow (b) Flow cytometric analysis of Treg T cell 
development from WT, 3G7A Rag1-/- or 3G7B Rag1-/- donor derived bone marrow within 
individual recipients. (c) Graphs depict the ratio of 3G7 Rag1-/-: WT bone marrow versus the 
frequency of Foxp3 Treg cells generations. Closed symbols are the means (±s.e.m.); open 
symbols are individual mice. (P=>0.001 between WT and 3G7 Rag1-/- conditions  
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3.6 Exploring Treg potential  
For completeness we wanted to study if 3G7 primary T cells responded atypically 
upon in vitro activation. It remained a possibility that the Treg derived TCR, 
although not instructive for thymic Treg T cell development, may still be instructive 
for the acquisition of this cell fate following T cell activation. To study the magnitude 
of the response we quantified CD69 induction and CFSE dilution at various time 
points following 3G7 T cell activation. To profile the quality of effector cell 
differentiation within the same cells, we also measured cytokine production and 
Foxp3 expression 3-4 days following T cell activation. For comparison we used WT 
primary T cells activated with CD3/CD28 in vitro. 
3.6.1 Spontaneous activation of 3G7 T cells in vitro 
In contrary to the evidence for the auto-reactive nature of the 3G7 TCR, peripheral 
T cells in 3G7 mice remained wholly naïve in phenotype. However, we observed 
that upon culturing single cell suspensions from the spleens of 3G7 mice in vitro, T 
cells would now spontaneously activate (Figure 9a). The levels of CD69 on 3G7 
CD4 T cells from these splenic cultures mirrored those levels expressed by 3G7 
CD4 T cells activated in the presence of CD3/CD28 beads, and thus was in 
accordance with authentic activation. In addition, CFSE dilution peaks showed 3G7 
T cells went on to actively proliferate. Expectedly, this spontaneous activation was 
not supported in single cell suspensions from WT mice, suggesting this was a 
property unique to the 3G7 TCR.  
 
In order to limit responses observed to those mediated by the 3G7 TCR/T cells 
alone we next plated single-cell-spleen suspensions from 3G7 Rag1-/- splenocytes. 
Although notably devoid of any B cells these cultures were also able to support 
spontaneous activation, however activation was further increased when cultures 
were supplemented with WT B cells (Figure 9b). This transition from the naïve state 
seen in vivo to full activation in vitro seemed to result from the mechanical 
disruption of the splenic architecture that would normally segregate T cells from 
APCs during homeostasis. Presumably, forcing interactions between these cell 
types, through the disruption of their spatially distinct niches, lead to T cell 
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activation in vitro. Although, here the role of exogenous ligands introduced as a 
consequence of culture conditions cannot be entirely eliminated. 
 
Irrespective of the ligand, the functional consequence of 3G7 activation on effector 
differentiation could be accessed via cytokine production and Foxp3 expression on 
day 4 following T cell activation (Figure 9c-d). However, percentages of cells 
producing IL-2 and IFN-gamma were not statistically different between activated 
WT or 3G7 Rag1-/- T cell cultures, whilst the percentage of Foxp3, CD25high cells 
was actually statistically lower in 3G7 Rag1-/- cultures. Thus activated 3G7 T cells, 
either via self-recognition or via CD3 stimulation, did not seem to behave atypically 
and displayed no bias in differentiation towards the Treg lineage.  
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Figure 9 Spontaneous activation of 3G7 TCRαβ Treg transgenic primary T cells 
in vitro 
 
Flow cytometric analysis of (a) Responsiveness of 3G7 or WT spleen suspensions, following 1 
or 4 days in culture either alone or in response to CD3-CD28 stimulation (as measured by CD69 
induction or CFSE dilution respectively) (b) Responsiveness of spleen suspension from 3G7 
monoclonal mice or WT mice, as measured by the frequency of cells inducing CD69 expression 
after 18 hours, when cultured alone or with purified WT splenic B cells (B220+) or following 
CD3-CD28 stimulation. Numbers denotes the percentage of cells which are deemed CD69positive 
or CFSE- (with percentages less than 5% not being annotated) (c) Flow cytometric detection of 
intranuclear or intracellular staining of Foxp3, IFN-gamma or IL-2 in cells following 3 days of 
activation as described in b. (d) Graphs depict the percentage of CD4 T cells expressing Foxp3, 
IFN-gamma and IL2 from 3G7 monoclonal or WT spleen suspension following 3 days of 
activation in vitro. Closed symbols are the means (±s.e.m.) 
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Discussion 
Treg T cell development had not been observed in conventional TCR transgenic 
mice. This was an early indication that TCR specificity maybe crucial for thymic 
Treg T cell development. Critically, Treg T cell development could be restored in 
conventional TCR Tg mice when cognate antigen was expressed via a second 
transgene which emulated the expression of self-peptides. This suggested that 
increased specificity to self-derived-antigen was a crucial determinant for Treg T 
cell selection. Considering this, we decided to explore the effect of expressing a 
Treg TCR on Treg T cell development in two TCRαβ Tg mice. Although the TCR 
sequences were identical between the two strains, TCR avidities were different 
(high or low) as a consequence of differing TCR expression levels. Using 3G7 
hybridoma cells we were primarily able to confirm the auto-reactive nature of this 
Treg derived receptor. Thus, without the need to decipher the 3G7 TCR specificity 
or having to introduce antigen via a second transgene, we used the differing levels 
of TCR expression levels exhibited between the transgenic strains, to manipulate 
the quality of TCR signalling received. This gave us a model to look at the 
instructive capacity of both TCR specificity and TCR avidity in Treg T cell 
commitment. 
  
However, despite the Treg origin of 3G7 TCR, neither of the TCRαβ Tg strains 
generated Treg T cells. As stated, differing levels of surface TCR between the 
strains allowed us to look at a spectrum of signalling potential from the 3G7 TCR. 
These results suggested that the higher levels of TCR signalling in 3G7B mice led 
to increased negative selection and advanced CD4 down regulation rather than 
being instructive towards the Treg T cell lineage. Noticeably, even when TCR 
signalling was intrinsically tuned down in 3G7B thymocytes, and thus the quality of 
the signalling broadened, this did not allow for a window of signalling opportunity 
which was instructive for Treg cell development. Lower expression of the 3G7 TCR 
in the A strain carried with it minimal deleterious consequence in terms of CD4 
development however nor did it lead to Treg T cell development. Previously, 
groups had attempted to produce monoclonal Treg TCR transgenic mice, with only 
the minority of receptors giving rise to Treg T cells. Further investigation associated 
the lack of Treg T cell development to the artificiality of using a monoclonal system 
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rather than a failing associated with the encoded TCRs, whereby the observed low 
frequency of Foxp3 cells in these settings was suggested to be a result of clonal 
competition. In these studies, the instructive capacity of a given Treg TCR could be 
visualised once the precursor frequency of these receptors was adjusted to more 
physiological levels. However, adjusting the clonal frequency of transgenic T cells 
in our system did not restore the instructive capacity of the 3G7 TCR for the Treg T 
cell lineage. Therefore, our data would suggest that not all Treg TCR Tg models 
can be manipulated to recapitulate tTreg development. We can conclude that 
although Treg T cell development may indeed include a ‘TCR instructive’ step, the 
specificity of the TCR alone is not enough to prescribe for the Treg lineage.  
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Chapter 4. A role for self-reactivity in CD4 T cell 
responses to foreign-antigens 
4.1 Introduction 
It is now understood that the TCR repertoire is broadly self-reactive. In the 
periphery, naïve T cell survival requires IL-7 signaling and spMHCII recognition (as 
discussed previously). However, interactions made between different TCRs and 
spMHCII molecules in the periphery are not equal, with some clonotypes seeing 
self-antigens better than others. This has lead to an increasing interest in 
determining if sub-threshold TCR signaling events play a role beyond just 
homeostatic maintainence and survival. 
4.1.1 Clonotypic selection and Avidity 
As a result of antigenic challenge, T cells undergo activation initiated by specific 
interactions made between their TCRs and pMHCII molecules on APCs. As 
described earlier, these interactions drive the clonal expansion of specific 
clonotypes that are able to recognise the given pathogen. During the acute phase 
of an immune response, the strength of TCR signalling seems to be the major 
determinant in clonal selection and features the outgrowth of the highest avidity 
clones. This bias allows for avidity maturation, at least at the population level, 
despite the fact that individual TCRs are fixed (Busch and Pamer, 1999). Following 
the peak of infection, a large proportion of the responding population die by 
apoptosis leaving behind a much smaller pool of T cells. What controls the 
clonotypic composition of this remaining population remains somewhat of an 
unknown and although there is evidence for the continued selective expansion of 
the highest avidity clones there is also evidence for the extensive reshaping of the 
TCR repertoire. Understanding which clonotypes persist and why remains a 
complex but fundamental question in T cell immunology. Here we will consider a 
role for self-reactivity in the clonotypic selection of CD4 T cell immune responses. 
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4.1.2 A role for self-reactivity in dictating reactivity to cognate antigen 
The specificity and sensitivity of a T cells TCR is vital for its role in immune 
responses. Although the generated of the TCR repertoire is based around the 
recognition of self-antigens, the main purpose of the TCR repertoire is to recognise 
foreign-antigens. At first this strategy of selection appeared to be highly counter-
intuitive, however recently we have started to understand the relevance of self-
antigens in dictating T cell responses to foreign-antigens.  
 
It is firstly important to recognise the highly cross-reactive nature of the TCR; where 
one TCR can recognise many different antigens, sometimes even simultaneously. 
In fact, studies have been able to visualise the recruitment and accumulation of 
self-antigen at the immunological synapse, during responses to foreign antigen 
(Wulfing et al., 2002, Irvine et al., 2002). In such scenarios, recognition of self-
antigens in concert with the recognition of foreign-antigens has been suggested to 
provide a unique mechanism to increase the intrinsic sensitivity of a T cell and the 
likelihood of subsequent activation. This could theoretically occur in multiple ways: 
Firstly, the binding of TCRs to spMHCII (in conjunction to pMHCII) may act to 
structurally stabilise the partnership between a T cell and an APC, leading to a 
better quality interaction. In addition, spMHCII interactions may help to increase the 
recruitment of TCR signalling molecules to the synapse, something that may be 
particularly beneficial when foreign antigen is limiting. Thus the physical 
accumulation of self-antigen to the SMAC presents at least one mechanism of how 
self-peptide may contribute to T cell activation especially in scenarios where foreign 
antigen may be sparce (Krogsgaard et al., 2007). 
 
In other cases, recognition of self (prior to antigen encounter) may act to increase 
TCR sensitivity to future antigens. Here high avidity interactions with self-antigen 
during thymic selection or in the periphery, may maintain the TCR signalling 
components in a state of partial phosphorylation (Stefanova et al., 2002, Persaud 
et al., 2014). In this regard, low level basal signalling achieved through self-
recognition may act to polarize the downstream components of the TCR signalling 
pathways toward a state of responsiveness which would allow for increased TCR 
sensitivity upon TCR triggering (Mandl et al., 2013). Recently, evidence for such a 
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role for spMHCII mediated interactions has been confirmed both in vitro and in vivo 
and by multiple laboratories. Briefly, experiments that cultured naïve T cells for set 
periods of time in vitro, and in the absence of MHCII contacts, demonstrated the 
rapid loss of pre-existing partial TCR ζ-chain phosphorylation or Erk 
phosphorylation, associated with an overall decrease in sensitivity (Stefanova et al., 
2002, Persaud et al., 2014). A role for spMHCII in the modification of the TCR 
signaling components was also confirmed in vivo through the administration of a 
monoclonal antibodies blocking MHCII (Stefanova et al., 2002) or via the transfer of 
CD4 T cells into MHCII deficient host (Smith et al., 2001, Kassiotis et al., 2003); 
both of which resulted in a decrease in T cell sensitivity at the population level. 
Thus T cells with enhanced capacity to recognise self, may be poised to respond 
with greater sensitivity upon antigen recognition (Persaud et al., 2014). In this way 
positive selection can be viewed as a mechanism that selects for T cells that will 
continue to see ‘self’ in a biologically meaningful and advantageous way once in 
the periphery (Vrisekoop et al., 2014). Sufficient levels of signalling as a 
consequence of self-antigen recognition may also partially influence the 
differentiation state of a CD4 T cell, leading to the acquisition of a more 
differentiated phenotype. The most obvious example of this is the Treg T cell, 
which assumes an ‘antigen experienced’ state in the absence of exposure to 
foreign antigen but instead as a consequence self-antigen-recognition. 
 
Another hypothesis is that T cells capable of recognising self to a sufficient degree 
may recognise foreign antigen similarly well (Mandl et al., 2013). In this way 
positive selection may provide a mechanism to select for TCRs with intrinsic 
capacity to recognise antigen broadly, and thus self-reactivity may correlate with 
antigen-reactivity (Stefanova et al., 2002). Although structural data (which could be 
used to conclusively confirm such a hypothesis) does not yet exist, functional 
studies have highlighted a direct relationship between the cells of the highest 
avidity in terms of selection in the thymus, and those cells that are the highest 
avidity clones during acute responses to foreign-antigen (Mandl et al., 2013). Here 
CD4 T cell clones, that exhibited TCR signalling at the upper end of the spectrum 
during selection, contributed most greatly during responses to infection. 
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4.1.2.1  A role for self-reactivity in memory formation 
One model for memory formation, suggests that TCR clonotypes are selected to 
form memory based on TCR avidity for foreign antigen (Mandl and Germain, 2014). 
However more recently another model for memory formation has been proposed, 
suggesting that the capacity to become a memory T cell is determined prior to the 
onset of the response. Here naïve CD4 T cells were sorted according to their levels 
of self-reactivity and then high versus low (self-reactive) cells were competed 
against each other in response to infection (Mandl et al., 2013). This study 
highlighted clonotypes that were most self-reactive contributed to a greater extent, 
than clonotypes comparatively lower in self-reactivity to the memory T cell pool. 
4.1.3 Measuring self-reactivity  
A single TCR has the potential to recognise many different, un-characterised self-
peptides. In addition, these interactions are typically of low avidity as otherwise 
they would fuel autoimmunity. This means that we can rarely directly measure the 
quality (or self-reactivity) of TCR-spMHCII interactions. Instead surrogate markers 
of self-reactivity have conventionally been employed to provide a read-out for the 
inferred self-reactive nature of a T cell clone. Perhaps the best described of these 
markers is CD5. A more comprehensive overview of such markers and their uses is 
described in 4.3. 
 
4.2 Aims 
The TCR is critical in determining the future of a T cell, but how and to what extent 
is still not fully understood. Although TCR specificity to self-antigen is well studied 
during thymic development, conventionally CD4 T cell differentiation has become 
more directly associated with exogenous antigen recognition. In this regard, TCR 
specificity, the strength and duration of this signaling, as well as the cytokine 
environment have been shown to collaborate in determining different CD4 T cell 
fates. However, such interactions between a TCR and its foreign cognate ligand 
are extremely rare. Instead the vast majority of TCR engagements are with self-
peptides. Whilst most work has centered on establishing the fundamental role of 
self-recognition during T cell development, much less has focused on a role for 
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self-reactivity in the periphery. Given the fundamental role of the strength of TCR 
signaling to foreign peptide in determining cell fate decisions, we aimed to elucidate 
how recognition of self-peptides may influence future CD4 T cell responses. 
4.3 Results 
4.3.1 EF4.1 FV infection model  
Here, we used a well-characterized model to study the factors that are involved in 
the evolution of the CD4 T cell response to retroviral infection. We used infection of 
C57BL/6 (B6) mice with Friend virus (FV), a retroviral complex of Friend murine 
leukemia virus (F-MLV) and spleen focus-forming virus (SFFV), to achieve a 
protracted infection that is eventually cleared. Due to the limiting precursor 
frequencies of FV reactive T cells that exist within a polyclonal repertoire, an in-
house TCRβ-transgenic strain (EF4.1) was used as a source of virus-specific CD4 
T cells. Adoptive transfer of purified EF4.1 CD4 T cells, into host mice at the time of 
infection allowed us to track and study CD4 T cell responses to FV infection.  
4.3.2 Functional avidity of Vα2 and Vα3 in vitro. 
The association of the Vβ1 Tg TCRβ chain with endogenous TCRα chains in EF4.1 
T cells generates a semi-polyclonal repertoire, enriched for TCR clonotypes 
reactive with the F-MLV env122-141 epitope (Antunes et al., 2008). In vitro peptide 
stimulation of EF4.1 T cells with env122-141, revealed a multiclonal virus-specific 
population. Collectively, the responding population made up ~4% of total EF4.1 
CD4 T cells (Figure 10a). Responding T cell clones could be sub-categorized into 
two families, according to their usage of TCRα chains; with T cells either 
expressing TCR Vα2 chains (encoded by Trav14 gene segments) or Vα3 chains 
(encoded by Trav9 gene segments). The composition of virus specific T cells within 
the pre-immune repertoire expressing either a Vα2 or Vα3 chain, was 25% or 75% 
respectively (Figure 10a) (Antunes et al., 2008). In vitro activation of EF4.1 T cells 
also revealed that TCRVα usage could segregate T cells in respect to their 
functional avidity. Importantly, the pairing of the Vβ1 transgene with either Vα2 or 
Vα3 chains created clonotypes with higher or lower functional avidity, respectively 
(Figure 10b) (Antunes et al., 2008, Young et al., 2012b).   
Chapter 4 Results 
 
97 
 
Figure 10 TCR Vα usage in env122-141–specific EF4.1 TCRβ-transgenic CD4 T cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Flow cytometric gating showing TCR Vα usage in activated (CD69high) EF4.1 TCRβ 
transgenic CD4 T cells responding following 18 hours stimulation with the 10-5 M env122-141 
peptide. (b) Characterisation of the functional responsiveness of Vα2 or non Vα2 (Vα3) env-
reactive donor T cells following 18 hours of env122–141 peptide stimulation (at varying doses). 
Responses were measured by CD69 induction and are plotted as percentage of maximal 
response. Dashed line indicates 100% of maximal response. Closed symbols are the means 
(±s.e.m.) and are representative of more than 5 independent experiments. 
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4.3.3 Switch between Vα2 and Vα3 families 
As mentioned, in order to unequivocally identify virus-specific CD4 T cells over the 
course of infection, we used an adoptive transfer system where WT mice received 
allotypically marked EF4.1 TCRβ-transgenic CD4 T cells at the time of FV infection 
(Antunes et al., 2008). This system not only allowed us to track the expansion of 
total virus-specific EF4.1 CD4 T cells but also allowed us to assess the relative 
contribution of Vα2 (high avidity cells) or Vα3 (low avidity cells) at different points in 
the response. Here, we used the measured functional avidities as a read-out for a 
T cells avidity. 
 
Following transfer, EF4.1 T cells exhibited typical kinetics, expanding over 200-fold 
during the first 7 days (the peak of infection). Expectedly, this expansion was 
followed by the sharp contraction of the response over the following weeks as virus 
was cleared (Figure 11). As has been previously published, although initially 
outnumbered in the pre-immune repertoire, virus-specific Vα2 T cells 
homogenously dominated during the primary response (Thorborn et al., 2014). This 
saw Vα2 clonotypes climb from ~25% to ~75% in all mice by day 7. This would 
suggest that avidity was a key determinant in shaping the clonotypic hierarchy 
within the primary response, but what happens past the peak was not known. Here, 
we followed the ensuing response and found, that on average the frequency of Vα2 
clonotypes progressively declined, although this was wildly variable between 
individual hosts (Fig. 11). Nevertheless, the clear evolution of the CD4 T cell 
repertoire suggested that distinct forces existed for the recruitment of clonotypes 
into primary or memory responses. 
 
 
 
 
 
 
 
 
  
Chapter 4 Results 
 
99 
 
Figure 11 Evolution of the Vα virus-specific CD4 T cell response over the course 
of FV infection 
 
 
 
 
 
(a) Absolute numbers and (b) Vα composition of env-reactive donor EF4.1 CD4 T cells in the 
spleens of recipient mice after adoptive T cell adoptive transfer and FV infection Closed 
symbols are the means (±s.e.m.); open symbols are individual mice; n=9–61 mice per time 
point; P<0.001 between Vα2 frequency on day 7 and any later time point, Mann–Whitney rank 
sum test. 
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Dominance of a high avidity Vα2 clones at the peak of infection seemed to agree 
with the clonal selection theory, whereby the T cells receiving the highest TCR 
signalling would proliferate the most, outcompeting the rest. However, the late 
dominance of lower avidity Vα3 clones, in most of the mice, was harder to 
rationalise. Although our data, measuring the functional responsiveness of EF4.1 T 
cells, had suggested that Vα3 F-MLV reactive clones were of lower avidity than 
Vα2 clones, this was limited to behavior observed in bulk Vα2 and Vα3 populations 
in vitro. It was important to consider that within these families there existed the 
potentially for much diversity. It was also possible that clonotypes activated under 
in vitro conditions may be distinct from those that are recruited in vivo. We 
therefore wanted to look at the behaviour of individual clonotypes that were 
responsible for driving the responses observed in vivo.  
4.3.4 Diversity of virus-specific T cell clonotypes increases over time. 
To examine whether the observed changes in clonotypic composition were indeed 
caused by differences in TCR reactivity between responding CD4 T cells, we first 
identified the frequency of unique TCR clonotypes. This was achieved via the deep 
sequencing of the endogenous TCRα chains in virus-specific EF4.1 CD4 T cells, 
followed by bioinformatics analysis. Exclusive usage of the Vβ1 transgene, by all 
virus-specific T cells allowed for TCRα sequencing to be sufficient to determine the 
identity of the TCR clones. In addition, to validate that the observed changes were 
not the result of the expression of a second TCR by responding clones we used 
EF4.1 TCRα-/- mice as donors for T cell transfer and sequencing. Other members 
of the lab jointly collaborated to do this work. 
 
For determination of the pre-immune repertoires, a cohort of naïve CD4 T cells 
from the respective EF4.1 donor mice used were purified and processed. Following 
which, the remaining EF4.1 CD4 T cells were transferred into mice on the same 
day as being infected with FV. Then at different time points following FV infection, 
activated donor EF4.1 CD4 T cells (CD4+CD45.2+CD44+) were sorted from 
individual hosts. Total RNA was then isolated from these populations, before being 
reverse transcribed into cDNA. Purified cDNA was then used as template for the 
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amplification of Trav14 (encoding Vα2)- or Trav9 (encoding Vα3)-containing 
rearrangements. Due to the diversity exhibited between TCR sequences, primers 
had to be designed toward conserved sequences between the Trav families. To 
this end, forward primers were targeted to Trav promoter regions and reverse 
primers to common Trac constant regions. This resulted in a PCR product of 
approximately 500bp in length, following which these amplicons could then be 
sequenced using 454 sequencing.  
 
454 sequencing can process comparatively longer reads than Illumina sequencing. 
This allowed for the sequencing of the full PCR product (representative of a single 
TCR), without the need for its fragmentation. Firstly, adaptor sequences were 
added to each end of the PCR product. Addition of such adaptors targeted the PCR 
product to associate with ‘capture’ beads, themselves coated with complementary 
adaptor sequences. ‘Bead-capture’ conditions were such to limit the attachment of 
just one DNA strand per bead. Bead-associated DNA strands could then be 
amplified via emulsion PCR guided by primers specific for the protruding adaptor 
sequences. Following this, beads coupled with the amplified product were sorted 
into wells, thus in this way each well would contain information derived from a 
single TCR. TCR sequences could then be determined via pyro sequencing. 
Between 4,500 and 43,000 nucleotide sequences per sample were obtained. 
Nucleotide sequences were then filtered for productive rearrangements. The 
protein sequence was predicted and annotated by the ImMunoGeneTics (IMGT) 
online tool HighV-QUEST. Nucleotide sequences giving rise to identical CDR3s at 
the protein level were classified as clonotypes. Grouping clones into clonotypes of 
conserved amino acid sequences allowed us to trace (identified) clonotypes 
throughout the infection. Considering that TCR repertoires between mice are never 
identical, due of the random nature of TCR recombination, we used two EF4.1 
donors to ask if clonotypes (and their behavior) were conserved (public) or 
exclusive (private) between mice.  
 
Subsequent sequencing of the pre-immune repertoires of donor EF4.1 CD4 T cells 
revealed initial diversity of Vα2 and Vα3 compartments to be comparable (Figure 
12). Analysis of the TCR repertoires at the peak of infection (day 7) revealed that 
the virus-specific Vα2 response was almost exclusively (~90%) dominated by a 
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single clonotype (CDR3 sequence CAAITGNTGKLIF), indicated in red. Notably, 
this Vα2 ‘red’ clonotype was also the single largest clone within the Vα2 pre-
immune repertoire, and was conserved between mice; perhaps indicating an 
increased propensity for this clonotype to be selected and maintained during T cell 
development. Interestingly, the peak of the virus-specific Vα3 response was also 
dominated by a single clonotype, similarly annotated in red due to its corresponding 
behavior (CDR3 sequence CVLSGDYSNNRLTL) (Fig). However, this clonotype 
was less prolific, only comprising ~55% of total Vα3 cells on day 7. This allowed for 
a greater level of diversity within the responding Vα3 repertoire. In addition, and in 
contrast to its Vα2 counterpart, this particular red clonotype was very rare (<0.5%) 
in the pre-immune repertoire.  
 
Past the peak of infection, the substitution of the Vα2 family for the Vα3 family, was 
again evident at the population level. Despite this, the red Vα2 clonotype remained 
high (>60%) within virus-specific Vα2 cells, although this was slightly reduced in 
comparison with its peak due to the emergence of another clonotype (indicated in 
orange). In contrast, the newly dominant Vα3 family was considerably more 
polyclonal, containing distinct sub families of clonotypes. Notably, the virus-specific 
Vα3 response was characterized by the emergence of two new families of 
distinctive behaviors. The first group was comprised of two ‘public’ clonotypes 
(indicated by green colours; CDR3 sequences CALDNTNTGKLTF and 
CALNVGDNSKLIW), which together made up ~10% of all virus-specific Vα3 cells. 
Notably, their frequency remained remarkably consistent throughout the course of 
infection. The second group comprised of multiple clonotypes (indicated by blue-
purple colours), all sharing the same SNNRIFF motif in their CDR3 sequences, 
created by the use of the Traj31 segment. This group contained clonotypes that 
were not always conserved between mice, but collectively increased in frequency 
to 30–50% of the virus-specific Vα3 cells by day 49 of infection. 
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Figure 12 Clonotypic diversity of virus-specific CD4 T cells increases over the 
course of FV infection. 
 
 
 
 
 
 
 
 
 
(a)	 Frequency of various Vα2 and Vα3 clonotypes in total EF4.1 CD4 T cells from two 
uninfected donor mice (pre-immune; donors 1 and 2) or in env-reactive EF4.1 CD4 T cells from 
the spleens of recipient mice after adoptive T  
cell transfer from the indicated donor and FV infection. Each bar graph represents an individual 
mouse. Clonotypes with frequencies <0.5% are not plotted for simplicity. Identical clonotypes 
within Vα2 and Vα3 subsets are marked with the same color, with red color indicating the 
dominant Vα2 and Vα3 clonotypes. The scale of the Vα2 and Vα3 plots are adjusted to the 
relative ratio of the two subsets at a given time point. 
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These findings revealed three distinct types behaviour, which correlated with 
different CDR3 TCR motifs. The first was exemplified by the ‘red’ clonotypes that 
universally dominated the primary response. Importantly clonotypes exhibiting this 
behaviour existed within both the Vα2 and Vα3 populations. The second, 
exemplified by green clones, was unique due to the proportional stability of the 
clones throughout the response. The third was exemplified by the more diverse 
blue clonotypes, which collectively dominated at later time points driving the 
clonotypic switch from the Vα2 family to Vα3 family. Thus, the clonotypic diversity 
of virus-specific EF4.1 CD4 T cell population increased over time owing to the 
decrease in the proportion of initially dominant red clonotypes in conjunction with 
the proportional increase in blue clonotypes from within the Vα3 population. 
Although common motifs within CDR3 regions could be used to discriminate and 
group clonotypes, they could not predict the respective avidities of distinct 
clonotypes. 
4.3.5 Generation of hybridoma cell lines. 
To interrogate differences between clonotypes we measured their functional 
avidities alongside accurate measurements of TCR affinity. To this end, we 
generated multiple hybridoma cell lines representing the three families of 
clonotypes, ‘red’ Vα2, ‘blue’ Vα3 and ‘green’ Vα3 (Figure13). Most of the hybridoma 
clones expressed comparable levels of TCR apart from one of the green 
clonotypes (CDR3 CALDNTNTGKLTF) (Figure 13a). Levels of activation achieved 
following in vitro peptide stimulation at a range of peptide doses, was then used to 
calculate functional avidities and hence infer the relative avidities of the different 
hybridomas cell lines. Reassuringly, different hybridomas from the same family 
behaved almost identically to each other in functional assays, suggesting that they 
were representative of their larger clonotypic families. Furthermore, in vitro 
stimulation of ‘red’ and ‘blue’ hybridomas reproduced the differences in functional 
avidity observed between the bulk EF4.1 env-specific Vα2 and Vα3 populations 
(Figure 13b). Notably the green clonotypes exhibited higher functional avidities 
than other Vα3 clonotypes.  
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Figure 13 Generation and characterisation Vα2 ‘red’, Vα3 ‘blue’ and Vα3 ‘green’ T 
cell hybridoma cell lines. 
 
 
 
 
 
 
 
(a) CDR3 sequences and TCRβ expression levels in newly generated hybridoma cells lines 
representing the indicated Vα2 ‘red’, Vα3 ‘blue’ and Vα3 ‘green’ clonotypes (b) Responsiveness 
of the same hybridoma cells lines as in a to overnight stimulation with varying amounts of 
env122–141 peptide, as measured by CD69 induction. Closed symbols are the means (±s.e.m.) 
and are representative of more than 3 independent experiments. 
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We reasoned that differences in the functional responsiveness of clonotypes, could 
arise from underlying differences in TCR affinity for pMHCII. We decided to explore 
this via the use of MHCII tetramers. MHC tetramer technology was first introduced 
in 1996 as a way to identify antigen-specific T lymphocytes (Altman et al., 1996). 
Tetramers are multimeric structures consisting of fluorescently tagged pMHCII 
molecules. Binding of cognate TCRs to tetramer complexes, allows for the 
detection of specific clones via the identification of fluorescence carried by the 
tetramer complex. In addition to detecting antigen-specific cells, tetramers have 
also been used as a way to measure the strength of TCR-pMHCII interactions, 
where it is assumed that TCRs of high affinity will be more efficient at binding 
tetramer than comparatively lower affinity TCRs. Therefore, we decided to employ 
the use of env-pMHC tetramers, generated by our collaborators, to interrogate the 
affinities of the different hybridoma cell lines, Surprisingly however, the measured 
functional avidity of the clones correlated weakly with binding affinity towards 
cognate antigen, as measured in this way. Indeed, when stained with titrated 
amounts of an Ab-env125-135 tetramer, assuming higher concentrations of tetramers 
are required to measure lower affinity interactions, the apparent affinity of Vα3 ‘blue’ 
clones and Va3 ‘green’ clones was only marginally lower than that of the Vα2 ‘red’ 
clones (Figure 14a-b).  
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Figure 14 Affinity of Vα2 ‘red’, Vα3 ‘blue’ and Vα3 ‘green’ T cell hybridoma cell 
lines. 
 
 
 
 
 
 
(a) CDR3 sequences representing the indicated Vα2 ‘red’, Vα3 ‘blue’ and Vα3 ‘green’ 
clonotypes and the frequency of Ab-env125–135 tetramer-positive cells, at different tetramer 
concentrations, (b) The frequency of Ab-env125–135 tetramer-positive cells, at different tetramer 
concentration, following staining of the three selected hybridoma cells lines (lines or best fit are 
plotted) Closed symbols are the means (±s.e.m.) and are representative of more than 3 
independent experiments. (c)	Effective two-dimensional TCR affinities for Ab-env125–135 of T-cell 
hybridomas as in b measured by the micropipette adhesion frequency assay and normalized by 
TCR surface density. Each individual data point represents the affinity of a single T cell. 
Numbers in the plot represent the effective affinity geometric mean of the population. (n.s) 
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However, although tetramers have been widely used as a correlate of TCR affinity, 
some studies have suggested this correlation to be tenuous or limited. More 
recently, micropipette adhesion assays have been applied to specifically study 
TCR-ligand interactions, and has allowed for more accurate measurements of 
affinity. Specifically, this technique allows for the assessment of 2-dimensional (2D) 
interactions, rather than three-dimensional (3D), between receptors and ligands, 
both anchored to apposing surfaces (Chesla et al., 1998). Additionally, and unlike 
multimeric tetramer approaches, this assay interrogates a single receptor ligand 
bond (Chesla et al., 1998). In this assay, red blood cells (RBC) are immobilized on 
a pressurized micropipette, having been loaded with pMHCII. Each RBC thus acts 
as a surrogate APC in this system. Next an immobilized T cell, on a second pipette, 
is forced into contact with the RBC, enabling TCR:pMHC interactions between the 
two cells. The T cell is then pulled away from the contact and the force required to 
break this interaction is measured. This is repeated many times, allowing for a 
measurement of the frequency of productive bonds, in addition to the mechanical 
force needed to break them (Chesla et al., 1998). Thus to validate our findings from 
tetramer based approaches, we sent our hybridoma clones to collaborators who 
performed this assay. However, measurements of 2-dimensional TCR affinity for 
Ab-env125-135 using this micropipette adhesion frequency assay, again revealed only 
minor differences in effective TCR affinities between the clonotypes (Figure 14c) 
(Huang et al., 2010) This data suggested that functional avidity did not correlate 
well with TCR affinity towards antigen.  
4.3.6 Clonotypic evolution of virus-specific CD4 T cells depends on pre- and 
post-infection selection events 
Precise measurement of TCR affinity towards antigen had only revealed minor 
differences between clonotypes. In addition to TCR affinity for antigen, recent 
studies have also indicated a role for self-reactivity in determining CD4 T cell 
responses toward cognate antigen (Mandl et al., 2013, Malherbe et al., 2008, Tubo 
et al., 2013a, Persaud et al., 2014). We therefore wanted to investigate if clonotypic 
behaviour correlated better with the levels of self-reactivity than with foreign 
antigen. It was possible that increased self-reactive potential could set intrinsic 
sensitivity towards antigen, thus dictating the different responsiveness of the 
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clonotypes. It was also possible, that an enhanced ability to recognise spMHC, 
once antigen availability had become limiting, could drive the preferential 
maintenance of the most self-reactive clones.  
4.3.7 Ly6c expression distinguishes Vα2 and Vα3 at the population level. 
Due to the unknown nature of the self-peptides recognised by each clonotype, we 
could not use the hybridoma cell lines to measure respective TCR affinities towards 
self-antigens. In order to compare self-reactivity, and without the knowledge of the 
fine self-specificity of each TCR, we used surrogate markers of self-reactivity. 
Initially we looked for evidence for differences in self-reactivity between the bulk en-
reactive Vα2 and Vα3 families from within EF4.1 mice. Here, the self-reactive 
capacity of a T cell population was accessed according to the expression of Ly6c, 
CD44 and CD5.  
 
Perhaps the best-described marker for self-reactivity is the expression of CD5 on 
naïve CD4 T cells. CD5 itself, is a negative regulator of TCR signalling, and is first 
expressed during T cell development in the thymus. Here, its expression is thought 
to be proportional to the degree of TCR signalling received (Azzam et al., 1998, 
Tarakhovsky et al., 1995, Mandl et al., 2013). With higher levels of CD5 expression 
on thymocytes, indicative of higher levels of TCR signalling encountered by 
thymocytes during positive selection. CD5 expression is not set indefinitely in the 
thymus and requires continued maintenance in the periphery, achieved via MHCII 
derived signalling. In this regard, the expression of CD5 on peripheral CD4 T cells 
is used to report the intensity of recent self-pMHC engagements (Azzam et al., 
1998, Smith et al., 2001, Mandl et al., 2013). Although currently the best-
characterised and most sensitive marker for self-reactivity, distribution of CD5 is 
relatively narrow when accessed by antibody staining. Therefore, perceivably small 
differences in the expression between cells may equate to relatively large 
differences in their potential self-reactivity. Beyond CD5, work has shown that Ly6c 
expression on naïve CD4 T cells can also serve as a marker for self-reactivity. In 
fact, Ly6c expression can split naïve CD4 T cells into two distinct Ly6chigh or Ly6clow 
fractions. Here, naïve CD4 T cells present a comparatively greater range in 
distribution of Ly6c expression, than that observed using CD5. Additionally, and 
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unlike with CD5, Ly6c expression is inversely proportional to a clones self-reactivity 
(Martin et al., 2013). Again unlike CD5, CD4 T cells also only acquire Ly6c 
expression as they leave the thymus (McHeyzer-Williams and McHeyzer-Williams, 
2004). After which, loss of Ly6c expression is proportional to the ability of a clone to 
recognise self-antigens in the periphery (McHeyzer-Williams and McHeyzer-
Williams, 2004). Thus, it is established that Ly6clow naïve T cells are comparatively 
more self-reactive than Ly6chigh naïve T cells. Heightened self-reactivity may also 
be reflected in the expression of CD44, on CD4 T cells. CD44 is conventionally 
used as a marker of T cell activation as it is recruited to the immunological synapse 
during T cell activation. The heterogeneity of CD44 expression within the peripheral 
CD4 T cell pool, suggests that sufficiently strong TCR signalling to self-antigen can 
drive CD44 expression in the absence of foreign-antigen-activation. However, its 
need for strong TCR signalling perhaps restricts its ability to report for only the 
most self-reactive clones. 
 
4.3.7.1 Heterogeneity of the naïve pool: Ly6c expression  
Staining with labelled cognate pMHCII tetramer allowed us to detect naïve F-MLV 
env-specific CD4 T cells from within the naïve CD4 repertoire of EF4.1 mice. 
Additional staining for TCR Vα2 chains, allowed us to distinguish high and low 
avidity clones accordingly (Figure 15). TCR Vα2 antibody staining was used, as 
Vα3.2 antibodies did not capture all the Vα3 family members. Although this 
approach didn't allow for resolution of the individual ‘red’, ‘blue’ and ‘green’ 
clonotypes, it did reveal differences in Ly6c expression between high and low 
avidity families; the Vα2 and non-Vα2 tetramer positive CD4 populations 
respectively. Tetramer bound non-Vα2 cells were heterogeneous in Ly6c 
expression, and comparable to the bulk (non-specific) CD4 T cell population. In 
contrast, Vα2 tetramer positive cells were all high for Ly6c expression. This 
property seemed unique to Vα2 F-MLV env-specific cells as tetramer negative Vα2 
cells were again comparable to the bulk CD4 T cell population. As the degree of 
Ly6c expression is thought to be inversely proportion to self-reactivity, this result 
predicted the Vα3 population to contain more self-reactive cells than the Vα2 
population. However, this particular tetramer seemed to bind some env122-141-
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specific T cell clones but not others as it only allowed for the detection of ~5% of all 
the env-specific cells available. Since this tetramer-based strategy was severely 
limited to the visualisation of only a minority of FV-specific clones, we wanted to 
confirm this result using additional approaches. 
 
Figure 15 Heterogonous expression of Ly6c on Vα2 or non-Vα2 virus-specific 
naive EF4.1 CD4 T cells 
  
 
 
 
 
 
 
 
(a) Flow cytometric example of Ly6c expression on Vα2 or non-Vα2 (Vα3) virus-specific (Ab-
env125-135+) on non-specific (Ab-env125-135-) on EF4.1 CD4 T cells that were not stimulated. 
Numbering denotes the percentages of cells in each gate. 
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To identify all env-reactive T cells, we sorted naïve (CD44low/int CD25-) CD4 T cells 
from EF4.1 mice into Ly6clow or Ly6chigh fractions and subsequently stimulated them 
in vitro (Figure 16). Gating on activated cells, prior to the first cell division, we next 
accessed differences in the Vα composition between these fractions. Interestingly 
the activated Ly6clow fractions consisted of mainly Vα3 cells, with minimal 
representation from the Vα2 population. In contrast the activated Ly6chigh fraction 
was heavily enriched for Vα2 cells, comprising ~40% of the response, compared to 
the 25% observed in unsorted cells. Next by calculating the relative distribution of 
Vα2 or Vα3 T cell clones, between the Ly6chigh and Ly6clow cells we estimated that 
6% of Vα2 cells compared to 23% of Vα3 cells lay within the Ly6clow fraction. This 
was in agreement with the tetramer data, suggesting that the Vα3 population 
contained more self-reactive clones. Next we aimed to resolve the self-reactivity of 
the individual clonotypes from within Vα3 population using TCR based sequencing 
techniques. 
 
EF4.1 CD4 T cells were sorted into three fractions, CD44lowLy6chigh (most naïve), 
CD44lowLy6clow (intermediate) and CD44high (memory-phenotype), spanning the 
spectrum from the most naive to most self-reactive T cells (Figure. 17a). We then 
sequenced these fractions and asked how the Vα3 ‘red’, ‘blue’ and ‘green’ 
clonotypes where distributed between them. TCR sequencing revealed that the 
majority of cells from the ‘red’ or ‘blue’ Vα3 sub-families were CD44lowLy6chigh, the 
most naïve in phenotype. In sharp contrast, the vast majority of ‘green’ clonotypes 
were in the intermediate CD44lowLy6clow fraction, with the remaining split between 
naïve and memory-phenotypes (Figure 17b). These findings suggested that 
perhaps the remarkable proportional stability of ‘green’ Vα3 clonotypes was due to 
their pre-differentiated phenotype (Tubo et al., 2013a, Persaud et al., 2014). 
However, differences in self-reactivity, as reflected by CD44 and Ly6c levels, could 
not account for the disparate behaviour exhibited by the ‘red’ and ‘blue’ using Vα2 
or Vα3 clonotypes.  
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Figure 16 Distribution of Vα2 or non-Vα2 virus-specific EF4.1 CD4 T cells into 
Ly6high or Ly6clow fractions. 
 
 
 
 
 
 
 
 
(a) Flow cytometric example of the sort strategy used to isolate naïve EF4.1 CD4 T cells into 
Ly6chigh (least self-reactive) or Ly6clow (more self-reactive) fractions (purity >98%). Sorted 
fractions where then activated with 10-5M of env122–141 peptide in vitro (b) Flow cytometric gating 
to show the frequency of Vα2 env-reactive cells (CD69+) in Ly6chigh or Ly6clow (as in a) fraction 
following 18 hours of env121-142 peptide stimulation. Number denote the frequency of Vα2 cells in 
each gate (c) Graphs show the percentage or distribution of env-reactive Vα2 or Va3 CD4 
EF4.1 T cell into activated Ly6chigh or Ly6clow fractions. Bars on the graphs plot the means; open 
symbols are individual experiments. 
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Figure 17 Vα3 ‘green’ clonotypes are overtly self-reactive in the pre-immune 
repertoire 
 
 
 
 
 
 
 
EF4.1 CD4 T cell were sorted into three fractions, CD44lowLy6chigh (most naïve), CD44lowLy6clow 
(intermediate) and CD44high (memory-phenotype). These populations then were sequenced to 
analyses the how Vα3 red, blue and green clonotypes where distributed between them. (a) Flow 
cytometric example of Ly6c and CD44 expression in total EF4.1 CD4 T cells. Cells were sorted 
as CD44lowLy6chigh, CD44lowLy6chigh or CD44high. (b) Frequency of the indicated Vα3 clonotypes 
was determined by next generation TCR sequencing within the fraction. The fractions were 
purified from two separate EF4.1 donor mice and processed separately. Bars on the graphs 
represent individual mice. 
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4.3.8 Generation and characterisation of monoclonal mice and hybridoma 
cell lines. 
 Analysis of the pre-immune differentiation states did not reveal any major 
discrepancies between ‘red’ and ‘blue’ clonotypes. Due to the weak nature of TCR-
spMHC interactions, the finer dexterity of self-recognition by a clone might not be 
fully reflected by these markers. Developing thymocytes have been reported to 
display hyper-sensitivity to self-ligands, in part due to their ectopic expression of a 
specific voltage gated sodium channel in thymocytes (Hogquist and Jameson, 
2014). This allows for what are considered as ‘weak’ self-mediated interactions in 
mature T cells to induce strong selection signals in thymocytes (Lo et al., 2012). 
Perhaps then, finer differences in self-reactivity could be better accessed during 
development where sensitivity to self is heightened. We therefore reasoned that 
assessments of self-reactivity between clonotypes may be better studied through 
the generation of TCRαβ Tg mice which would allow us to study thymocyte 
development. Furthermore, since TCR signaling can differ between hybridoma cell 
lines and primary T cells, we reasoned affinity measurements for antigen, 
previously performed on hybridomas cells, would also be better accessed on 
primary T cells generated in these mice.  
4.3.9 Clonotypic behaviour correlates better with self-reactivity than affinity  
To this end, one ‘red’ and one ‘blue’ hybridoma cell line was used to template for 
TCRs to generate two TCRαβ doubly transgenic mouse strains EVα2 (Vα2-red 
clone) and EVα3 (Vα3-blue clone) respectively. To limit TCR expression to that of 
the transgenic TCR chains alone, mice were crossed onto a Rag1-/- background, 
preventing the expression of endogenous TCR chains. In addition, mice were then 
rendered free from the presence of the endogenous retrovirus Emv2.  
 
Emv2, a relic of previous retroviral infection, is a replication-defective, single-copy 
endogenous retrovirus (ERV) present in B6 mice (King et al., 1988). Emv2 shares 
80% homology with F-MLV, and importantly expresses an envelope-derived 
epitope almost identical to the F-MLV derived epitope. Previous work in the lab 
showed sequence identity between the two epitopes to be corresponding, with the 
exception of a single amino acid substitution, a Y instead of an L at position 128 
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(Young et al., 2012b). Although emv2 is normally replicative defective, due to 
mutations, its stable integration allows for emv2-derived products to be expressed 
to the immune system in a similar manner to self-derived proteins. In addition, in 
immunodeficent Rag1-/- mice, it has been reported that emv2 can recombine with 
other dormant endogenous viruses (Young et al., 2012a). This can result in 
replication competent virus, with the potential to affect MLV-specific T-cell 
development and subsequent response. Thus to prevent the potential of emv2 to 
serve as a self-ligand or to contribute to spontaneous resurrection of endogenous 
viruses, it was crossed out of the B6 germline.  
 
4.3.9.1 Characterisation of the EVα2 and EVα3 mice. 
T cell development proceeded normally in both the EVα2 and EVα3 mice. Although 
in both instances T cell development was considerably skewed towards the CD4 T 
cell lineage, this was considerably more pronounced in the former (Figure 18a). 
These differences were also reflected in a statistically significant increase in both 
the frequency and in the absolute numbers of SP CD4 T cells in EVα2 mice as 
compared to EVα3 mice, indicative of more efficient positive selection as a result of 
stronger TCR signaling (Figure 18b). Furthermore, levels of CD5, which correlates 
with self-reactivity, were significantly higher in EVα2 than in EVα3 SP CD4 T cells. 
Collectively suggesting EVα2 T cells were able to recognize self-ligands to a 
greater extent (Figure 18b-c). 
 
Peripheral CD4 T cell numbers, which also reflect the degree of self-reactivity 
(Kassiotis et al., 2003), were comparable to WT levels in EVα2 mice; whilst being 
significantly reduced in EVα3 mice (Figure 19). Although mature CD4 T cells in 
both monoclonal strains were all naïve in phenotype (CD44lowCD25low), a greater 
proportion of cells were Ly6clow in EVα2 mice, signifying a higher degree of self-
reactivity (Figure 20a). Although CD5 expression was comparatively lower in 
peripheral T cells compared to that in thymocytes, mature EVα2 T cells still 
maintained significantly higher levels than mature EVα3 T cells, confirming 
continued heightened self-reactivity in the periphery. These pronounced phenotypic 
differences in self-reactivity between the monoclonal EVα2 and EVα3 T cells 
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correlated remarkably well with their inferred avidities toward env-peptide 
stimulation in vitro. And although two-dimensional TCR affinity measurements for 
cognate peptide did reveal differences in the recognition of cognate peptide 
between the clones, this sensitivity only differed by a factor of two, arguably too 
small to account for the large disparity in their functional avidities (Figure 20e). 
Thus we concluded that although small differences in antigen affinity did exist, the 
functional avidity of ‘red’ EVα2 and ‘blue; EVα3 T cells, better correlated with self-
reactivity. 
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Figure 18 Characterisation of thymocyte development in monoclonal EVα2 and 
EVα3 TCR transgenic mice 
 
 
(a)	 Flow cytometric analysis of thymocyte development in EF4.1, EVα2 and EVα3 TCR 
transgenic mice. Number denote the percentage of cells CD4-single positive thymocytes (b) 
Absolute number of thymocytes, CD4 single-positive and CD8 single-positive thymocytes in the 
same mice as in a (c) CD5 levels (d) and MFI in post-selection CD4 single-positivee thymocytes 
from the same mice as in a Closed symbols are the means (±s.e.m.); open symbols are 
individual mice; numbers within the graph denote the P values accordingly; horizontal dashed 
lines represent the mean values for control EF4.1 mice. 
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Figure 19 Characterisation of lymphocyte development in monoclonal EVα2 and 
EVα3 TCR transgenic mice 
 
 
 
 
(a) Flow cytometric analysis of splenic CD4 subsets in EF4.1, EVα2 and EVα3 transgenic mice. 
Numbers denote the percentage of cells within each gate (b) Flow cytometric example of Ly6c 
distribution in naive splenic CD4 T cells from EF4.1, EVα2 and EVα3 mice. Horizontal dashed 
lines represent the mean values for control EF4.1 mice. (c) and of CD5 expression levels in 
naive splenic CD4 T cells from the same mice. 
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Figure 20 Characterisation of reactivity to self and foreign-antigen of monoclonal 
EVα2 and EVα3 TCR transgenic mice 
 
 
 
(a) Absolute number of naïve splenic CD4 T cells in EVα2 and EVα3 mice. (b) Ly6c (c) and CD5 
mean fluorescence intensities (MFI) to infer levels of self-reactivity in CD4 T cells from within 
the same mice as in a. Closed symbols are the means (±s.e.m.); open symbols are individual 
mice; numbers within the graph denote the P values accordingly; horizontal dashed lines 
represent the mean values for control EF4.1 mice. (d) Responsiveness of EVα2 and EVα3 T 
cells to overnight env122–141 peptide stimulation. Responses were measured by CD69 induction 
and are plotted as means (±s.e.m., n=3–4). (e)	Effective two-dimensional TCR affinities for Ab-
env125–135 of primary T cells measured by the micropipette adhesion frequency assay and 
normalized by TCR surface density. Each individual data point represents the affinity of a single 
T cell. Numbers in the plot represent the effective affinity geometric mean of the population.  
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4.3.10 Generation of a ‘green’ TCR monoclonal mouse 
Thus the behaviour of all three clonotypes correlated better with sensitivity to self 
than toward foreign antigen. The most overtly self-reactive TCRs seemed to belong 
to the ‘green’ family of clonotypes. Therefore, for completeness we also generated 
a TCR L23 monoclonal mouse templated from a ‘green’ clonotypes. Subsequent 
characterisation of the L23 mice, as described below, showed strong evidence for 
the self-reactive nature of this clonotype family. 
4.3.10.1  Characterisation of the L23 ‘green’ clonotypes mice 
Characterization of the L23 monoclonal mice, revealed that L23 T cells expressed 
CD5 at significantly higher levels than those observed in EVα2 and EVα3 T cells. In 
addition, loss of Ly6c marked a much larger fraction of peripheral T cells in the L23 
mice as compared to EVα2 and EVα3 T cells. Further still although the majority of 
peripheral L23 T cells were naïve (CD44lowCD25-) in phenotype, there also existed 
an intermediate (CD44intCD25-) population suggesting the acquisition of a slightly 
more differentiated state. This was despite the extremely low expression levels of 
TCR in L23 T cells. Perhaps, itself hampered in expression, as a consequence of 
its overt self-reactivity. However, such low levels of TCR precluded direct 
comparisons between L23, EVα2, EV3 and EF4.1 T cells in any in vitro or 
functional assays. Collectively these data confirmed our previous findings 
attributing the stability of the ‘green’ Vα3 clonotypes to their pre-immune 
differentiation state, established by their overtly self-reactive nature.  
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Figure 21 Characterisation of the monoclonal L23 TCR transgenic mice re-affirms 
the overtly self-reactive nature of the green clonotypes. 
 
 
 
 
 
 
(a) Flow cytometric analysis of CD5 levels in thymocytes and peripheral naïve splenic CD4 T 
cells in EF4.1 and L23 monoclonal mice (b) Levels of TCRβ on peripheral naïve splenic CD4 T 
cells from the same mice as in a. (c) Expression levels of CD5 on peripheral naïve CD4 T cells 
from EVα2, EVα3 and L23 monoclonal mice, expressed as a percentage of those observed in 
control EF4.1 CD4 T cells. Horizontal dashed lines represent the mean values for control EF4.1 
mice. (d) Expression of Ly6c on peripheral naïve CD4 T cells from EVα2, EVα3 and L23 
monoclonal mice. (e) Flow cytometric analysis of splenic CD4 subsets in WT and L23 
monoclonal transgenic mice. Closed symbols are the means (±s.e.m.); open symbols are 
individual mice. 
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4.4 Discussion 
Our findings highlight the prominent role for the TCR in dictating the clonotypic-
composition of CD4 T cell responses. Most studies attribute the ability of a T cell 
clonotype to perform to the affinity of its given TCR towards cognate peptide. 
However, our study lends support towards to a growing field of evidence, 
supporting the importance of self-reactivity is setting sensitivity towards antigen, 
over just affinity for antigen alone. Further still, although it has been well 
established that clonal selection and dominance are key features of primary T cell 
responses, it remains unknown as to whether these remain key features in memory 
repertoire selection. Our analysis of the evolution of the CD4 TCR repertoire in 
responses to retroviral infection clearly highlighted differences between the primary 
and memory TCR repertoires. Using deep sequencing of the TCRα chains of TCRβ 
Tg EF4.1 T cells, we were able to show the progressive diversification of the T cell 
response over time, rather than repertoire narrowing. TCR repertoire evolution was 
driven by the proportional loss of high avidity early responders, allowing for the 
emergence of the lower avidity clonotypes later in the response. Our results 
support a prominent role for TCR self-reactivity in determining responsiveness to 
antigen however the molecular basis behind this remains to be defined. 
Furthermore, the TCR extrinsic factors driving the diversification of the clonotypic 
response remained to be resolved. We next wanted to understand the selective 
forces which were driving the proportional rise in cells of lower avidities at later time 
points in FV infection, and to establish why this differed so wildly between different 
mice. 
 
  
Chapter 5 Results 
 
126 
 
Chapter 5. The role of APCs in the diversification of 
the CD4 T cell response. 
5.1 Introduction  
5.1.1 Aim 
It is now established that clonal selection and clonal dominance are key features of 
primary T cell responses. However, extensive analysis of TCR repertoires 
throughout immune responses has highlighted differences between the primary 
and memory CD4 T cell repertoires; suggestive that distinct criteria may exist for 
each. In this study, we have explored this question by using TCR clonotypic 
analysis at different time-points during chronic retroviral infection. Previously, we 
were able to show that discrete families of clonotypes dominated at different 
phases in the response, and that distinct clonotypic behaviours segregated with 
their functional avidity. In this regard, clonotypes of the highest functional avidity 
(red clones) responded rapidly and dominated the early response, whereas the 
comparatively lower avidity clonotypes (blue clones) were favored at later time 
points.	 This ultimately led to the diversification, rather than the progressive 
restriction, of the responding CD4 T cell repertoire. In addition, data showed that 
clonotypic sensitivity and functional responsiveness to F-MLV better correlated with 
self-reactivity than with affinity towards foreign-antigen. However, the mechanisms 
or forces behind the clonotypic evolution remained un-resolved. Moreover, why in 
some mice the clonotypic switch was observed but in others not, remained unclear. We 
therefore wanted to explore T cell extrinsic factors, that may differ between individual 
mice, and that may be influencing the clonotypic evolution of the evolving CD4 T cell 
response. 
5.1.2 Clonal Selection and Diversity 
Although TCR avidity is critical in establishing the clonotypic hierarchy in many 
CD4 T cell responses, other parameters must exist in order to balance clonal 
selection with diversity. These parameters presumably have the potential to narrow 
the gap between higher and lower avidity clonotypes by overhauling TCR avidity 
hierarchies.  
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5.1.2.1  Interclonal competition  
Competition for limited resources allows for the evolution of a given population, this 
is equally true for CD4 T cell populations (Raff, 1992). The ability of a T cell to 
compete will not only be affected by its own ability to recognise antigen but also by 
their competitors ability (McHeyzer-Williams and Davis, 1995). Here clonotypes of 
the same specificity but differing avidities or functional avidities may not only 
compete for access to antigen but also for growth factors and the physical space 
available. Therefore, the faster a clone is able to respond the less prohibited its 
expansion will be due to the relative availability of such factors. Progressively as 
the available space is filled, expansion ceases, limiting the recruitment of clones 
that saw antigen less well or later. Therefore, the faster the response the more the 
initial advantage of high avidity clonotypes is retained (Thorborn et al., 2014). 
Conversely, slower responses, and hence slower completion, may permit 
clonotypes of a broader range of avidities to be recruited. Thus the clonotypic 
composition of the CD4 T cell repertoire may be largely dictated by the speed of 
the response (Thorborn et al., 2014).  
 
Competition can also be linked to the precursor frequency of a particular clonotype. 
In order to become activated a T cell must first find an APC presenting its cognate 
peptide (Vrisekoop et al., 2014). These events can be rare, especially when 
considering the vastness of the periphery in respect to a single T cell. Therefore. 
increasing the number of T cells utilising a given TCR (precursor frequency) will act 
to significantly increase the likelihood and decrease the time taken for a clonotype 
to make contact with its cognate-peptide (Vrisekoop et al., 2014). In this way, 
clonotypes with higher precursor frequencies presumable already have a head start 
in the race. Although the parameters that dictate the size of clonal families is not 
established, presumable clonotypes with heightened self-reactivity may be better 
represented in the peripheral pool due to their ability to ascertain pro-survival 
signalling. 
5.1.2.2  Antigen availability 
Antigen availability will alter the degree of clonal competition between clonotypes. 
For example, increasing amounts of antigenic pMHCII complexes will prime an 
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increasing number of clonotypes. This will presumably lesson competition and 
allow for a greater range and diversity of clonotypes to be recruited. Conversely 
limiting availability of antigen will enforce fierce interclonal competition, selecting for 
the cells most efficient at recognising antigen, presumably the cells of highest 
avidities. In addition, the abundance or density of pMHCII complexes expressed at 
the level of a single APC may too be important; where high densities of pMHCII will 
trigger a more intense TCR signal allowing for the recruitment of lower avidity 
clonotypes in conjunction with higher avidity clonotypes. Conversely, too much 
antigen may also limit the success of certain clonotypes potentially rendering the 
cells anergic or leading to their elimination from the response via activation induced 
cell death (AICD). Presumably, this would most impact those clonotypes with 
highest sensitivity toward antigen.  In these ways the levels and availability of 
antigen can influence the ensuing CD4 T cell response. 
5.1.2.3  APC availability 
As CD4 T cells cannot recognise antigen in its native form, the availability of 
antigen will be intrinsically limited by the availability of APCs at any given time. In 
this way the number of APCs presenting antigen can influence the clonal 
composition. Presumably the greater the availability of APCs and pMHCII, the more 
clonotypes recruited and the greater the diversity of the responding pool. 
Furthermore, different types of APCs have been associated with instructing for 
divergent CD4 Th cell subsets. As different Th subsets, specifically germinal centre 
associated Tfh, have been associated with differences in long-term longevity, APCs 
may also effect long-term representation of certain clonotypes. 
5.1.3  Antigen presentation: Quality, Quantity and Location. 
As discussed any variability in antigen load or availability of antigen presenting 
cells could impact the clonotypic composition of a given CD4 T cell response. Thus 
the potential for different APCs as critical regulators of T cell fate should be 
considered more generally.  
 
A role for different APCs in dictating T cell fate is first evident when studying T cell 
development in the thymus. Very early experiments, using reconstitution of 
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irradiated hosts with donor bone marrow, showed that subsequent T cells that 
emerged from the thymus (now seeded with donor APCs) were newly restricted by 
the MHCII haplotype of the donor cells. This not only highlighted the role of APCs 
in mediating the quality of the selected T-cell repertoires but also suggested that 
distinct APCs had the capacity to contribute to this process: in this scenario donor 
bone-marrow derived cells in addition to host thymic epithelial cells (TECS) (Longo 
and Schwartz, 1980). It is now well established that different types of antigen 
presenting cell colonise distinct parts of the thymus. In the thymic cortex, cTECs 
are the main APC type. Here they mediate positive selection events. Studies have 
suggested that these cells may exhibit special proteolytic antigen processing 
pathways (Hogquist and Jameson, 2014), that allows them to generate and present 
unique peptide repertoires suggested to be essential for efficient positive selection 
(Klein et al., 2014, Marrack and Kappler, 1987). In addition, cTECs promote 
clusters of ‘nurse cells’ to envelope developing thymocytes, generating a special 
micro-environment thought to optimize T-cell selection and promote proliferation 
(Nakagawa et al., 2012, Shortman et al., 1986), although the necessity of these 
architectures remains to be fully understood (Pezzano et al., 2001). Negative 
selection occurs in the medulla, and involves distinct thymic APCs, these being 
mainly mTECs and thymic DCs whose main role is in mediating negative selection. 
In addition, various thymic APC subsets have been associated with different 
capacities in their ability to promote tTreg cell differentiation (Lee et al., 2011).  
 
 
The organisation of different APC types into discrete anatomical niches has 
become a subject of much interest and debate (Matzinger and Guerder, 1989). 
When trying to understand why this patterning exists in vivo, much research has 
suggested that thymic APCs differ in their ability to perform certain tasks necessary 
for TCR repertoire selection, which in turn determines their contribution and 
attendance at positive or negative selection events during T cell development 
(Wilkinson et al., 1995, Klein et al., 2009). On the other hand, research has also 
contested this theory, concluding that diverse thymic APC types are equally 
efficient at mediating positive and negative selection as well as in the selection of 
tTreg T cells (Yasutomo et al., 2000, Martinic et al., 2003, Proietto et al., 2008). 
These studies proposed that the spatial organization of APCs (in vivo) dictated the 
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capacity of a certain APCs to perform and not the other way round. Clearly, when 
some of these anatomical or numerical barriers were abolished, for example in in 
vitro aggregate cultures, where cells are randomly positioned, diverse APCs could 
fulfill roles not conventionally associated with them in vivo (Yasutomo et al., 2000) 
However, whilst different APCs may appear to support efficient thymocyte selection 
in vitro (as accessed by the numerical output of SP thymocytes), the quality of the 
selected repertoires are most likely drastically impacted. This could have large 
implications of the protective capacities of these selected repertoires which is 
something better accessed in vivo rather than in vitro. Nonetheless, experiments 
comparing the efficiency of non-thymic APCs versus thymic APCs at mediating 
negative selection, conclusively showed the former to be far less efficient in this 
regard (Wilkinson et al., 1995). As availability of MHC derived signaling was not 
limited in these experiments, this suggested that this difference was mediated by a 
qualitative rather than a quantitative difference conclusively highlighting the 
potential for diverse APCs in influencing CD4 T cell fate.  
 
Different APCs have also been suggested to assume different roles in the clonal 
selection of CD4 T cells in the periphery. Exogenous antigen, is mainly internalized 
by three types of professional APCs in the periphery 1) DCs 2) B cells and 3) 
Macrophages. Antigen is then processed by the APCs and subsequently displayed 
to CD4 T cells in the form of pMHCII complexes. Diverse APCs have been shown 
to differ in the way they capture and process exogenous antigen and in their 
expression of co-stimulatory molecules, as well as in factors that promote the 
cellular adherence between T cells and APCs (Hamilos, 1989). All such factors co-
operate to install qualitatively distinct signals in the partnered CD4 T cells, 
potentially instructing for diverse cells fates accordingly. In this regard, differences 
in the type of APC a T cell receives its signal from, may go some way in explaining 
the observations from several studies which showed relatively surprising plasticity 
of a single T cell clone, although other factors must be considered here too (Tubo 
et al., 2013a, Stemberger et al., 2007, Gerlach et al., 2010). In addition to the 
qualitative differences that may exist between professional APCs, they also vary 
wildly in their absolute numbers and anatomical locations. These spatial and 
numerical considerations likely influence the capacity of certain cell types or 
subsets to perform as proficient APCs. Classically, DCs are thought to be the main 
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antigen presenting cells, responsible for priming T cells during an immune 
challenge. However, in some regards B cells have perhaps been unfairly dismissed. 
Studies have shown that activated B cells (Malynn et al., 1985), but not naive B 
cells, were able to prime and expand T cell populations (Lassila et al., 1988). This 
seemed to ‘put to bed’ the idea that B cells might significantly contribute to early T 
cell responses, as although they vastly dominant over DCs in terms of absolute 
numbers, low precursor frequencies of antigen-specific B cells and a dependency 
on T cell help to expand them, would presumably hinder them in this capacity. 
However, B cells can also become activated independently of the BCR, which 
could perhaps unleash them from the numerical, anatomical and qualitative 
limitations associated with naïve B cells; as clearly in vitro B cell can perform as 
proficient APC when given the opportunity.  
 
Another obvious example for the role for different APCs in impacting CD4 T cell 
responses was revealed by studies that investigated the conditions that permitted 
Treg T cell proliferation (Walker, 2004). Treg T cells are often termed as occupying 
an anergic phenotype in vitro, i.e. they remain unresponsive when activated via 
their TCR. However, experiments that interrogated various sources of APCs, APC 
types and maturation states, revealed that in fact Treg T cell cells could proliferate 
extensively when stimulated in the context of the right APC. In these experiments 
the direct expansion of functional Treg T cells could be only be achieved in the 
presence of antigen loaded mature CD86high DCs, by not isolated splenic B cells or 
CD86low DCs (Yamazaki et al., 2003). Thus highlighting the potential for diverse 
APCs in shaping the clonotypic composition of many types of CD4 T cell responses. 
 
  
Chapter 5 Results 
 
132 
 
5.2 Results 
5.2.1 Effect of infection kinetics on the composition of virus specific T cells. 
Although B6 mice are resistant to FV, with all mice eventually controlling the virus, 
individuals vary in their efficiency to do so. Viral loads were measurement by the 
copy number of F-MLV per 1x106 spleen cells from FV infected mice. Viral copy 
number was determined by real-time qPCR, using primers that specifically 
amplified the envelope of F-MLV. Measuring F-MLV copy number revealed that 
although mice had near identical viral titres at day 7, by d35 viral loads where 
highly variable (Figure 22b). Interestingly, this was reflected in a corresponding 
divergence in the quality of the CD4 T cell repertoires between mice. Thus, we 
considered that viral load might be directly influencing the clonotypic composition of 
the responding cells. Since strong signalling can lead to cell death or anergy it was 
possible that antigen, if persistently high, could eventually become detrimental; 
presumably with greatest negative impact on the most sensitive clonotypes 
(Persaud et al., 2014). Such a relationship was suggested by a strong correlation 
between F-MLV copy numbers, from the spleens of infected mice and the 
corresponding frequency of virus-specific Vα2 clones within those mice. However, 
a positive correlation between the two argued against antigen compromising the 
clones of highest avidity (Vα2) (Figure 22a). Rather, this suggested higher viral 
loads favoured the maintenance of the Vα2 clones. To better understand if CD4 
clonotypic responses were associated with the abundance of antigen, we decided 
to manipulate viral kinetics to study how this subsequently influenced the 
responding CD4 T cell repertoire. To this end, we either infected adult B6 mice with 
N-tropic F-MLV (F-MLV-N), or neonatal B6 mice with B-tropic F-MLV (F-MLV-B). 
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Figure 22 Viral load correlates with the persistence of Vα2 virus-specific CD4 T 
cells. 
 
 
 
 
 
(a) Frequency of Vα2 env-reactive donor EF4. 1 CD4 T cells plotted against copies of F-MLV 
env DNA in the spleens of recipient mice 35 days after adoptive T cell transfer and FV infection. 
Each symbol is representative of an individual mouse; the open symbol, represents a single 
mouse which was excluded from the regression analysis. (b) Copies of F-MLV env DNA in the 
spleens of recipient mice that were infected as adults with FV or F-MLV-N or as neonates with 
F-MLV-B. In all case, EF4.1 CD4 T cells were transferred into adult recipients and then 
analysed in the days following T cell transfer. Each symbol is an individual mouse. The dashed 
line denotes the detection limit.   
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Figure 23 Effect of infection kinetics on the clonal composition of virus-specific 
CD4 T cells. 
 
 
 
 
(a) Absolute numbers (top) and Vα composition (bottom) of env-reactive donor EF4.1 CD4 T 
cells in the spleens of recipient mice after T cell adoptive transfer into adult mice either infected 
with F-MLV-N at the time of T-cell transfer or with F-MLV-B as neonates (n=4–15 mice per time 
point; P<0.001 between the two types of host on days 14–35, Mann–Whitney rank sum test). 
Closed symbols are the means (±s.e.m.); open symbols are individual mice; the dashed line 
represents the frequency of Vα2 cells in pre-immune env-reactive EF4.1 CD4 T cells  
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Murine leukaemia viruses can be divided into distinct groups according to their 
tropism: B tropic, N tropic, and NB tropic (Yoshikura, 1975). Viral tropism relates to 
the specificity of the virus towards a given host or a host tissue. Thus N and B 
tropic viruses preferentially grow in N or B mouse types, whereas NB-tropic viruses 
can propagate in both (Yoshikura, 1975). B6 are a B type mouse strain and thus 
are particularly non permissive to F-MLV-N, specifically due to its restriction by the 
host Fv1b allele. Therefore, F-MLV-N is quickly eliminated in adult B6 mice (Figure 
22b). This leads to lower levels of virus, as accessed by qPCR, and for shorter 
durations of time. Importantly, F-MLV-N viral tropism is determined by a pair of 
adjacent amino acids within the viral capsid, and therefore does not alter the quality 
of the T cell envelope epitope recognised (Stevens et al., 2004). Contrastingly, 
prolonged infection with inflated viral loads can be achieved through the infection of 
neonatal B6 mice with WT F-MLV-B (Figure 22b). Although adult B6 mice are 
resistant to F-MLV-B, its delivery into young mice, results in immunological 
tolerance and thus persistent infection (Erlebacher, 2013). In order to study CD4 T 
cell responses in this setting, EF4.1 T cells were subsequently transferred into 
neonatal-infected hosts when they reached adulthood. These distinct infection 
regimès allowed us to study the effect of low-level infection (F-MLV-N) or non-
resolving (neonatal F-MLV-B infection) infection on the clonotypic composition.  
 
Initial expansion of total EF4.1 T cells was proportional to the degree of viral 
replication exhibited between the two infections (Figure 23 top panel). At day 7, 
Vα2 clones dominated the response in all the neonatal F-MLV-B infected hosts. 
Whilst on average this was also true for F-MLV-N infected hosts, there was a much 
greater degree of heterogeneity between mice already by day 7 (Figure 23 bottom 
panel). In fact, past day 7, the frequency of Vα2 clones rapidly declined 
homogenously in the non-persistent infection. This was in sharp contrast to the 
exclusive maintenance of Vα2 clones in the non-resolving infection. This data 
advocated that the clonotypic composition was directly influenced by antigen, 
whereby continually high levels maintained clones of the highest avidity, thus 
preventing the clonotypic switch towards clones of lower avidity. This was perhaps 
surprising considering that higher avidities and affinities are normally favored at low 
levels of antigen, as the more sensitive the TCR presumably also the more efficient 
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they are at recognizing antigen at low densities (Walker et al., 2010).  In contrast, 
low affinity and avidity T cells have been shown to be better established in the 
context of higher levels of antigen (Leggatt, 2014). We therefore reasoned a 
distinct parameter must be responsible for selecting for lower avidity clones 
besides antigen.  
5.2.2 Clonal replacement requires cognate B cell interactions 
Induction of CD4 T cell responses require interactions with APCs, as T cells can 
only recognise antigen in the context of MHC. Thus we reasoned, the effect of 
higher viral loads on CD4 T cell responses must be mediated through APCs. It was 
therefore important to consider the impact of viral load on the quality and quantity 
of both antigen and the APCs themselves. Non-specific and specific activation of B 
cells is not only critical for the initiation of B cell responses to infection, but also for 
their ability to perform as proficient APCs. Conventionally, antigen presentation to 
CD4 T cells by B cells is considered a heavily one-sided interaction, allowing B 
cells to obtain T cell help. However, we considered that these T-B cell 
collaborations may be equally important for the CD4 T cell response. Thus we 
decided to study the B cell response to FV infection. 
 
To this end, host mice were infected with FV, following which the frequency of 
CD38lowGL7hi cells within IGDlowB220high B cells (germinal centre phenotype), were 
measured at the indicated time-points during infection (Figure 24a). We observed 
that the B cell response to FV, compared to the bulk CD4 T cell response, was 
temporally distinct in regards to its activation kinetics. This saw, the proportion of 
germinal centre cells (CD38lowGL7hi cells within IGDlowB220+ B cells) remaining 
unchanged at day 7, the peak of the CD4 response. In fact, the frequency of 
activated B cells only started to increase following day 10 post infection, following 
which it then continued to steadily increase throughout the course of infection. 
Although B cell activation was delayed when compared to the bulk CD4 T cell 
response, it in-fact temporally matched the late proportional rise of low avidity Vα3 
clonotypes (Figure 24a). To better understand the relationship between these two 
responses, we decided to manipulate the kinetics of B cell activation to study how 
this might impact the clonotypic replacement of Vα2 for Vα3 clonotypes. To this 
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end, we transferred EF4.1 T cells into mice co-infection with F-MLV and Lactate 
Dehydrogenase Virus (LDV).  
 
Figure 24 B cell responses in FV infected hosts, temporally match the 
proportional rise Vα3 virus-specific clonotypes 
 
 
 
 
 
 
(a) Frequency of CD38lowGL7high of B220highIgDlow splenic B cells in recipient mice 
over the course of FV infection and following T cell adoptive transfer (b) and (left) 
the Vα3 composition of env-reactive donor EF4.1 CD4 T cells in the spleens of 
recipient mice after T cell adoptive transfer. Closed symbols are the means 
(±s.e.m.). 
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LDV infection is known to result in the polyclonal activation of B cells. As this 
activation is T cell independent, it reportedly allows for rapid and mass proliferation 
of cells irrespective of their BCR specificity (Montes et al., 2007). Indeed, we 
observed that in comparison to infection with FV alone, B cell responses to co-
infection were greatly accelerated, rapidly expanding from day 3 through until day 7 
and reaching their peak at d10 (Figure 25a-b). Co-infection also induced higher 
levels of MHCII expression on B cells by day 7 as compared to FV infection alone 
(Figure 25c). Critically, this accelerated B cell response was mirrored by a faster 
decline in Vα2 clonotypes within responding EF4.1 T cells (Figure 26). An increase 
in their numerical response, alongside their heightened levels of MHCII would 
presumably enhance the capacity of B cells to contribute to antigen presentation in 
co-infected mice. It was therefore tempting to suggest that the progressive 
contribution of B cells acting as APCs, may be influencing the clonotypic evolution 
of the CD4 T cell repertoire. However, as infection of LDV has dramatic effects 
beyond just the polyclonal activation of B cells, we could not exclude a role for 
other APCs in this system (Robertson et al., 2008). Therefore, we next examined 
the specific requirement for T-B cell interactions in mediating the clonotypic switch.  
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Figure 25 Accelerated and polyclonal B cell activation is achieved through 
FV/LDV co-infection. 
 
 
 
 
(a) Frequency of CD38lowGL7high of B220highIGDlow  in splenic B cells over the course of FV 
infection or FV/LDV co-infection. Closed symbols are the means (±s.e.m.)(b) Flow cytometric 
analysis of the frequency of CD38lowGL7high from B220highIgDlow  populations in splenic B cells on 
day 7 post FV infection or FV/LDV co-infection. Numbers denote the percentage of cells in the 
gates(c) MHCII expression on total B cells (B220+) from the same mice at 7 days post infection, 
compared with uninfected control mice. 
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Figure 26 Accelerated clonal replacement of virus-specific Vα2 CD4 T cells is 
achieved in FV-LDV co-infected mice 
 
 
 
 
 
(a) Absolute numbers (top) and Vα composition (bottom) of WT env-reactive donor EF4.1 CD4 
T cells in the spleens of recipient mice after adoptive T-cell transfer and FV infection (n=3–8 
mice per time point) or FV/LDV co-infection (n=3–9 mice per time point). Closed symbols are 
the means (±s.e.m.); open symbols are individual mice   
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Signaling lymphocytic activation molecule (SLAM)-associated protein (SAP), 
encoded by the Sh2d1a gene, is required for the formation of prolonged T–B cell 
conjugates. Thus, the lab generated EF4.1 T cells deficient in this molecule, in 
order to delineate a requirement for interactions mediated by SAP. Sh2d1a 
deficient or WT EF4.1 T cells were transferred in WT hosts, which had either been 
infected with FV or co-infected with FV and LDV (Figure 27a). The clonotypic 
compositions of the respective CD4 T cell populations were then compared over 
the course of the infections. 
 
The magnitude and activation kinetics of Sh2d1a deficient EF4.1 T cells, in 
response to both infections, were comparable to those observed in WT EF4.1 T 
cells. However, the use of Sh2d1a deficient EF4.1 T cells resulted in the exclusive 
maintenance of Vα2 clonotypes throughout the course of infection. This was in 
sharp contrast to the clonal replacement of Vα2 clonotypes observed when WT 
EF4.1 T cells were transferred into co-infected mice (Figure 27a). Thus, via the 
attenuation of T-B cell conjugates, as a result of Sh2d1a deficiency, we negated the 
accelerated decline in Vα2 cells previously observed in co-infected hosts (Figure 
26). However, as Sh2d1a deficiency only reduces the efficiency of T-B interactions, 
it did not exclude the possibility of these conjugates forming. Therefore, to deny 
these interactions absolutely, lab members repeated these experiments using 
transfer of WT EF4.1 T cells into B cell deficient hosts (Ighm-/-). It was observed 
that T cell transfer, into infected Ighm-/- but not into WT hosts, resulted in the stable 
maintenance of virus-specific Vα2 clonotypes, irrespective of the infection setting 
(Figure 27b).  
 
Collectively this data suggested, that T-B cell interactions were somehow mediating 
the clonotypic switch. However, it was hard to delineate the exact role played by B 
cells in this process due to their multifaceted roles during infection. Although 
cognate interactions between B cells and T cells are known to be responsible for 
the clonal selection of B cells, via the provision of T cell help, a role for B cells in 
reciprocally influencing the clonal selection of the CD4 T cell response had not 
been reported. To try and dissociate a role for B cells as APCs, from other B cell 
dependent processes, the lab next reconstituted Ighm-/- hosts with MHCII sufficient 
or deficient bone marrow (Figure 27c). Reconstitution of Ighm-/- hosts by the 
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respective donor bone marrow, either generated B cells sufficient or deficient in 
MHCII and therefore capable or incapable of B cell mediated antigen presentation. 
These bone marrow chimeric mice were then used as hosts for infection and EF4.1 
T cell transfer. On day 14 post infection, the clonotypic composition of responding 
CD4 EF4.1 T cells were analysed. It was observed that following FV-LDV co-
infection; Vα2 high avidity clonotypes were now only maintained in hosts where B 
cells lacked expression of MHCII (Figure 27c). Contrastingly, hosts with MHCII 
sufficient B cells, capable of antigen presentation, significantly reduced the 
frequency of Vα2 clones, in a dose-dependent manner (Figure 27c). Therefore, we 
concluded that the clonotypic replacement of CD4 T cell clonotypes was driven by 
antigen presentation by B cells.  
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Figure 27 Clonal replacement of virus-specific Vα2 CD4 T cells requires cognate 
B-cell interaction 
 
 
 
(a) Absolute numbers (top) and Vα composition (bottom) of Sh2d1a−/− (right) env-reactive donor 
EF4.1 CD4 T cells in the spleens of recipient mice after adoptive T cell transfer and FV infection 
(n=3–8 mice per time point) or FV/LDV co-infection (n=3–9 mice per time point). (b) Absolute 
numbers (top) and Vα composition (bottom) of env-reactive donor EF4.1 CD4 T cells in the 
spleens of WT or Ighm−/− recipient mice after adoptive T-cell transfer and FV infection (n=4–11 
mice per time point) or FV/LDV co-infection (n=4–23 mice per time point). (c) Absolute numbers 
(top) and Vα composition (bottom) of env-reactive donor EF4.1 CD4+ T cells in the spleens of 
Ighm−/− mice previously reconstituted with WT (n=18) or H2-Ab1−/− B cells (n=14) 14 days after 
adoptive T-cell transfer FV/LDV co-infection, plotted against the level of B-cell reconstitution. 
Closed symbols are the means (±s.e.m.); open symbols are individual mice  
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5.2.3 Clonal replacement is independent of differing T effector 
differentiation potential 
We next wanted to examine exactly how antigen presentation by B cells could be 
mediating this. We considered that T-B cell interactions might be qualitatively 
different from interactions made between T cells and other APC types. Clearly, the 
overall quality of the TCR signal induced in individual naïve clonotypes is 
dependent on both the TCR and the nature of the partner APC. We next 
considered how these factors could influence the evolution of the virus-specific 
CD4 T cell response. 
 
Many studies have reported a role for the strength of TCR signaling in determining 
the quality of effector cell differentiation, with high and low avidity interactions 
favoring Th1 and Th2 cellular differentiation respectively. In addition, strong TCR 
signaling in the context of T-B cellular interactions has been shown to elicit Tfh cell 
differentiation (King et al., 2008, Fazilleau et al., 2009). Thus, we considered that 
each different clonotype might have a tendency to produce certain types of effector 
cells (Tubo et al., 2013a). In this way, the long-term representation of a clonotype 
may be intrinsically linked to the stability of its acquired Th lineage; with some 
effector populations potentially being more stable than others. For example, Tfh 
cells are thought to be dependent on interactions made with germinal center B cells, 
thus their maintenance is presumably associated with the continuation of the 
germinal centre reaction. It was therefore possible that B cells promoted the 
differentiation of particular clonotypes into different effector populations, affecting 
both their functionality and longevity.	 We therefore hypothesised that high avidity 
interactions between Vα2 clonotypes and B cells could promote preferential 
differentiation into (potentially short lived) Tfh cells. In contrast, lower avidity 
interactions exhibited by Vα3 clonotypes may instead favour their differentiation 
into potentially longer-lived Th1 cells. To confirm if distinguishing patterns of 
differentiation could be responsible for the persistence of a given clonotype we 
accessed the representation of the different clonotypes within different effector cell 
populations during FV infection.  
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5.2.3.1 Clonotypic replacement affects the Th1 subset. 
To first examine the distribution of virus-specific Vα2 or Vα3 clonotypes within Th1 
effector cell populations we used Prdm1GFP reporter EF4.1 T cells. Here, EF4.1 
TCRβ-transgenic CD4 T cells also carried a GFP reporter in the Prdm1 locus. As 
the introduction of the GFP cassette into the locus disrupts normal gene function, 
cells homozygous for the Prdm1GFP reporter allele are deficient in B lymphocyte–
induced maturation protein-1 (Blimp1), encoded for by Prdm1. Blimp1 is thought to 
directly repress Bcl6 and is therefore thought to be crucial for Th1 differentiation. 
Therefore, EF4.1 T cells where kept heterozygous for the allele, allowing for both 
GFP and Prdm1 expression (from distinct alleles), and thus concomitantly 
preserving and marking Th1 differentiation. 
 
Congenically marked EF4.1 Prdm1GFP+/- T cells and WT EF4.1 T cells (serving as 
internal controls) were transferred in B6 recipients at the time of infection. The 
clonotypic compositions of these responding populations were then accessed 
throughout the course of infection. Following FV challenge, only a minority of donor 
env-specific EF4.1 Prdm1GFP+/- cells expressed GFP, perhaps as a consequence of 
the heterozygosity of the reporter allele (Figure 28a). Nonetheless, the composition 
of Vα2 cells remained consistent between GFP+ and GFP- Prdm1GFP+/- T cells as 
well as consistent to those observed in activated WT EF4.1 cells from within the 
same mouse (Figure 28b). This seemed to argue against preferential differentiation 
of certain clonotypes into the Th1 lineage. However, the visualisation of just a 
minority of total Th1 cells, by GFP expression severely limited this approach. Thus, 
in order to further examine evidence for clonotypic segregation between Th 
lineages, we targeted our approach to Tfh differentiation. 
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Figure 28 Clonal replacement in virus-specific CD4 T cells occurs independently 
of Blimp-1 dependent Th1 differentiation. 
 
 
 
 
 
 
(a) Flow cytometric analysis and detection of virus-specific WT or Prdm1(GFP+) or (GFP-) 
EF4.1 CD4 T cell donor populations from the same recipient. Numbers denote the percentage 
of cells contained in each gate. (b) Vα2 frequency in GFP+ and GFP− Prdm1 or WT EF4.1 CD4 
T cell donor populations over the course of FV infection. Closed symbols are the means 
(±s.e.m.) 
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5.2.3.2 Clonotypic replacement affects the Tfh subset 
To examine if clonotypic replacement of Vα2 clones was due to their preferential 
differentiation into Tfh cells, we targeted deletion of Bcl6 to EF4.1 T cells.  
 
Bcl6 is thought to be the master transcription factor for Tfh cells; therefore, Bcl6 
deficient T cells cannot become Tfh cells. We reasoned that is Tfh cell 
differentiation was indeed critical for mediating the clonotypic evolution of the CD4 
T cell response then its abrogation would prevent the switch. To this end, EF4.1 T 
cells were crossed to carry an OX40-Cre allele, in conjunction with Cre conditional 
Bcl6 (Bcl6c) and YFP (Gt(ROSA)26SorYFP) reporter alleles. As OX40 is up 
regulated upon strong TCR engagement, Cre expression and activity could be 
targeted to activated T cells. This approach would, theoretically, result in Cre 
mediated excision of the Bcl6c genes (guided by the recognition of loxP sites) in all 
activated Bcl6c EF4.1 T cells. However, Cre conditional systems are rarely 100% 
efficient, either due to the ectopic expression of Cre or its incomplete deletion of 
target genes. In an attempt to monitor the efficiency of Cre expression, we also 
used T cells carrying Gt(ROSA)26SorYFP reporter alleles. This reporter works 
through the incorporation of YFP into the constitutively expressed Rosa26 locus, 
which is preceded by a loxP flanked ‘STOP’ cassette. In the absence of Cre, the 
‘STOP’ cassette prevents the transcription of YFP. Conversely, expression of Cre, 
allows for the excision of the stop cassette, and hence YFP expression. This acts 
to permanently mark cells, and their descendants, whom have expressed Cre. In 
this regard we used the YFP reporter to not only track cells that have expressed 
Cre, but also to mark activated Bcl6c EF4.1 T cells that had presumably also 
deleted Bcl6. As ‘WT’ controls, EF4.1 CD4 T cells carrying just the OX40cre and 
YFP reporter alleles (Gt(ROSA)26SorYFP) but not the Bcl6c allele were used. In 
these cells T cell activation lead to Cre mediated YFP expression, whilst the Bcl6 
allele remained undisturbed and functional.  
 
Numerically, responses elicited by WT or Bcl6c EF4.1 T cells were equivalent 
(Figure 29 top). However, the proportion of YFP- cells within the activated Bcl6c 
EF4.1 T cell population, statistically increased over time. The proportional increase 
of this YFP- population contrasted to its relative stability in WT EF4.1 T cells, 
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suggesting Tfh cell differentiation to be important to at least some of the responding 
clones. However, whilst the overall Bcl6c YFP- fraction increased in representation, 
the composition of Vα2 cells remained consistent between YFP+ and YFP- fractions 
within the same host. Equal distribution of clonotypes between these fractions, 
suggested Vα2 clones were no more likely to promote Tfh cell differentiation than 
Vα3 clones. Moreover, as clonotypic replacement was evident in both the YFP+ and 
YFP- fractions we concluded that disallowing Tfh differentiation did not prevent the 
clonotypic switch between Vα2 and Vα3 cells. Collectively this data argued that 
clonal replacement was not a consequence of the selective differentiation of 
clonotypes into divergent Th lineages.  
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Figure 29 Clonal replacement in virus-specific CD4 T cells occurs independently 
of Bcl6-dependent Tfh differentiation 
(a) Absolute numbers of env-reactive donor WT or Bcl6c EF4.1 CD4 T cells in the spleens of 
recipient mice after adoptive T cell transfer and FV infection (n=3–9 mice per time point). (b) 
YFP expression on day 7 in the same env-reactive donor EF4.1 CD4+ T cells as in a (c) 
Frequency of YFP+ cells overtime, within WT (see text) or Bcl6c EF4.1 CD4 T cells in the 
spleens of recipient mice. (d) Vα2 frequency in YFP+ and YFP− Bcl6c env-reactive donor EF4.1 
CD4 T cells over the course of FV infection. Closed symbols are the means (±s.e.m.); open 
symbols are individual mice. 
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5.2.4 Clonal evolution is not driven by alternative forms of the epitopes. 
Variability in the nature of the proteases, cathepsins and differences in the cellular 
processing machinery between different APCs can result in distinct epitope 
determinants being presented by different cell types. It was therefore possible that 
differences in processing of antigen by B cells could lead to a change in the quality 
of peptides presented. Such a shift in the quality of peptides presented could 
theoretically reverse the functional avidities of the responding clonotypes, 
potentially favoring different clones accordingly. To investigate such a role, we 
restricted the CD4 T cell response to one pre-processed epitope alone, by 
transferring EF4.1 T cells into peptide immunized WT mice. However, the 
clonotypic replacement of Vα2 virus-specific CD4 T cells was still observed within 
these mice; suggesting that clonal replacement of Vα2 clones was not mediated by 
the presentation of alternative forms of the env epitope later in the response 
(Figure 30). 
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Figure 30 Clonal replacement in virus-specific CD4 T cells is not driven by 
epitope variation. 
 
 
 
 
 
 
 
(a) Absolute numbers (left) and Vα composition (right) of env-reactive donor EF4.1 CD4 T cells 
in the spleens of env122–141 peptide immunised mice after adoptive T-cell transfer (n=6 mice per 
time point) Closed symbols are the means (±s.e.m.); open symbols are individual mice. 
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5.2.5 Clonal replacement is driven by asynchronous expansion of high and 
low avidity clonotypes. 
We next considered an alternative hypothesis, to explain the clonotypic 
replacement of high avidity clones for low avidity clones (Figure 31). We reasoned, 
that instead of all virus-specific clones responding synchronously, but with distinct 
abilities to persist, clonotypes could respond with identical kinetics but instead may 
be asynchronously recruited. In this model, ‘red’ high avidity clones would expand 
early during infection followed by the delayed expansion of ‘blue’ low avidity 
clonotypes. Considering their already established role, we suspected that antigen 
presentation by B cells could be mediating a second wave of recruitment. However, 
the heterogeneous nature of the EF4.1 Vα3 population hindered our ability to 
visualise evidence for the temporal recruitment of blue clonotypes. Therefore, to 
test this we used EVα3 TCR Tg mice, where the TCR transgene was originally 
templated from a public blue clonotype, as a source of monoclonal blue T cell 
clonotypes.  
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Figure 31 Synchronous versus Asynchronous expansion models. 
 
Figure 31 Synchronous and Asynchronous expansion models. 
Both models could be applied to explain the clonal replacement of the Vα2 ‘red’ clonotypes for 
the Vα3 ‘blue’ clonotypes over the course of FV infection.  
Model A Synchronous: In this model, we assume that both Vα2 and Vα3 clonotypes expand at 
the same time. To explain the clonotypic switch we assume Vα2 clonotypes would expand 
significantly more, than the Vα3 initially.  However, at later time points clonal contraction would 
also be more pronounced in the Vα2 population, leaving the Vα3 to increase in their 
proportional representation as a consequence.  
Model B Asynchronous: In this model, we suggest that Vα2 and Vα3 clonotypes are 
temporally recruited in accordance with their functional avidities. Here, it is not until the Vα2 
(high functional avidity) red clonotypes have expanded and began to contract until the (lower 
functional avidity) Vα3 blue clonotypes are recruited. This would see two waves of clonal 
recruitment and would explain why Vα3 populations monopolize the CD4 T cell responses at 
later time points in FV infection.  
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To study the efficiency of recruitment at distinct time points, marked EVα3 T cells 
were either transferred into WT hosts at the time of infection or into hosts which 
had been infected 10 days prior (Figure 32). The efficiency of recruitment of EVα3 
T cells was then measured 7 days later. In addition, and to access the role for B 
cell mediated recruitment, we also used hosts co-infected with FV and LDV. Again, 
we either delivered EVα3 T cells on the day of infection or 10 days post infection, 
when the B cell response was at its peak. When T cells were transferred on the 
same day that mice had received FV challenge, we observed only a minimal 
expansion of EVα3 T cells (Figure 32a-b). Here, the absolute numbers of activated 
EVα3 T cells recovered were used to measure the level of recruitment. Total 
numbers were calculated from the observed frequencies of activated EVα3 T cells 
(CD45.2+,Vα3+,CD44+), as ascertained by flow cytometric analysis, multiplied by 
total cell counts (Figure 32b). Similarly, low numbers of expanded EVα3 T cells 
were also observed in mice which had been co-infected with FV and LDV on the 
same day as T cell transfer. Lack of expansion seemed to be due to inefficient 
activation of EVα3 T cells, with the majority of recovered cells not up-regulating the 
activation marker CD44 (Figure 32c). Furthermore, EVα3 T cells transferred on day 
10 of FV infection, only expanded marginally better than in the previous conditions. 
However, the majority of EVα3 T cells were now CD44high in phenotype, indicating 
improved levels of activation (Figure 32c). Strikingly, expansion of EVα3 T cells 
was largely improved when T cells were delivered on day 10 of co-infection with FV 
and LDV (Figure 32a-b). This was also reflected in homogenously high CD44 
expression (Figure 32c). Notably, these mice had received EVα3 T cells at the 
peak of their B cell response. This suggested that the degree of recruitment was 
dependent on the availability of activated B cells capable of presenting antigen. To 
highlight this, we labelled EVα3 T cells with CFSE before their transfer into hosts 
pre-infected with FV or FV and LDV (Figure 32d). CFSE is a cell permeable 
fluorescent dye that allows for flow cytometric assessment of cellular proliferation 
due to the progressive halving of CFSE fluorescence within daughter cells following 
each cell division (Lyons and Parish, 1994). The complete loss of CSFE dye, owing 
to levels of proliferation that exceeded the number of cell divisions CFSE can 
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visualise was only achieved when EVα3 T cells were transferred into mice at the 
peak of the B cell response. 
 
Importantly, this pattern of recruitment contrasted with the strong expansion of Vα2 
clonotypes within the first 7 days of infection, proving families of clonotypes were 
temporally recruited. We continued to monitor the response of transferred EVα3 T 
cells, following their initial expansion, to study their ability to persist. However, 
similarly to the Vα2 response, expansion was followed by the sharp contraction in 
the absolute number of responding EVα3 T cells (Figure 32a). This suggesting that 
once activated, EVα3T cells did not behave atypically. These results demonstrated 
that clones of lower avidity/‘blue’ clonotypes were recruited later than clones of 
higher avidities/’red’ clonotypes, in a B cell dependent manner. 
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Figure 32 Asynchronous expansions of higher- and lower-avidity clonotypes. 
 
 
(a) Flow cytometric detection of CD45.2 donor EVα3 Rag1−/− Emv2−/− CD4 T cells and 
CD45.1/CD45.2 host CD4 T cells following transfer either on the day of infection (d0 of infection, 
d0–7) or 10 days after infection (d10 of infection, d10–17) with FV or FV/LDV. In both setups, T-
cell expansion was analysed 7 days after transfer (n=5–9). (b) Absolute number of activated 
(CD44high) EVα3 CD4 T cells recovered from the spleens of FV or FV/LDV co-infected recipients 
7 days after transfer either on the day of infection (d0–7) or 10 days after infection (d10–17). 
Closed symbols are the means (±s.e.m.); open symbols are individual mice (c) Flow cytometric 
detection of CD44 levels on CD4 T cell population gated as in a. (d) Responsiveness, as 
measured by CFSE dilution, of EVα3 Rag1−/− Emv2−/− CD4 T cells following transfer into 
recipients 10 days after infection (d10 of infection, d10–17) with FV or FV/LDV. Numbers denote 
the percentage of cells in each gate or deemed CFSE- 
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Figure 33 Following their late recruitment, lower-avidity clonotypes then display 
identical kinetics to higher-avidity clonotypes. 
 
 
 
 
 
 
 
(a) Absolute number of env-reactive donor EVα3 CD4 T cells recovered from the spleens of FV 
or FV/LDV co-infected recipients 7 days after transfer either on the day of infection (left) or 10 
days after infection (d10–17) and then over the course of FV infection or FV/LDV co-infection 
(nd, not detected). Closed symbols are the means (±s.e.m.). 
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5.2.5.1 Diversification of the immune response is not driven by a unique 
mode of antigen presentation by B cells 
Recruitment and expansion of clonotypes of lower avidities seemed to be driven by 
B cell mediated antigen presentation. To understand if qualitative differences in 
antigen presentation between B cells and other APCs were responsible for this, we 
tested if DCs could also recruit EVα3 T cells. To this end, we transferred marked 
cohorts of EVα3 T cells into F-MLV infected B cell deficient Rag1-/- hosts (Figure 
34). Here, and in contrast to the minimal expansion of EVα3 T cells in WT F-MLV 
infected hosts, EVα3 T cells expanded considerably in infected Rag1-/- hosts. To 
control for expansion that would be driven by homeostatic-proliferation we also 
transferred EVα3 T cells into un-infected Rag1-/- hosts, but this resulted in 
comparatively little expansion. Thus, by alleviating interclonal competition we also 
alleviated the dependency of EVα3 T cells on priming by B cells. Henceforth, we 
propose a quantitative rather than qualitative role for B cells in our system, in which 
increased numbers of activated B cells, participating in antigen presentation, acts 
to relax interclonal competition. This effectively allows lower avidity cells a window 
of opportunity to expand, resulting in second wave of recruitment which 
subsequently drives the evolution and diversification of the CD4 T cell response.  
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Figure 34 Low-avidity clonotypes can be primed by diverse APCs in the absence 
of interclonal competition. 
 
 
 
 
 
 
 
 
(a) Flow cytometric detection of EVα3 CD4 T cells recovered 7 days after transfer into 
lymphocyte-deficient Rag1−/− Emv2−/− recipients that were either left uninfected or were F-MLV-
B-infected. Each symbol represents an individual mouse (b) Absolute numbers of EVα3 CD4 T 
cells recovered from the spleens of recipient mice describe in a Each symbol is an individual 
mouse. 
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5.2.6 B cells promote TCR diversity in various CD4 T cell responses. 
Our model would predict that settings that feature polyclonal activation of B cells or 
B cells as dominant APCs, would also feature the induction of lower-avidity 
clonotypes in addition to higher-avidity clonotypes. Vaccine strategies often involve 
the co-administration of adjuvants, which are essential for engaging the adaptive 
immune response towards vaccine-associated antigens. Different adjuvants will 
elicit different responses/effects, some of which involve the polyclonal activation of 
B cells and the up-regulation of MHCII. Thus, we wanted to examine if B cells 
played a similarly important role in conditioning the composition of CD4 T cell 
responses in a vaccine regimen.  
 
To test this prediction, we compared the EF4.1 CD4 T cell response in WT or in 
Ighm-/- mice immunized with env121-142 peptide. Interestingly the clonotypic 
replacement of Vα2 T cells was only observed in B cell sufficient hosts, but not in B 
cell deficient Ighm-/- hosts (Figure 35a); highlighting the requirement for B cells in 
the process. We further tested this model in another immunization setting where 
mice were challenged with the tumor cell line FBL-3 cells. Critically, this FV induced 
tumor cell line expresses the F-MLV envelope epitope but does not produce 
infectious viral particles (Klarnet et al., 1989). EF4.1 CD4 T cells were either 
transferred into tumor challenged WT or Ighm-/- mice. Again the replacement of Vα2 
virus-specific CD4 T cells was only observed in B cell sufficient WT, but not in 
Ighm-/- hosts (Figure 35b). Thus, following peptide vaccine immunization and tumor 
challenge, B cells were required for the realization of the full clonotypic diversity of 
the CD4 T cell response.  
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Figure 35 B-cell-dependent expansion of lower avidity CD4 T-cell clonotypes 
occurs in diverse infection or immunization settings 
 
(a) Absolute numbers (left) and Vα composition (right) of env-reactive donor EF4.1 CD4 T cells 
in the spleens of WT or Ighm−/− (B cell deficient) recipient mice after adoptive T cell transfer and 
env122–141 peptide immunization (n=6–9 mice per time point). (b) Absolute numbers (left) and Vα 
composition (right) of env-reactive donor EF4.1 CD4 T cells in the spleens of WT or Ighm−/− (B 
cell deficient) recipient mice after adoptive T-cell transfer and FBL-3 tumor challenge (n=3–8 
mice per time point) Closed symbols are the means (±s.e.m.); open symbols are individual 
mice. 
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5.2.7 B cells balance TCR diversity 
The naïve T cell repertoire is under constant selective pressure, whereby T cells 
must use their TCRs to host interactions with spMHC in order to be maintained. 
Cells neglecting to do so die or are outcompeted by clones whom presumably have 
a higher avidity for spMHC. This competition among CD4 T cells is essential for the 
tuning, maintenance and self-limitation of the naïve T cell repertoire. We therefore 
considered whether B cells might play a similar role in maintaining the diversity of 
the TCR repertoire during homeostasis 
 
Clearly, antigen presentation by B cells played an important role in relaxing clonal 
competition during infection, subsequently allowing for the diversification of the 
responding CD4 T cell repertoire. We therefore predicted that B cells would play a 
similarly important role in supporting a diverse TCR repertoire during homeostasis, 
maintaining lower avidity clones alongside higher avidity clones. To test this, we 
asked if the diversity of a polyclonal TCR repertoire was preserved in the absence 
of B cells. Although TCR repertoires cannot be predicted, due to the random nature 
of TCR recombination, B6 mice have a preferred usage of TCRVβ gene families 
(Figure 36). We could therefore use this highly reproducible TCRVβ fingerprint to 
measure TCR repertoire maintenance upon transfer of polyclonal WT CD4 T cells 
into hosts either lacking just T cells (TCRα-/-) or both T and B cells (Rag1-/-). 
Representation of TCRVβ members was ascertained using a panel of fluorescently 
labelled antibodies that stain up to 75% of all possible endogenous TCRVβ. 
Therefore, the percentage expression and relative representation of certain TCRVβ 
families (TCRVβ signature) could be measured. TCRVβ signatures were compared 
between the input and expanded populations in the respective hosts, following 21 
days of reconstitution. Relative distribution/representation of the TCRVβ families 
within individual mice was displayed as heat maps, with similarities between 
TCRVβ signatures accessed by unsupervised hierarchal clustering (Figure 36b/37). 
Strikingly, the TCRVβ usage between the input (WT mice) and the reconstituted 
TCRα-/- host mice were indistinguishable by clustering analysis, suggesting that 
TCRVβ diversity was perfectly preserved during reconstitution in the presence of B 
cells (Figure 37). In sharp contrast, the majority of mice reconstituted in the 
absence of B cells (Rag1-/- hosts), exhibited considerable skewing away from the 
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input TCRVβ signature. This resulted in these Rag1-/- hosts clustering away from all 
other hosts (Figure 37). Furthermore, these TCRVβ usage profiles were unique to 
each Rag1-/- host, presumably driven by the private expansion of individual clones 
in the individual mice, indicative of a TCR driven process.  
 
Figure 36 Expression of endogenous TCRVβ chains in WT polyclonal CD4 T cells. 
 
 
 
 
 
 
 
 
(a)The percentage of T cells expressing TCR Vβ2, Vβ3, Vβ4, Vβ5.1/5.2, Vβ6, Vβ7,Vβ8.1/8.2, 
Vβ8.3, Vβ9, Vβ10b, Vβ11, Vβ12, Vβ13, Vβ14 or Vβ17a in WT CD4 T cells as determined by 
flow cytometric analysis.(b) Heat-map depicting the same data as in a. 
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Figure 37 TCR repertoire skewing, during CD4 T cell reconstitution, in the 
absence of B cells 
 
 
 
 
 
(a) Heat-map of hierarchically-clustered WT donors and Tcrα−/− (T cell deficient) or Rag1−/− (B 
cell and T cell deficient) recipients of purified WT CD4 T cells according to the frequency of the 
indicated Vβ family before (WT (input)) or 21 days after T-cell reconstitution (Tcrα−/− or Rag1−/− ) 
Each column is an individual mouse. 
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A polyclonal repertoire will contain a range of clones, some engaging spMHC better 
than others. Our model would predict that reconstitution of TCRα-/- hosts would 
result in the retention of a greater range of TCRs avidities. Conversely it would 
predict, that reconstitution of Rag1-/- hosts would lead to a reduction in TCR 
repertoire diversity driven by the out competition of lower avidity clones by higher 
avidity clones in conditions where MHCII derived signaling was limiting. A direct 
comparison of the avidity of T cells selected in the presence or absence of B cells 
was difficult to access; however, we observed that CD5 levels were significantly 
reduced in the most expanded TCRVβ families of Rag1-/- hosts (Figure 39). 
Maintenance of CD5 expression, by naive CD4 T cells, is known to be regulated by 
MHCII contacts made in the periphery (Smith et al., 2001). Studies which have 
experimentally deprived CD4 T cells of MHCII contact, showed T cells to sensory 
adapt CD5 to permit for increased TCR sensitivity (Smith et al., 2001). As the 
reconstitution of lymphopenic hosts, is promoted by MHCII recognition, we 
reasoned that reduced CD5 expression was reflective of insufficient MHCII 
availability in the absence of B cells. A reduction in the overall numbers of 
reconstituted T cells between hosts was also indicative of this. However importantly, 
TCRVβ usage skewing was not a direct result of the reconstitution efficiency as it 
also characterized hosts with comparable numbers of expanded CD4 T cells 
(Figure 38). 
 
Lower expression levels of CD5 within Rag1-/- reconstituted CD4 T cells, could also 
be driven via the selective outgrowth/advantage of individual clones that were 
originally CD5low in phenotype. In the absence of TCR repertoire sequencing of the 
expanded clonotypes in these hosts, we were unable to unanimously discredit this. 
However, CD5 levels were equally down regulated in the most negatively skewed 
TCRVβ families within Rag1-/- host mice, arguing against this. In addition, selective 
outgrowth of previously CD5low cells would also presumably be driven by their 
heightened capacity to signal. However usage of the Nur77GFP reporter for TCR 
signaling (Moran et al., 2011) revealed that Rag1-/- reconstituted CD4 T cells 
received significantly lower overall TCR signals (Figure 38). Here T cells express 
GFP, due to its integration into the immediate early gene Nr4a1 (Nur77) locus, 
following antigen receptor stimulation (Moran et al., 2011). Furthermore, expression 
of GFP directly correlates with the strength of TCR signaling. Therefore, the 
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comparatively higher signaling capacity of reconstituted TCRα-/- T cells, suggested 
that B cells were necessary to provide optimal signaling. Optimal signaling would 
therefore be most important for the expansion of the lowest avidity clonotypes. We 
therefore concluded that B cells are also important for the maintenance of TCRVβ 
repertoire diversity during reconstitution of lymphopenic host. 
 
Figure 38 TCR repertoire skewing in T cell-reconstituted Rag1-/- hosts 
independently of the extent of reconstitution. 
 
 
 
 
 
 
 
 
(a) Numbers of donor CD+ T cells 21 days after reconstitution of Tcrα−/− or Rag1-/- Emv2-/- 
recipients with purified WT CD4 T cells. Each symbol is an individual mouse. Mice selected for 
comparable T cell reconstitution (rectangle) were then analyzed for Vβ usage. (b) Heat-map of 
hierarchically-clustered WT donors and Tcrα−/− or Rag1-/- Emv2-/-  recipients from (a), according 
to the frequency of the indicated Vβ family before (WT (input)) or 21 days after T cell 
reconstitution (Tcrα−/− or Rag1-/- ) Each column is an individual mouse. 
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Figure 39 Balanced TCR diversity during CD4 T-cell reconstitution requires B 
cells. 
 
 
 
 
 
 
 
 
 
 
(a) Flow cytometric detection of CD5 and Vβ6 expression in donor CD4 T cells from Tcrα−/− (T 
cell deficient) or Rag1−/− (B cell and T cell deficient) recipients of purified WT CD4 T cells. (b) 
CD5 median fluorescent intensity (MFI) plotted against the divergence from the input frequency 
of each detected Vβ family in donor CD4+ T cells from the same recipients as in a. Only three 
recipients are plotted for clarity. The horizontal dashed line represents the CD5 MFI in control 
cells (P<0.001 between CD5 levels in T cells from the two types of host, Mann–Whitney rank 
sum test). (c) Frequency of GFP+ cells in donor CD4 T cells 21 days after T-cell reconstitution of 
Tcra−/− or Rag1−/− recipients with purified CD4 T cells from Nur77-GFP transgenic donors. 
Each symbol represents an individual mouse. 
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5.3 Discussion 
Here we show that the clonal replacement of higher avidity clonotypes for lower avidity 
clonotypes was dependent on antigen presentation by B cells. Our results support 
a model whereby the degree of B cell activation and hence capacity to act as 
proficient APCs, determines the recruitment of lower avidity T cell clonotypes later 
in the response. Thus, this leads to the progressive diversification of the antigen-
selected TCR repertoire. Further still, we report that B cell-mediated clonotypic 
selection of CD4 T cells is also important in shaping the TCR repertoire during T 
cell reconstitution of lymphopenic recipients. Thus B cell mediated antigen 
presentation plays fundamental roles TCR repertoire evolution during viral infection, 
and preservation during T cell homeostasis. 
 
Chapter 6 Discussion 
 
171 
 
 
Chapter 6. Discussion 
6.1 Brief summary of finding 
This study was aimed at analysing the role of TCR specificity and avidity in 
mediating the selection of CD4 T cell repertoires, both during development and in 
antigen-selected responses. 
6.2 Role of TCR specificity and avidity in Treg cell commitment 
We initiated this study by first investigating a role for TCR specificity and avidity 
during T cell development. We reasoned that one of the most pronounced effects 
of TCR signalling (and hence specificity and avidity) during development was the 
thymic generation of Treg T cell populations. Thus we began this work by 
investigating the prescriptive capacity of a Treg derived TCR, expressed in various 
settings, at mediating thymic Treg T cell differentiation. To gauge the importance of 
TCR specificity in this regard, we used a self-reactive Treg derived TCR to 
template for a Treg TCRαβ Tg mouse. To explore a role for TCR avidity, we 
propagated two Treg TCRαβ founder strains, 3G7A and 3G7B. Here, although 
TCR specificities were identical between the strains, TCR expression differed by a 
factor of two and thus allowed for different intrinsic signalling capacities between 
the mice. This gave us a model to look at the instructive capacity of both TCR 
specificity and avidity in Treg T cell commitment. 
 
6.2.1 In the thymus 
Although in the thymus, TCR-specificity to self-antigen appears to be a primary 
determinant for tTreg cell commitment we found that TCR-specificity and self-
reactivity alone were not sufficient to instruct for this lineage. Indeed, analysis of 
the 3G7 Treg TCR Tg mice showed the complete absence of thymic Foxp3 
Treg T cells. Instead T cell development was increasing distorted in an avidity 
dependent fashion. This was most pronounced in the 3G7B Rag-/- mice, when 
the TCR was expressed at higher levels and was clonally distributed, leading to 
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increased negative selection and a decreased thymic output in conjunction with 
abnormal expression of many developmental markers. These findings 
highlighted some of the diverse conservation mechanisms that have evolved to 
limit and manage overtly self-reactive thymocytes during development. In the 
3G7A Rag-/-, where TCR levels were comparatively lower, signalling was now at 
optimal levels for CD4 lineage commitment, however the mice remained 
completely devoid of tTreg T cells. 
6.2.2 In the periphery  
 
Despite the Treg origin of the 3G7 TCR receptor, but consistent with the thymic 
phenotype, the periphery of these mice was also devoid of Treg T cells. An 
interesting observation was that despite the clear auto-reactive nature of the 3G7 
TCR, peripheral T cells in 3G7 mice remained wholly naïve in phenotype.  In the 
3G7 Rag proficient mice, it was plausible that immune-tolerance was maintained 
despite this, by the presence of a Treg T cell population (which presumably utilised 
endogenously derived TCRs) in these mice. However, when 3G7 mice were 
backcrossed onto the Rag1-/- background, hence excluding the possible 
contribution of other TCRs and abrogating Treg T cell development, we did not 
observe spontaneous auto-immunity. In addition, 3G7 T cells were not anergic, as 
spontaneous activation could be observed when culturing single-cell spleen 
suspensions in vitro overnight in PFHM. We suggested that the transition from the 
naïve state (as observed in vivo) to full activation (as observed in vitro) resulted 
from the mechanical disruption of the splenic architecture that would normally 
segregate T cells from certain antigens or APCs. Thus we reasoned that 3G7 T 
cells remained in a state of ignorance in vivo, which clearly when disrupted could 
lead to T cell activation in vitro. However, we did not conclusively test this 
hypothesis, via disrupting the splenic architecture or antigenic niches in vivo. 
 
6.2.3 In vitro   
There is evidence that Tcon cells can convert to the Treg lineage later in life. 
Although the role for TCR signalling in this process has been explored, whereby 
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TCR signalling is thought to open the Foxp3 promoter region, a role for TCR 
specificity is less well understood. TCR repertoire studies, which have compared 
the TCR repertoires of tTreg cells and total systemic Treg T cells have shown them 
to be largely overlapping. The conclusion from these studies was that the major 
contributor to the mature Treg pool where tTreg T cells, suggesting that the 
contribution of peripherally converted Tregs to be was minimal (Pacholczyk et al., 
2007). A second hypothesis to explain this observation is that certain TCRs may be 
instructive toward both tTreg and pTreg T cell development. Thus some TCRs may 
poise T cells to become Treg cells, if not in the thymus than once in the periphery. 
Whilst TCR repertoire analysis comparing peripherally converted pTreg T cells and 
thymically generated tTreg T cell populations would be required to most 
appropriately explore such a relationship we decided to explore the potential for 
this in our system. Specifically, we asked is Tcon cells expressing the 3G7 Treg 
derived TCR would be prone to differentiate into Treg cells upon activation. We 
observed that despite activation induced by self-antigen or by CD3/CD28 mediated 
activation and at titrating amounts, 3G7 T cells were not prone to differentiate into 
regulatory T cells. 
6.2.4 Lessons from the Treg TCR Transgenics. 
Two studies, which interrogated the TCR ‘instructive’ hypothesis for Treg T cell 
commitment, through the generation of Treg TCR Tg mice, observed very few to no 
Treg T cells in these mice (Leung et al., 2009, Bautista et al., 2009). Whilst these 
observations could have led to the dismissal of the TCR-instructive model, instead 
it was proposed that stunted Treg T cell potential was probably a result of the 
prohibitively high precursor frequencies in monoclonal TCR Tg animals, rather than 
a failing of the TCR itself. It was therefore reasoned, that the intrinsic capacity of 
given Treg TCRs to encode the Treg cell fate could then be restored through 
adjusting the precursor frequencies in monoclonal mice to physiological levels. 
Indeed, in many, but notably not in all, seeding Treg TCR Tg progenitor cells into 
polyclonal T cell environments restored the Treg T cell potential of these TCRs. 
This suggested that there is a thymic 'niche' size which acts to limit Treg cell 
development in vivo; perhaps itself an important mechanism to regulate the 
contribution of Treg T cells to the polyclonal repertoire (Hogquist and Moran, 2009). 
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However, adjusting the clonal frequency of transgenic T cells in our system did not 
restore the instructive capacity of the 3G7 TCR for the Treg lineage. Thus our data 
suggest that not all Treg TCR Tg models can be manipulated to recapitulate tTreg 
T cell development. Overall these results suggested that although Treg T cell 
development may be a TCR-instructive process, this can be overridden by a variety 
of factors including precursor frequency and niche availability, suggesting TCR 
specificity alone is simply not enough.  
 
6.3 Role of TCR specificity and avidity during antigen selected 
responses 
Next we aimed to understand the role for TCR signalling in the clonal selection of 
CD4 T cells during retroviral infection. Furthermore, we aimed to decipher the 
factors that contributed to TCR sensitivity and the overall functional responsiveness 
of a T cell. To this end, we used a TCRβ transgenic mouse strain, with an 
increased frequency of virus-specific CD4 T cells, to specifically track the CD4 
responses during FV infection. In addition, as the usage of different Vα chains by 
virus-specific CD4 T cells, marked cells according to their functional avidity this 
allowed us to study a role for the quality of TCR signaling in clonal selection. 
Specifically, this model allowed us to assess the relative contribution of Vα2 (high 
avidity cells) or Vα3 (low avidity cells) at different points in the response.  
 
In brief, our findings supported a critical role for TCR signalling in determining 
clonal selection during CD4 T cell responses, as has been reported previously 
(Hogquist and Jameson, 2014, Tubo and Jenkins, Cohen et al., 2002, Moran et al., 
2011, Busch and Pamer, 1999, Kim et al., 2013a). However, it also highlighted 
some un-anticipated results, revealing a hierarchy of factors that contribute to 
setting the intrinsic sensitivity of a T cell when responding to foreign-antigen. The 
critical findings can be summarised into three main points and will be discussed 
accordingly: 
 
• We showed evidence for the clonal evolution, and the diversification of 
CD4 T cell responses over the course of retroviral infection.  
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•  We showed evidence that T cell sensitivity to antigen better correlated 
with self-reactivity than TCR affinity toward foreign-antigen. 
 
• We highlighted an essential role for B cells, as APCs capable of mediating 
the clonal selection of CD4 T cell repertoires. 
 
6.3.1 Clonal evolution: Three types of clonotypic behavior 
A characteristic feature of the B cell immune response is affinity maturation. Here, 
B cells progressively enhance the affinity of their immunoglobulin receptors during 
the course of infection. This involves multiple rounds of somatic recombination 
events, which act to diversify their antigen receptors, followed by affinity 
discrimination that positively selects the most successful recombinants. Unlike B 
cells, a T cells antigen receptor is fixed and hence cannot undergo further 
modifications at the sequence level. Instead, it has been suggested that TCR 
repertoires may undergo affinity maturation at the population level, via the selective 
expansion of the highest affinity clones. This has been suggest to act to focus the 
TCR repertoire (Busch and Pamer, 1999). However, it must be considered that this 
‘repertoire focusing’ would be at the expensive of repertoire richness and diversity, 
which could be potentially catastrophic when the antigen receptor is fixed (ie there 
is no going back). Thus we wanted to understand if the same, or if diverse TCR 
clonotypes contributed to the acute or memory phases during retroviral infection.  
 
As has been previously published, EF4.1 CD4 T cell responses to FV infection 
were characterised by the dominance of clones of highest avidity at the peak of 
infection (Antunes et al., 2008, Thorborn et al., 2014). However, tracking of the 
protracted response revealed (quite unexpectedly), the clonal replacement of 
previously dominant high avidity cells for clonotypes of comparatively lower 
avidities. We therefore aimed to understand, the driving forces behind this.  
 
TCR repertoire analysis revealed that indeed the clonotypic switch observed at the 
population level was driven by diverse families of clonotypes coming from within 
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the larger Vα2 and Vα3 populations. As diverse behaviours correlated with 
distinctive CDR3 regions, as accessed at the protein level, this suggesting this was 
also a TCR driven process. We then went on to categorise the three types of 
clonotypic behaviours accordingly: 
 
The first was exemplified by clonotypes that universally dominated the primary 
response, annotated as ‘red’ clonotypes. Indeed, the ‘red’ clonotypes showed the 
lowest diversity both within the Vα2 and Vα3 subsets.  At least within the Vα2 
population, they remained the dominant population (>60%) at all times, although 
their relative contribution to the overall response progressively decreased over the 
course of the infection. Presumably these clonotypes would be responsible for 
progressive enrichment of high avidity CD4 T cell and concomitant loss of diversity 
in conditions where engagement of additional clonotypes is prevented.  
 
The second type of clonotypic behaviour (green clones) was unique due to the 
relative stability of these clonotypes throughout the response. Thus a green 
clonotypes’ representation within the total responding population was minimally 
affected by the behaviour of other competing clonotypes. Closer characterisation of 
the ‘green family’ members revealed their remarkable stability correlated with their 
established differentiation state, with evidence for an acquired maturation 
phenotype prior to the infection. This was initially reflected in the loss of Ly6c and 
with the acquisition of CD44 expression on green clonotypes derived from a naïve 
semi-polyclonal population and was re-affirmed via the characterisation of 
monoclonal TCR Tg mice bearing a representative TCR. It is currently unclear if 
this apparent pre-activation state of the ‘green’ stems from higher than average 
self-reactivity or from cross-reactivity with environmental antigens. Nevertheless, 
the results support the notion that the fate of at least some clonotypes following 
infection is predetermined by earlier TCR encounters.  
 
The third type of clonotypic behaviour, and potentially the most pronounced was 
that exhibited by a diverse family of the Traj31-using ‘blue’ clonotypes. Although, 
no one family member dominated the response, collectively they monopolised the 
CD4 T cell response at later time points and thus were responsible for the 
clonotypic switch from the Vα2 family to Vα3 family. 
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Clearly different clonotypes has distinct temporal behaviours associated with their 
TCRs and presumably with the quality of TCR signalling they supported. 
6.4 Avidity, Affinity and Self-reactivity 
As all the clonotypes shared the same antigen reactivity, recognising the gp-70 
envelope glycoprotein of FV, we next sought to understand what parameters 
associated with their TCRs were driving differences in their functional avidities (as 
observed in vitro) and their responsiveness as observed (in vivo). 
6.4.1 Limitations in the field 
Defining the binding properties associated with a TCR, and understanding how 
they impact the overall sensitivity of a T cell, should provide a better understand of 
how many T cell fate decisions are encoded by TCR signalling. Indeed, many 
studies have tried to understand the structural, biochemical and biophysical 
framework that underpins these interactions (Stone et al., 2009). However, this 
have been very challenging, predominately as the nature of these interactions fall 
at the lower detection limits of current biophysical techniques (Cole et al., 2007, 
Cole et al., 2014).  Another important and confounding factor, is the incorrect usage 
and definition of these properties within the literature. In this regard, TCR affinity 
and avidity are often interchangeably used and incorrectly described. This coupled 
with limitations in the tools available to measure them, makes accessing their real 
contributions to cellular fate hard to decipher. A clear example of this is the 
widespread use of TCR tetramers to define properties of the TCR.  
 
The use of MHCII tetramers has undoubtedly revolutionised CD4 T cell biology, 
allowing for the visualisation of antigen-specific CD4 T cells from heterogeneous 
repertoires, as well as being used as a proxy for TCR affinity measurements (Stone 
et al., 2009).  However, recent work has suggested their use in the characterisation 
of finer properties of the TCR as well as their breadth of recognition (the number of 
specificities that can be assessed simultaneously by a single tetramer) may both be 
severely limited (Sabatino et al., 2011, Newell et al., 2009). In regard to their usage 
in affinity measurements: affinity is defined as the strength of a 1:1 
interaction/monomeric interaction. However, due to the relatively weak nature of a 
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TCR-pMHCII interactions, tetramers must be multimeric complexes in order to 
permit the visualisation of T cells bearing cognate TCRs (Matsui et al., 1991). Thus 
tetramers are neither a true measurement of affinity nor of avidity, as although they 
potentially measure multiple TCR interactions rather than a simple one, it remains 
impossible to determine exactly how many TCRs they truly engage. In addition, the 
weak nature of TCR-pMHCII interactions, may also limit the capacity of tetramers 
to visualize low affinity or avidity TCRs and thus tetramers may only allow for the 
visualization of the highest affinity or avidity TCRs. This means that the contribution 
of less ‘fit’ CD4 T cells to antigen selected responses may be vastly 
underestimated as a consequence (Sabatino et al., 2011). Further still, the 
responsiveness of a given T cell can rely on more than just the affinity and avidity 
of TCR-pMHCII interactions, and can be strongly influenced by the organization of 
components of the TCR signaling cascade (Viola and Lanzavecchia, 1996). These 
additional factors complicate clean measurements of individual parameters further 
(Huang et al., 2010). However, more sophisticated techniques are evermore 
becoming available, which should act to enrich the immunologists’ toolbox. These 
in combination with many of the traditional approaches should aid a better 
understanding of the parameters that shape TCR signaling quality and downstream 
CD4 T cell fate decisions. In this study, we used a combination of new and old 
approaches in order to first accurately capture the entire responding CD4 T cell 
repertoire and then to compare affinity, functional avidity and self-reactivity at the 
level of individual clonotypes. 
 
6.4.2 Appreciating a role for self-reactivity 
Although there is general consensus for the role of TCR signal strength in dictating 
responses to antigen, the underlying factors responsible for functional differences 
are still a matter of debate. Traditionally, TCR affinity towards foreign-antigens 
have been considered as the dominant factor in the clonal selection of the CD4 T 
cell response, where it was assumed clonotypes of higher affinities performed 
better. Thus one possible explanation for the differences between the functional 
responses observed between Vα2 and Vα3 clonotypes was differing TCR affinities 
to foreign antigen. We imagined, that in the case for ‘red’ clonotypes, higher TCR 
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affinity for antigen may increase their functional responsiveness and thus the 
likelihood of red clonotypes to expand upon exposure to antigen. However, precise 
measurements of TCR affinity towards cognate antigen revealed little difference 
between the diverse clonotypes. Instead our findings supported an important role 
for self-reactivity in setting the clonotypic hierarchy during the CD4 T cell response 
(McHeyzer-Williams and Davis, 1995; Savage et al., 1999; Weber et al., 2012; 
Corse et al., 2011). 
 
Studies of functional responses of CD4 T cells upon immune challenge have 
largely dismissed a role for self-recognition. Although these interactions are 
comparatively weaker, the vast majority of interactions a TCR will make is with self-
antigen rather than with foreign-antigen. As with foreign-antigen, different TCRs 
recognise self-antigen with varying affinity and avidities. Here, even small 
differences in signalling encode vastly different cell fates; clearly exemplified in 
positive and negative selection events during thymocyte development. However, 
only recently have these interactions been suggested to contribute in setting the 
intrinsic sensitivity of a T cell to foreign-antigens (Mandl et al., 2013, Vrisekoop et 
al., 2014, Wulfing et al., 2002). Indeed, our study lends support to these recent 
findings, highlighting the importance of self-reactivity, rather than affinity for 
antigen, in determining a CD4 T cells responsiveness during infection. To date the 
most compelling models for how TCR self-reactivity may influence responses to 
foreign-antigen are as follow: One model which suggests that strong self-reactivity 
during positive selection acts to select and predict TCRs that also have similarly 
heightened binding kinetics to antigenic pMHC (Mandl et al., 2013). A second, 
which suggests that self-recognition prior to antigen encounter poises a T cell in a 
sensitized state allowing more efficient responses upon TCR triggering (Persaud et 
al., 2014). Our results are more consistent with the latter notion as responding 
clonotypes were similar in their affinities toward F-MLV. However, as a direct 
mechanistic link between self-reactivity and antigen sensitivity was not examined in 
this current study, we are unable to validate this assumption. Thus the question still 
remains: how does TCR recognition of self-ligands instruct for such diverse cellular 
fates? 
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6.5 B cell as critical regulators of CD4 T cell responses 
We also report that the progressive diversification of the CD4 T cell response to FV 
infection was driven by the asynchronous expansion of virus-specific clonotypes, in 
a B cell dependent fashion (Schematic 4). This highlighted two major findings, first 
that clonotypes were recruited in successive waves according to their avidity; and 
second that the late recruitment of clonotypes was depended the availability of 
antigen-presenting B cells. Thus our findings uncover an additional dimension to 
the antigen-presenting contribution of B cells, in the clonotypic selection of CD4 T 
cells. 
 
Studies have long reported a role for the quality of different APC types, in 
influencing CD4 T cell fate decisions. However, these have mainly centered on 
qualitative differences between APCs. For example, variations in TCR signalling 
imparted by the nature of the APC or its expression of co-receptors and co-
stimulatory molecules, have been described to influence the functionality or 
longevity of an activated CD4 T cell. Instead, our results favor a more simplistic role 
for B cells acting as APCs.  Rather than exhibiting a unique trait, we suggest that B 
cells may influence the clonal selection of CD4 T cell responses via their numerical 
contribution to CD4 T cell priming. In this study we observed that the degree of B 
cells that contributed to antigen presentation, rather than the role of a specific 
subset, directly correlated with the recruitment of lower avidity ‘blue’ clonotypes. In 
addition, and in the absence of high avidity clonotypes, diverse subsets of APCs 
were sufficient in priming blue clonotypes of lower avidity. This clearly argued 
against a unique type of antigen presentation exhibited only by B cells. Thus we 
concluded that asynchronous expansion of lower avidity clonotypes, which was 
dependent on the timing of B cell engagement in the response, coupled with 
waning response of higher avidity clonotypes were the major forces underlying 
TCR repertoire evolution during FV infection. In addition, we suggest that rather 
than providing qualitatively distinct signals, antigen presentation by B cells simply 
acts to increase the availability of pMHCII complexes and provide the necessary 
abundance of antigenic stimulation to allow priming and expansion of all clonotypes 
irrespective of TCR avidity. In this way antigen presentation by B cells acts to 
diversify the responding CD4 T cell repertoire 
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Schematic 4 
 
 
 
  
 
 
 
 
 
 
 
 
B cells diversify the antigen-selected CD4 T cell repertoire 
 
High avidity (‘red’) clonotypes are recruited early in the response to infection. Lower avidity 
(‘blue’) clonotypes are recruited progressively later in the response and in a B cell dependent 
manner. Here, antigen presentation by B cells serves to narrow the (avidity) gap between the 
‘red’ and ‘blue’ clonotypes by reducing clonal competition. This then allows for the progressive 
diversification of the antigen-selected CD4 T cell response to Friend Virus infection.  
Time/days post infection  
High avidity clone 
Low avidity clones 
Activated B cell 
pMHCII 
Naïve B cell 
MHCII 
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6.5.1 B cell regulate the quality of TCR repertoires during homeostasis 
Our data also novelly show that B cell-mediated clonotypic selection of CD4 T cells 
shaped the TCR repertoire during T cell reconstitution of lymphopenic recipients. 
This suggested that B cells might not only be an important determinant in TCR 
repertoire evolution during viral infection, but also during T cell homeostasis.  Our 
prediction would be that B cells also heavily contribute to the availably of MHCII 
derived signalling at the ‘steady-state’, known to be critical for T cell homeostasis. 
Thus they act to relax interclonal competition, resulting in the maintenance of 
clones that recognise self-antigen to lesser extents alongside clones that recognise 
self-antigen increasing well. Although the overall avidity of clonotypes supported in 
B cell proficient versus deficient hosts could not be directly measured due to the 
unknown of the selecting self-antigens, differential expression of markers of self-
reactivity were in alignment with this prediction.  
 
Although not explored in this study, the maintenance of a more diverse range of 
TCRs may not always be advantageous. Although diversity has the obvious 
advantage of achieving a higher probability of clones that may be able to recognise 
any given pathogen, it also increases the potential for auto-reactive T cells in the 
repertoire. This coupled with the consideration that interactions between TCRs and 
auto-antigen are typically described to be within the lower range of avidities, 
suggests B cells may be key facilitators in the onset of T cell mediated 
autoimmunity. Indeed, there are many studies that may support a role for B cells in 
selecting for a pathogenic TCR repertoire (Serreze et al., 1996). For example, in 
non-obese diabetic (NOD) mice a broad repertoire of auto-reactive T cells 
contribute to the development of diabetes and autoimmunity in these mice. 
Interesting NOD MuMT mice, NOD mice deficient in B cells, are disease free.  
However upon B cell reconstitution of NOD muMT mice, spectra-typing of the TCR 
repertoire revealed the progressive re-instalment of the diabetogenic TCR 
repertoire, and the subsequent re-establishment of autoimmunity in these mice 
(Vong et al., 2011). Although in this context deleterious, this study further supports 
a role for B cells in the diversification of the T cell repertoire during homeostasis. 
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Furthermore, we were able to confirm a role for B cells in promoting TCR diversity 
in various T cell immune responses. Our data would suggest that in infections or 
immunizations where B cells are dominant APCs, T cells of lower avidity would be 
recruited alongside T cells of higher avidity, making it an important consideration in 
vaccine design. Perhaps in support of this, a study which examined the evolution of 
polyclonal CD4 T cell repertoires in response to combined TLR agonists, peptide or 
protein vaccination were able to show the nature of the vaccination regime was 
able to predictably shape TCR repertoires (Baumgartner et al., 2012). Whereby 
peptide vaccines preserved high avidity clones whilst protein vaccines skewed 
repertoires towards low avidity clones. The mechanism for the selective 
preservation of low avidity cells over high avidity cells was not elucidated, although 
a key role for CD27 derived signalling was suggested as necessary. Interesting 
CD27 is a T-B cell co-stimulatory molecule, with CD27-CD70 interactions shown to 
be critical in order to regulate B-cell activation by T cells (Kobata et al., 1995). 
Considering the role B cells play in our system, perhaps the difference in 
repertoires can be explained by the degree of involvement of B cells acting as 
APCs between the vaccine regimes. At least in our study we were able to show 
that the availability of B cells acting as APCs in vaccination setting, directly 
influenced the diversity and range of avidities recruited. Clearly deciphering some 
of these underlying principles involved could revolutionise vaccine development 
and drug design. 
6.6 Implications for this work 
Diverse, specific T cell repertoires are required for sufficient protection against 
future infections or for controlling escape mutants in chronic infections. 
Understanding how to elicit stable and diverse repertoires would be important in 
targeted vaccine design. DCs have conventionally been associated with being the 
major contributors to T cell priming and as a result have promoted many DC based 
vaccination strategies. An important finding of our study, is the relationship 
between the degree of antigen presentation by B cells and the associated 
diversification of the CD4 T cell response. B cells appear to be largely dependent 
on their activation state in order to perform as professional APCs. Limiting 
precursor frequencies of antigen specific B cells at the start of an infection, and 
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hence the assumed time it would take to expand these initially few to sufficient 
numbers that would allow them to significantly contribute to CD4 T cell priming, has 
largely lead to their dismissal as major contributors to this process. However, B 
cells can capture, process and present antigen for which they are not specific for 
and can be activated in multiple ways besides directly through the BCR (such as 
via TLRs). This would override the numerical limitations associated with the low 
precursor frequencies of antigen-specific B cells. In fact, B cells have been 
calculated to outnumber DCs at the steady-state by two orders of magnitude 
(Breton et al., 2015), hence their recruitment as APCs through BCR independent 
mechanisms of activation, could make them tour de force and provide a 
mechanism which would allow for the predictable diversification of CD4 T cell 
repertoires. Thus targeted manipulation of B cell activation or antigen presentation 
to CD4 T cells, might provide an amenable way of controlling the quality of the 
antigen-specific TCR repertoire during infection, vaccination or autoimmunity.  
 
In addition, it is also important to consider that outside of the laboratory, natural 
host immune systems are never entirely naïve. In fact, the mammalian immune 
system is always fluctuating in its degree of activation even at an apparent ‘steady 
state’. Indeed, in non-sterile environments, even asymptomatic hosts, carry multiple 
viruses and bacteria as part of their microbiome, all of which may be recognised by 
the immune system (Virgin). The maintenance of this equilibrium between host and 
microbiome as well as the continual and often simultaneous challenge of the host 
by infectious agents has been shown to significantly alter future responses to 
pathogens. Hence symbiotes as well as past and present pathogens are able to 
physiologically imprint a host, and thus partially dictate disease severity and the 
immune control of future pathogens, this is known as the genotype/phenotype 
relationship (Virgin). Thus considering our findings, a host in which B cells are pre-
activated may result in the selection of qualitatively distinct TCR responses 
accordingly. This may go some way to explain why disease progression can be so 
radically different in otherwise very similar hosts. Again, this further highlights the 
need for our better understanding of T cell extrinsic factors capable of influencing 
the quality of CD4 T cell responses in a given host at a given time.  
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Finally, the observation that self-reactivity correlated better with a CD4 T cells 
functional responsiveness than with TCR affinity toward antigen, should have major 
implications for future adoptive T cell based therapeutics. Conventionally, TCR 
gene transfers have been used to generate engineered T cells of given specificities 
and avidities towards foreign antigen, with the aim that their delivery may enrich 
existing TCR repertoires and aid functional responses to pathogenic challenge. 
However, in light of a role for self-reactivity, rather than cellular transfer approaches, 
conditioning of the existing repertoire via self-like proteins could be used to 
optimize the functional avidity of the endogenous repertoire. Indeed previous work 
from our lab has already demonstrated that self-like proteins, derived from 
endogenous retroviruses rather than exogenously introduced, can heavily influence 
TCR repertoire formation and optimize responses to retroviral infection (Young et 
al., 2012b). Taking inspiration from the endogenous retroviruses in this instance, it 
would be possible to introduce synthetic antigens, whose expression would mimic 
that of self-derived proteins, at various stages or places during T cell development 
as a method to tailor CD4 T cell repertoires. Thus therapeutic conditioning of the T 
cell repertoire via the introduction of self-like antigens may provide a tractable way 
to select for and to sensitise endogenous clonotypes in the pre-immune repertoire 
of individuals, with the aim that they then go on to perform better upon infection. 
6.7 Concluding Remarks  
Perhaps the popular discussion of nature vs nurture can be recycled to look at the 
relationship that exists between the T cell and its TCR. This analogy can be used to 
describe how cell fate is dependent on not only the intrinsic properties of the cell, 
the genetically encoded TCR ("nature"), but also by extrinsic events such as the 
APC is meets (“nurture”). This body of work suggest a prominent role for the TCR 
but also uncovers the powerful influence of additional T cell-intrinsic and -extrinsic 
factors that can reverse TCR-based hierarchies. These include both the maturation 
state of a CD4 T cell in the pre-immune repertoire and, importantly, differential 
recruitment or expansion of CD4 T cell clonotypes by diverse APC types. 
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6.8 Future work 
Although we were able to recognise a role for self-reactivity in influencing CD4 T 
cell responses to cognate antigen, a question which has not yet been addressed by 
this study and remains largely un-answered in the field is exactly howTCR 
recognition of self-ligands can sensitises and set T cell responses to foreign-
antigen. A model whereby the self-ligand repertoire of a given clonotype in addition 
to its antigen specificity were known would provide an elegant system whereby you 
could selectively withdraw the availability of self-ligand at different stages in T cell 
development, without influencing the entire TCR population. This would aid our 
knowledge of how, when and where self-recognition matters in terms of the 
conditioning of the CD4 T cell response. 
 
In addition, although we were able to understand that the diversification of the CD4 
T cell response to FV infection was achieved via the late recruitment of low avidity 
cells, beyond this point we did not characterise the capacity of each different 
clonotype family to give rise to long-term memory. Therefore in the future, we 
would like to follow the long-term memory repertoire to understand which clonotype 
persist in the host and why. As well as this, we aim to further characterise the 
different clonotypes potentials to contribute to different memory subsets. 
Considering the fact that functional responsiveness of a clonotype correlated better 
with the self-reactive potential of each naïve T cell clone, than its affinity toward 
cognate-antigen, we are also interested in understanding if these original 
differences are preserved in antigen experienced cells and during recall responses. 
In this regard we would like to test which clonotypes (red, blue or green) are 
recruited upon secondary exposure to antigen. Such a study would allow us to 
track which clonotypes respond upon antigen re-encounter and allow us to ask if 
antigen-experienced clonotypes retain behaviours from their past, or if following 
antigen encounter their sensitivity (originally set by self) is newly adjusted, now 
making them more or less equivalent.  
  
Another outstanding question is how multiple cell fate decisions are encoded by 
TCR signalling. Where TCR signalling is equal, but affinities are not, an interesting 
question is how a T cell then interprets this. For example, do T cells count the 
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number of triggered TCRs, like a signaling ‘Morse code’, or does the sum signal 
elicited by all the triggered TCRs matter more? Furthermore, the question of how 
TCR signaling results in genetic and epigenetic re-programming and mapping of T 
cell fate remains largely un-resolved in the field. Indeed, this signalling network 
remains somewhat of the missing link in the biology of T cell development. 
Understanding these intricacies should fuel our basic understanding of the T cell 
and unlock rational development of vaccination and immunotherapeutic 
approaches improving our weaponry against infectious disease, cancer and 
autoimmunity.			
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